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Abstract 
Mesenchymal stem cells (MSC) are a tissue-resident stromal cell population that are 
able to regulate immune responses, in particular the capacity for endothelial cells (EC) 
to support leukocyte recruitment. In this thesis we examined the ability of MSC from 
different sources (bone marrow, Wharton’s jelly and trabecular bone) to regulate 
neutrophil recruitment to inflamed EC and how these responses are altered upon 
adipogenic differentiation of MSC. Using two flow based adhesion models with varying 
degrees of proximity between MSC and EC, we observed that all MSC populations 
suppressed neutrophil recruitment. IL-6 and TGFβ were identified as common 
bioactive agents found in all co-cultures. Upon differentiation, MSC exhibited a 
diminished capacity to suppress neutrophil, but not peripheral blood lymphocyte, 
recruitment. Loss of suppression by MSC-derived adipocytes was reversed by 
neutralising IL-6. Adipose tissue-derived mature adipocytes and culture differentiated 
pre-adipocytes did not recapitulate the effects of MSC-derived adipocytes. These data 
suggest that crosstalk between tissue-resident MSC and EC, dampens the endothelial 
response to cytokines and limits the aberrant infiltration of circulating leukocytes during 
inflammation. Upon adipogenic differentiation, MSC lose this regulatory capacity. This 
could impact on the beneficial effects of MSC in chronically inflamed sites where 
aberrant infiltration of leukocyte is a main driver of the disease.  
 
 
  
Acknowledgments 
 
First and foremost I would like to thank my supervisors, Dr Helen McGettrick and 
Professor Gerard Nash for their guidance and support throughout my project. In 
particular, I would like to thank Helen for always offering advice and encouragement 
when I needed it the most and for giving me so many great opportunities throughout 
my project. I would also like to thank the BBSRC for funding the work.   
 
I would also like to thank all members of the Leukocyte Trafficking group, both past 
and present, for making the PhD such an unforgettable experience. In particular, I 
would like to thank Bonita, Jasmeet, Lewis, Clare, Phil, Mike, Myriam and Matt for all 
of the fun times in the lab. I would also like to thank Dr Nguyet-Thin Luu for providing 
the basis for much of the work done in this thesis. I would like to express my gratitude 
to the members of the Rheumatology Research group for offering advice about the 
direction of project and sharing their technical expertise. 
 
I would like to thank my friends and family for their love and support over the last 3 
years. In particular, I would sincerely like to thank my brother and sister, Sajid and 
Sadaf for their unwavering optimism and encouragement while I was writing up my 
thesis. Thank you for coping with my moaning and numerous attempts at giving up! I 
dedicate this thesis to you.  
 
Lastly, I would like to thank all of the blood donors without whom none of this work 
would have been possible.   
 Table of contents 
1. Introduction ........................................................................................................... 1 
1.1. Overview ........................................................................................................ 2 
1.2. Inflammation ................................................................................................... 2 
1.3. Leukocyte recruitment during inflammation .................................................... 3 
1.3.1. Margination and capture ............................................................................. 5 
1.3.2. Activation and firm adhesion .................................................................... 6 
1.3.3. Crawling and transendothelial migration .................................................. 8 
1.4.  Mesenchymal stem cell phenotype, origin and function ............................... 10 
1.4.1. Origin of MSC ........................................................................................ 11 
1.4.2. MSC in the bone marrow niche.............................................................. 13 
1.5. Immunomodulatory effects of MSC .............................................................. 15 
1.5.1. Effects on innate immunity ..................................................................... 17 
1.5.2. Effects on adaptive immunity ................................................................. 19 
1.6.  ..... Phenotypic and functional differences between MSC from different tissue 
sources ......................................................................................................... 21 
1.7. MSC crosstalk with EC and other tissue-resident stromal cells during 
homeostasis and inflammation ..................................................................... 23 
1.7.1. MSC interactions with stromal cells ....................................................... 24 
1.7.2. MSC interactions with EC ...................................................................... 25 
1.7.2.1. Regulation of angiogenesis ................................................................ 25 
1.7.2.2. Regulation of blood vascular permeability .......................................... 26 
1.7.2.3. MSC regulation of leukocyte recruitment to inflamed EC ................... 27 
1.8. IL-6 signalling during inflammation ............................................................... 31 
1.9. Effect of inflammatory environment on MSC phenotype and function .......... 33 
1.9.1. MSC response to inflammatory mediators ............................................. 33 
1.9.2. The potential effects of a chronic inflammatory environment on MSC 
behaviour ............................................................................................... 36 
1.10. Effect of differentiation on MSC immunomodulation .................................... 38 
1.11. Role of ectopic fat in chronic inflammation ................................................... 39 
1.11.1. Role of inflammatory cytokines in ectopic fat deposition ........................ 40 
1.11.2. Potential contribution of MSC to ectopic fat formation ........................... 41 
1.11.3. MSC in ectopic bone deposition ............................................................ 43 
1.12. Hypothesis and aims .................................................................................... 44 
2. Materials and Methods ........................................................................................ 46 
2.1. Isolation and culture of human umbilical vein endothelial cells .................... 47 
2.2. Isolation and culture of human MSC ............................................................ 48 
2.2.1. Culture of BMMSC ................................................................................. 48 
2.2.2. Isolation and culture of WJMSC ............................................................. 48 
 2.2.3. Isolation and culture of TBMSC ............................................................. 49 
2.2.4. Differentiation of human MSC ................................................................ 49 
2.3. Isolation and culture of human pre-adipocytes and mature adipocytes ........ 50 
2.3.1. Adipogenic differentiation of human pre-adipocytes .............................. 50 
2.4. Detachment of cells from tissue culture flasks ............................................. 51 
2.4.1. Freezing and thawing MSC ................................................................... 51 
2.5. Isolation of neutrophils and peripheral blood lymphocytes ........................... 52 
2.6. Proliferation kinetics of MSC in different culture media ................................ 53 
2.7. Flow cytometry ............................................................................................. 54 
2.7.1. Characterisation of MSC phenotype ...................................................... 54 
2.7.2. Detection of intracellular IL-6 and TGFβ signalling by flow cytometry ... 54 
2.8. Assessment of multilineage differentiation of MSC ...................................... 55 
2.9. Flow-based adhesion assays ....................................................................... 56 
2.9.1. Co-culture of HUVEC and MSC in channel slides ................................. 56 
2.9.2. Establishing HUVEC and MSC co-cultures on Transwell filter .............. 57 
2.9.3. The recruitment of leukocytes to EC from flow ...................................... 58 
2.9.4. Analysis of leukocyte adhesion and behaviour ...................................... 60 
2.10. Leukocyte recruitment by 3D collagen gels incorporating EC and MSC ...... 62 
2.11. Quantification of protein in culture supernatants .......................................... 66 
2.11.1. ELISA .................................................................................................... 66 
2.11.2. Membrane-based sandwich cytokine array ........................................... 67 
2.12. Gene expression analysis ............................................................................ 67 
2.12.1. RNA extraction and cDNA conversion ................................................... 67 
2.12.2. Quantitative PCR ................................................................................... 69 
2.13. Statistical analysis ........................................................................................ 69 
3. Isolation and characterisation of MSC from different tissue sources .......... 71 
3.1. Introduction .................................................................................................. 72 
3.2. Results ......................................................................................................... 73 
3.2.1. Comparison of different methods for isolating WJMSC ......................... 73 
3.2.2. Proliferation kinetics of BMMSC and WJMSC ....................................... 75 
3.2.3. Comparison of the phenotype of different MSC populations: ................. 78 
3.2.4. Comparison of the differentiation potential of the different MSC 
populations ............................................................................................ 82 
3.3. Discussion .................................................................................................... 84 
4. Capacity of MSC from different sources to regulate neutrophil recruitment 
to vascular EC ......................................................................................................... 88 
4.1. Introduction .................................................................................................. 89 
4.2. Results ......................................................................................................... 91 
 4.2.1. Ability of MSC from different sources to incorporate into endothelium ... 91 
4.2.2. Effects of MSC from different sources cultured in direct contact with EC 
on neutrophil recruitment ....................................................................... 91 
4.2.3. Effects of culturing MSC from different sources on opposite side of filters 
to EC on neutrophil recruitment ............................................................. 94 
4.2.4. Effect of MSC co-culture conditioned media on neutrophil recruitment . 97 
4.2.5. Effect of proximity between MSC and EC on neutrophil recruitment ... 101 
4.2.6. Role of IL-6 and TGFβ in the suppression of neutrophil recruitment by 
MSC from different sources ................................................................. 101 
4.2.7. Effects of passage on MSC-mediated suppression of neutrophil 
recruitment ........................................................................................... 108 
4.2.8. Assessment of downstream IL-6 and TGFβ signalling during co-culture ... 
  ............................................................................................................. 112 
4.3. Discussion .................................................................................................. 117 
5. Effect of differentiation on the capacity of MSC to regulate leukocyte 
recruitment ............................................................................................................. 126 
5.1. Introduction ................................................................................................ 127 
5.2. Results ....................................................................................................... 128 
5.2.1. Effects of MSC or MSC-derived adipocyte culture on leukocyte 
recruitment ........................................................................................... 128 
5.2.2. Effect of adipogenic differentiation on neutrophil recruitment in response 
to low-grade inflammation .................................................................... 133 
5.2.3. Effect of adipocyte co-culture on the expression of IL-6 signalling 
molecules ............................................................................................. 133 
5.2.4. Effect of adipocyte co-culture on the expression of TGFβ signalling 
molecules ............................................................................................. 138 
5.2.5. Effect of adipocyte co-culture on expression of adhesion molecules by 
EC ........................................................................................................ 138 
5.2.6. Roles of soluble factors in the loss of suppression by MSC-derived 
adipocytes ............................................................................................ 141 
5.2.7. Effect of fatty acid treatment of MSC-derived adipocyte on leukocyte 
adhesion .............................................................................................. 147 
5.2.8. Effects of human adipocytes on leukocyte recruitment ........................ 150 
5.2.9. Effect of BMMSC and BMMSC-derived adipocyte co-culture on the 
behaviour of migrated neutrophils ........................................................ 150 
5.3. Discussion .................................................................................................. 161 
6. General discussion ......................................................................................... 170 
6.1. Summary of main findings .......................................................................... 171 
6.2. Significance of these findings ..................................................................... 172 
6.3. Conclusion ................................................................................................. 177 
6.4. Future work ................................................................................................ 178 
 7. Appendix ......................................................................................................... 180 
Publications arising from this thesis ..................................................................... 187 
8. References ...................................................................................................... 189 
 
 
 
 
  
 Table of figures 
1. Introduction ........................................................................................................... 1 
Figure 1-1: The multiple stages of the leukocyte recruitment cascade..................... 4 
Figure 1-2: Immunomodulatory effects of MSC ...................................................... 16 
2. Materials and Methods ........................................................................................ 46 
Figure 2-1: Schematic of the microchannel slide and filter flow chambers. ............ 59 
Figure 2-2: Schematic of the perfusion system. ..................................................... 61 
Figure 2-3: Schematic of the 3D collagen gel model incorporating MSC and EC .. 64 
Figure 2-4: Morphology of neutrophils and EC on the surface and within the 3D 
collagen gel matrix. ................................................................................................ 65 
3. Isolation and characterisation of MSC from different tissue sources .......... 71 
Figure 3-1: Comparison of the morphology of WJMSC isolated by explant culture 
and enzymatic digestion. ........................................................................................ 74 
Figure 3-2: Proliferation kinetics of BMMSC and WJMSC in different culture media.
 ............................................................................................................................... 77 
Figure 3-3: The morphology of BMMSC, WJMSC and TBMSC. ............................ 79 
Figure 3-4: Expression of MSC markers by BMMSC, WJMSC and TBMSC. ......... 80 
Figure 3-5: Expression of MSC markers by BMMSC, WJMSC and TBMSC at 
different passages. ................................................................................................. 81 
Figure 3-6: Differentiation of BMMSC, WJMSC and TBMSC towards adipocytes or 
osteoblasts. ............................................................................................................ 83 
4. Capacity of MSC from different sources to regulate neutrophil recruitment 
to vascular EC ......................................................................................................... 88 
Figure 4-1: Adhesion of different MSC types to EC in microchannel slides. .......... 92 
Figure 4-2: Effect of MSC co-culture on neutrophil adhesion to inflamed EC in 
microchannel slides. ............................................................................................... 93 
Figure 4-3: Effect of MSC co-culture on the behaviour of adherent neutrophils in 
microchannel slides. ............................................................................................... 95 
Figure 4-4: Effect of the number of WJMSC seeded onto filters on neutrophil 
recruitment to TNFα treated EC in a filter flow based adhesion assay. .................. 96 
Figure 4-5: Effect of co-culture of EC with different MSC populations on neutrophil 
adhesion. ............................................................................................................... 98 
Figure 4-6: Effect of conditioned media from MSC cultured alone or with EC on 
neutrophil adhesion from flow. ............................................................................... 99 
Figure 4-7: Effect of conditioned media from MSC cultured alone or with EC on 
neutrophil behaviour. ............................................................................................ 100 
 Figure 4-8: Effect of varying closeness of contact between EC and MSC during co-
culture on suppression of neutrophil adhesion. .................................................... 102 
Figure 4-9: Effect of varying closeness of contact between EC and MSC during co-
culture on neutrophil behaviour. ........................................................................... 103 
Figure 4-10: Levels of IL-6 in EC and MSC mono-culture and co-culture 
supernatants cultured in varying degrees of closeness. ....................................... 104 
Figure 4-11: Effect of blocking actions of IL-6 or TGFβ on the capacity of MSC in 
co-culture to suppress neutrophil adhesion. ......................................................... 106 
Figure 4-12: Effect of blocking actions of IL-6 or TGFβ in MSC co-cultures on 
neutrophil behaviour. ............................................................................................ 107 
Figure 4-13: Effect of BMMSC and WJMSC passage on their ability to suppress 
neutrophil adhesion. ............................................................................................. 109 
Figure 4-14: Effect of BMMSC and WJMSC passage on the behaviour of 
neutrophils adherent to EC co-cultured with MSC. .............................................. 110 
Figure 4-15: Effect of MSC passage on the levels of IL-6 in EC and MSC mono-
culture and co-culture supernatants. .................................................................... 111 
Figure 4-16: Analysis of phosphorylated Smad2/3 or STAT3 in leukocytes or EC 
treated with TGFβ and IL-6. ................................................................................. 113 
Figure 4-17: Analysis of pSmad2/3 in EC during co-culture with BMMSC. .......... 115 
Figure 4-18: Analysis of pSmad2/3 in BMMSC during co-culture with EC ........... 116 
5. Effect of differentiation on the capacity of MSC to regulate leukocyte 
recruitment ............................................................................................................. 126 
Figure 5-1: Expression of adipocyte markers by BMMSC after adipogenic 
differentiation. ...................................................................................................... 129 
Figure 5-2: Effect of adipogenic differentiation of MSC on neutrophil adhesion. .. 130 
Figure 5-3: Effect of adipogenic differentiation of MSC on neutrophil behaviour. . 131 
Figure 5-4: Effect of adipogenic differentiation of MSC on PBL recruitment. ....... 132 
Figure 5-5: Effect of adipogenic differentiation of MSC on neutrophil recruitment in 
response to low dose TNFα. ................................................................................ 134 
Figure 5-6: Levels of IL-6 and sIL-6R in EC, BMMSC and BMMSC-derived 
adipocyte mono-culture and co-culture supernatants........................................... 136 
Figure 5-7: Expression of IL-6 related genes by EC, MSC and adipocytes. ......... 137 
Figure 5-8: Gene expression of TGFβ and decorin by EC, MSC and adipocytes.139 
Figure 5-9: Gene expression of adhesion markers by EC mono-cultures and co-
cultures after stimulation with TNFα. .................................................................... 140 
Figure 5-10: Effect of adipocyte conditioned media on neutrophil recruitment. .... 142 
 Figure 5-11: Effect of neutralisation of IL-6 and TGFβ in adipocyte co-culture on 
neutrophil recruitment. ......................................................................................... 143 
Figure 5-12: Comparison of cytokine secretion in EC, BMMSC and BMMSC-
derived adipocyte mono-culture and co-culture supernatants. ............................. 145 
Figure 5-13: Levels of CD105 in BMMSC and adipocyte mono-culture and co-
culture supernatants. ............................................................................................ 146 
Figure 5-14: Effect of OA treatment of adipocytes on neutrophil and PBL adhesion.
 ............................................................................................................................. 148 
Figure 5-15: Levels of IL-6 in EC and adipocyte mono-culture and co-culture 
supernatants after OA treatment. ......................................................................... 149 
Figure 5-16: Effect of undifferentiated and differentiated pre-AD on neutrophil and 
PBL adhesion. ...................................................................................................... 151 
Figure 5-17: Effect of mature AD on neutrophil and PBL recruitment. ................. 152 
Figure 5-18: Levels of IL-6 in EC, pre-AD and mature AD mono-culture and co-
culture supernatants. ............................................................................................ 153 
Figure 5-19: Effect of adipocyte differentiation on neutrophil adhesion and 
migration into 3D collagen gels in response to TNFα. .......................................... 154 
Figure 5-20: Effect of adipocytes co-culture on the position of migrated neutrophils 
within 3D collagen gels in response to TNFα. ...................................................... 156 
Figure 5-21: Effect of adipocyte co-culture on the average depth of neutrophil 
penetration into 3D collagen gels in response to TNFα........................................ 157 
Figure 5-22: Effect of BMMSC and BMMSC-derived adipocytes on neutrophil 
adhesion and migration into 3D collagen gels in the absence of cytokine. .......... 158 
Figure 5-23: Effect of adipocytes co-culture on the position and average depth of 
migrated neutrophils in 3D collagen gels in the absence of cytokine. .................. 160 
6. General discussion ......................................................................................... 170 
7. Appendix ......................................................................................................... 180 
Appendix 1-1: Effect of adipocyte differentiation on neutrophil adhesion to BEC and 
their migration into 3D collagen gels in response to TNFα. .................................. 181 
Appendix 1-2: Effect of adipocytes co-culture on the position of migrated 
neutrophils within 3D collagen gels in response to TNFα..................................... 182 
Appendix 1-3: Effect of adipocyte co-culture on the average depth of neutrophil 
penetration into 3D collagen gels in response to TNFα........................................ 183 
Appendix 1-4: Effect of osteoblast differentiation on neutrophil adhesion to BEC 
and their migration into 3D collagen gels in response to TNFα. ........................... 184 
Appendix 1-5: Effect of osteoblast co-culture on the position of migrated neutrophils 
within 3D collagen gels in response to TNFα. ...................................................... 185 
 Appendix 1-6: Effect of osteoblast co-culture on the average depth of neutrophil 
penetration into 3D collagen gels in response to TNFα........................................ 186 
 
 
 
  
 List of tables 
Table 2-1: List of cytokines analysed in the human XL cytokine array kit. ................. 68 
Table 2-2: List of primers used for qPCR. ................................................................. 70 
 
 
 
 
 
  
  
List of abbreviations 
AD Adipocytes 
ADMSC Adipose tissue mesenhcymal stem cells 
ANOVA Analysis of variance  
BEC Blood vascular endothelial cells 
BMMSC Bone marrow mesenchymal stem cells 
BSA Bovine serum albumin 
C/EBPα CCAAT enhancer binding protein 
CT Threshold cycle 
DC Dendritic cells 
EC Endothelial cells 
EDTA Ethylenediaminetetraacetic acid 
ELISA Enzyme-linked immunosorbent assay  
ESAM EC selective adhesion molecule 
FABP4 Fatty acid-binding protein 4 
FCS Foetal calf serum 
fMLP N-Formylmethionine-leucyl-phenylalanine  
HLA Human leukocyte antigen 
HSC Haematopoietic stem cells 
HUVEC Human umbilical vein endothelial cells 
IBMX Isobutyl-1-methylxanthine  
ICAM1 Intercellular adhesion molecule 1 
IDO Indoleamine 2, 3-dioxygenase  
IFNγ Interferon γ 
IL-1β Interleukin-1β 
IL-6 Interleukin-6 
IL-6ST IL-6 signal transducer 
ISCT International Society for Cell Therapy 
JAM Junctional adhesion molecules 
LFA1 Lymphocyte function-associated antigen 1 
LG DMEM Low gluocose Dulbecco's Modified Eagle Medium 
LPS Lipopolysaccharide 
MAC1 Macrophage-1 antigen 
MCP1 Macrophage chemoattractant protein 1  
MS Multiple sclerosis 
MSC Mesenchymal stem cells 
MSCGM Mesenchymal stem cell growth media 
NK Natural killer cells 
nmMSC non-myogenic MSC 
OA Oleic acid 
p Passage 
PBL Peripheral blood lymphocytes 
 PBMC Peripheral blood mononuclear cell 
PBS Phosphate Buffered Saline 
PBSA Phosphate Buffered Saline with bovine serum albumin 
PD Population doublings  
PDGFRα Platelet-derived growth factor receptor α  
PDT Population doubling time 
PECAM1 Platelet/endothelial cell adhesion molecule-1 
PGE2 Prostaglandin E2 
PHA Phytohaemagglutinin 
PMN Polymorphonuclear cells 
PPARγ Peroxisome proliferator activated receptor γ 
PSGL1 P-selectin glycoprotein ligand 1  
RA Rheumatoid arthritis 
sIL-6R soluble interleukin-6 receptor 
SLE Systemic lupus erythematosus  
SOCS3 Suppressor of cytokine signalling 3 
SS Systemic sclerosis 
STAT3 Signal transducers and activators of transcription protein 3 
TBMSC Trabecular bone mesenchymal stem cells 
TGFβ Transforming growth factor β 
TLR Toll like receptor 
TNFα Tumour necrosis factor α 
VCAM1 Vascular cell adhesion molecule 1  
VLA4 Very late antigen 4  
WJMSC Wharton's Jelly mesenchymal stem cells 
  
 
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Introduction  
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1.1. Overview  
This thesis primarily focuses on the capacity of mesenchymal stem cells (MSC) from 
different tissue sources to regulate leukocyte recruitment from flow, a key process in 
inflammation and how this capacity may change upon differentiation.  This introduction 
will detail the process of leukocyte recruitment during inflammation, the phenotypic and 
immunomodulatory characteristics of MSC, cross-talk between MSC and endothelial 
cells (EC) and the ability of other stromal cells to regulate recruitment. It will further 
explore the role of ectopic fat in inflammatory diseases and whether MSC may 
contribute to ectopic fat in sites of chronic inflammation. 
 
1.2. Inflammation 
Acute inflammation is characterised by localised pain, redness, heat and swelling that 
arise due to changes in endothelial behaviour and leukocyte recruitment within the 
tissue (Pober and Sessa, 2007). Initially, tissue-resident macrophages and mast cells 
become activated in response to pathogens or tissue damage and secrete pro-
inflammatory cytokines and chemokines at the affected site (Eming et al., 2007). These 
cytokines subsequently stimulate vascular EC to release nitric oxide and 
prostaglandins to cause vasodilation and increase local blood flow. This increases the 
number of leukocytes that come into contact with the endothelium and enables rapid 
recruitment of leukocytes to the inflamed tissue (Pober and Sessa, 2007). There is also 
increased vascular permeability causing plasma proteins and fluid to enter the tissue, 
which reduces the velocity of the blood and causes tissue oedema (Pober and Sessa, 
2007).  
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Once at the site of inflammation, neutrophils bind to opsonised pathogens via their 
complement and immunoglobulin Fc receptors which leads to phagocytosis and 
eventual destruction of the pathogen (Eming et al., 2007). Neutrophils generate 
reactive oxygen species and degranulate to release proteases that essentially kill the 
phagocytosed pathogen. As these molecules are highly toxic and can also damage 
host tissue, neutrophil activation must be tightly controlled. As such, during resolution 
neutrophils undergo apoptosis and are cleared by macrophages (Eming et al., 2007). 
Failure to resolve inflammation can cause leukocytes to be continually recruited, 
leading to further tissue damage and eventually chronic inflammatory diseases such 
as rheumatoid arthritis (McGettrick et al., 2012).  
 
1.3. Leukocyte recruitment during inflammation 
Leukocyte recruitment is a critical step in the initiation of inflammation, a process which 
is tightly regulated by both EC and the tissue stroma. During inflammation leukocytes 
are recruited from the circulation into the afflicted site predominantly from postcapillary 
venules, where the haemodynamic shear stress is significantly lower than arteries 
(≤0.5Pa vs. 1-2Pa respectively) (Lipowsky, 1985). EC respond to cytokines (tumour 
necrosis factor α, TNFα and interleukin 1β, IL-1β) produced by tissue-resident sentinel 
cells by increasing surface expression of cell-adhesion molecules and chemokines 
(Zhang et al., 2011). These proteins promote leukocyte capture from flow and enable 
their migration into the inflamed site (summarised in Figure 1-1). Leukocyte 
extravasation is a multi-step process consisting of the following stages; margination, 
rolling, activation and firm adhesion, crawling and transendothelial migration [reviewed 
by (Ley et al., 2007)].  
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Figure 1-1: The multiple stages of the leukocyte recruitment cascade.   
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1.3.1. Margination and capture 
Leukocyte margination to the vessel wall arises as a result of erythrocytes traveling 
along the centre of the blood vessel, where the flow velocity is highest, causing 
leukocytes to be pushed to the vessel wall, where they come into contact with EC 
(Abbitt and Nash, 2003). Margination thus increases the frequency with which 
leukocytes come into contact with EC. Cytokine-stimulated EC express selectin 
molecules (P- and E- selectin) which mediate initial capture of neutrophils and 
lymphocytes from flow and cause them to roll along the vessel wall (Ley et al., 2007; 
Luscinskas et al., 1995). P-selectin is released from Wiebel-Palade bodies fusing with 
the plasma membrane while E-selectin is synthesised de novo in response to cytokines 
(Ley et al., 2007). Purified P-selectin and E-selectin were shown to be capable of 
capturing neutrophils from flow in vitro, indicating that neutrophil tethering is mediated 
by both P- and E-selectin (Abbitt and Nash, 2001; Lawrence et al., 1994). In contrast, 
selectins were found to be less effective at capturing peripheral blood lymphocyte 
(PBL) from flow (Lalor and Nash, 1995). Indeed, blocking P-selectin did not completely 
abrogate rolling of CD4+ T-cells on TNFα-stimulated EC and it was observed that 
interactions between vascular cell adhesion molecule 1 (VCAM1) and very late antigen 
4 (VLA4) could support rolling (Luscinskas et al., 1995).  
 
P-selectin glycoprotein ligand 1 (PSGL1) is the most widely studied carbohydrate 
ligand that interacts with the N-terminal C-type lectin domain on P- and E-selectin (Ley 
et al., 2007).  Neutrophil rolling under high shear stress involves continuous binding 
and dissociation of selectins and their ligands  (Sundd et al., 2013). Coordinated rolling 
was recently found to be mediated by sling and tether interactions between P-selectin 
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and PSGL1. After margination, membrane tethers are formed at the rear of the 
neutrophil which bind to EC P-selectin via PSGL1 (Sundd et al., 2010). These 
interactions are temporary and rapidly detach from the EC by pulling causing the 
tethers to roll over to the leading edge of the neutrophil (Sundd et al., 2010). The tether 
forms a sling which then wraps around the neutrophil. The sling has punctate regions 
of PSGL1 along its length that interact with P-selectin on EC (Sundd et al., 2012). The 
rapid formation and breaking of bonds between P-selectin and PSGL1 along the sling 
causes the neutrophil to slowly roll along the endothelium. Interestingly, tethers and 
slings express lymphocyte function-associated antigen 1 (LFA1) uniformly along their 
surface which interacts with intercellular adhesion molecule (ICAM) 1 and 2 on the EC 
surface (Sundd et al., 2012). This interaction further reduces the velocity of the rolling 
neutrophils.  
 
1.3.2. Activation and firm adhesion 
The reduction in rolling velocity increases the exposure of neutrophils to chemokines 
presented on the endothelial surface which induce neutrophil activation. These 
chemokines can either be synthesised by the EC or actively transported from the 
adluminal surface (Ley et al., 2007). At the luminal surface of EC, chemokines are 
bound to heparin sulphates to prevent shear forces of the blood detaching them from 
the cell surface (Massena et al., 2010). CXC chemokines, such as IL-8, have been 
identified as key mediators of neutrophil activation and migration which signal via 
CXCR2 (Imaizumi et al., 1997). Furthermore, inhibiting CXCR2, but not CXCR1, was 
previously shown to abrogate firm adhesion and migration of neutrophils through 
TNFα-stimulated EC (Luu et al., 2000). In response to Interferonγ (IFNγ) stimulation, 
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EC upregulated CXCL9, CXCL10 and CXCL11 which interacted with CXCR3 on T-
cells (Sauty et al., 2001). Binding of chemokines to corresponding receptors on the 
leukocyte surface induces activation of chemokine receptor associated G protein 
coupled receptors (Ley et al., 2007). This triggers the activation of surface bound 
integrins which mediate firm adhesion.  
 
Integrin-mediated interactions are slow forming, therefore rolling and chemokine 
activation of leukocytes are essential steps for ensuring integrin activation and 
formation of bonds. Integrins are homologous transmembrane cell adhesion molecules 
composed of an α and β subunit which induce cell-cell adhesion and cell-extracellular 
matrix adhesion (via fibronectin and laminin) (Lefort et al., 2012). Firm adhesion of 
neutrophils is primarily mediated by members of the β2 integrin family, LFA1. These 
integrins are highly expressed on neutrophils in an inactive form and must undergo a 
conformational change to become active and bind to their target ligands (cell adhesion 
molecules, e.g. ICAM1) on the endothelium (Takagi et al., 2002). Chemokine-induced 
activation of integrins targets the cytoskeletal protein talin at the plasma membrane 
(Lefort et al., 2012; Shamri et al., 2005). Talin interacts with the cytoplasmic domain of 
the integrin β subunit and shifts it to an intermediate conformation (Lefort et al., 2012). 
This further reduces the velocity of the rolling neutrophils. Binding of both talin1 and 
kindlin3 however, causes the integrin to change to a high affinity state. The integrins 
(αLβ2) then form stronger interactions with their corresponding ligands (e.g. ICAM1) 
leading to neutrophil arrest (Lefort et al., 2012; Wegener et al., 2007). Chemokine 
activation of T-cells causes a conformational change in integrin VLA4 to a higher 
affinity state, enabling binding to VCAM1 expressed on EC through a similar 
mechanism (Ley et al., 2007). This causes firm adhesion of T-cells to the EC surface.  
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1.3.3. Crawling and transendothelial migration 
Firmly adherent neutrophils can then crawl along the endothelium to find the optimum 
site for transmigration. This is primarily mediated by integrin macrophage-1 antigen 
(Mac1) interactions with ICAM1 which ensure that the neutrophil remains attached to 
the EC while it protrudes pseudopodia to search for EC cell-cell junctions through 
which it preferentially migrates (Phillipson et al., 2006). Arrested neutrophils can 
undergo migration through the endothelium after 1-2min and migration reaches a 
maximum by 10min (Luu et al., 1999; Burton et al., 2011).  
 
The exact mechanism of neutrophil transmigration has not yet been fully elucidated. 
The process occurs mainly through a paracellular route (via intercellular EC junctions) 
and occasionally a transcellular route (through an EC) (Phillipson et al., 2006). 
Intravital microscopy of murine cremasteric venules revealed that approximately 90% 
of neutrophils transmigrated through the paracelllular route after IL-1β stimulation 
(Woodfin et al., 2011). Adhesion molecules including platelet/endothelial cell adhesion 
molecule 1 (PECAM1), ICAM1 and 2, junctional adhesion molecules (JAM) A, B and 
C, CD99 (single-chain type-1 glycoprotein) and EC selective adhesion molecule 
(ESAM) expressed between EC junctions facilitate neutrophil and lymphocyte 
transmigration (Ley et al., 2007; Woodfin et al., 2011). Paracellular migration also 
requires dissociation of adherens junctions, namely those formed by endothelial VE-
Cadherin (Su et al., 2002).  
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In a murine model of ischemia-reperfusion injury, infused allogeneic bone marrow-
derived leukocytes (deficient in ICAM2, JAMA, PECAM1 or TNFα receptors) showed 
differential capacity to migrate through the EC in cremasteric venules after IL-1β or 
TNFα treatment for 4h. Thus showing that these adhesion molecules facilitate 
transmigration in a cell-specific or stimulus-specific manner (Woodfin et al., 2011). 
Specifically, PECAM1, ICAM2 and JAMA mediated neutrophil transmigration was 
induced in response to IL-1β stimulation but not TNFα (Woodfin et al., 2009). TNFα 
was found to directly activate leukocytes migration via the TNFα receptor expressed 
on leukocytes and did not require the activity of ICAM2, JAMA and PECAM1 to exert 
its effect (Woodfin et al., 2009). Prostaglandin D2 has also been shown to be a promoter 
for neutrophil and T-cell migration although the exact mechanism of action is unknown 
(Tull et al., 2009; Ahmed et al., 2011). 
 
Ligation of adhesion molecules (e.g. ICAM1) cause activation of diacyl glycerol and 
inositol-1, 4, 5- trisphosphate within EC inducing an increase in intracellular calcium 
levels (Woodfin et al., 2011). This activates Rho GTPases which then stimulate 
myosin-light chain kinase, causing EC contraction. Consequently, adherens junctions 
between the EC open and the endothelial barrier weakens, allowing leukocytes to 
transmigrate (Woodfin et al., 2011).  
 
The phenotype of EC and their responses to cytokines are influenced by the local 
haemodynamic shear stress and the presence of stromal cells. Stromal cells such as 
MSC, fibroblasts and smooth muscle cells (Rainger and Nash, 2001; Luu et al., 2013; 
McGettrick et al., 2009) crosstalk with EC and regulate their capacity to induce 
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leukocyte recruitment from flow. Stromal cells may mediate their effects through the 
release of soluble chemokines which are presented to leukocytes on the surface of the 
EC (McGettrick et al., 2010b). This has been shown to alter the recruitment of 
leukocytes to inflamed endothelium [reviewed by (McGettrick et al., 2012)]. In this 
thesis we are primarily interested in MSC and their capacity to regulate recruitment 
and the mechanism underlying this process.  
 
1.4.  Mesenchymal stem cell phenotype, origin and function  
Mesenchymal stem cells (MSC) are non-haematopoietic, multi-potent tissue-resident 
precursor cells that display multipotent differentiation potential and immunomodulatory 
capabilities (Pal et al., 2009; Aggarwal and Pittenger, 2005; DiMarino et al., 2013; 
Bianco, 2007). Initial studies showed that the BM contained a small population of stem 
cells of non-haematopoietic origin that exhibited colony forming capabilities, as well as, 
osteogenic, adipogenic and chondrogenic differentiation potential in vitro and in vivo 
(Friedenstein et al., 1970; Friedenstein, 1976, 1974; Owen and Friedenstein, 1988). 
The bone marrow (BM) stroma was identified as the source of these cells as the 
isolated BM stem cells were able to rapidly adhere to culture plastics and displayed a 
fibroblastic morphology (Friedenstein et al., 1970; Friedenstein, 1976, 1974). These 
cells were subsequently termed MSC and it was suggested that these cells were not 
specific to the BM and were in fact a common progenitor population residing in other 
mesodermal tissues that play a role in tissue homeostasis (Caplan, 1991; Pittenger, 
1999). More recently it has been shown that MSC exist in small numbers in a variety 
of tissues including the bone marrow (BM), Wharton’s jelly (WJ), adipose tissue (AD), 
dental pulp, brain, and spleen (Sotiropoulou et al., 2006; Bianco, 2007). Within different 
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tissues, MSC are thought to exhibit heterogeneous phenotypes based on cellular size, 
colony-forming unit capabilities, surface marker expression, differentiation capacity, 
and function (Christodoulou et al., 2013; Baksh et al., 2007; Kern et al., 2006). Indeed, 
growing evidence suggests that the MSC niche is unique in distinct tissues and that 
variation in tissue microenvironments may lead to tissue-specific differences in MSC 
functions (Magatti et al., 2008; Wolbank et al., 2007; Chen et al., 2011; Chang et al., 
2006).  
 
The primary function of tissue-resident MSC is believed to be tissue homeostasis and 
repair. Three mechanisms have been proposed to describe their contribution to these 
processes. Initially, based on their in vitro differentiation capacity MSC were thought to 
replenish cells by differentiating down specific lineages (Pal et al., 2009). More 
recently, growth factors and cytokines secreted by MSC are thought to stimulate other 
cell populations to proliferate (Rubina et al., 2009). For instance MSC secrete pro-
angiogenic factors which stimulate EC and promotes new vessel formation, an 
important event in tissue repair (Rubina et al., 2009). Alternatively, it has been 
suggested that MSC fuse with other tissue-resident cell types e.g. Purkinje cells or 
cardiomyocytes which then leads to de novo regeneration of damaged cells (Alvarez-
Dolado et al., 2003).  
 
1.4.1. Origin of MSC  
MSC have been defined in the International Society for Cell Therapy (ISCT) 2006 
guidelines (Dominici et al., 2006) as a plastic adherent population that have colony-
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forming capacity, trilineage differentiation potential (osteogenic, adipogenic and 
chondrogenic), express a panel of stromal markers (CD73, CD90, and CD105) and 
lack expression of leukocyte and haematopoietic markers (CD45, CD34, CD14 or 
CD11b, CD79a or CD19 and human leukocyte antigen-DR; HLA-DR). Additional 
surface proteins (e.g. CD146 and CD271) are thought to identify highly potent (based 
on clonogenic and immunosuppressive capacity) MSC subpopulations as assessed by 
their ability to suppress T-cell proliferation (Maijenburg et al., 2012; Kuci et al., 2010). 
However, no specific MSC marker - based on either surface expression or function - 
has been identified. Moreover, “MSC” markers are also found on non-MSC stromal 
populations (e.g. fibroblasts) indicating that this criterion is too generic for defining a 
specific population in tissue (Kundrotas, 2012; Sewell and Smith, 2011; Halfon et al., 
2011). Therefore, the MSC isolated from distinct tissue sources are likely to be 
heterogeneous populations of cells containing contaminating progenitor cells at 
various stages of lineage commitment. This may explain in part why there are 
differences in the differentiation capacity of MSC from distinct tissues. Also of concern 
is that the morphology, differentiation capacity, and expression of “MSC” markers are 
modified to varying degrees by in vitro culture conditions (Eggenhofer et al., 2014). 
Identification of a unique, functionally relevant marker is urgently required to truly track 
MSC in vivo and elucidate their endogenous role in modulating inflammation. Further, 
this marker could also be used to track therapeutically infused MSC in vivo and assess 
their effector functions. Understanding the origin of MSC may identify early lineage-
specific markers that are exclusively expressed on MSC and could be used to 
distinguish these cells from other stromal cells and to investigate their tissue 
distribution and any tissue-specific functions [reviewed by (Munir and McGettrick, 
2015)]. 
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Little is known about the developmental origin of MSC, however recent evidence 
suggests there are at least 2 distinct lineages: neural crest and mesoderm (Morikawa 
et al., 2009; Crisan et al., 2008). MSC can differentiate into cells of the neural lineages 
and subsets of murine BM-derived MSC have been reported to express neural crest 
stem cell-specific genes (Morikawa et al., 2009), leading several groups to postulate 
this as their origin (Morikawa et al., 2009; Nagoshi et al., 2008). Additionally, murine 
neural crest-derived cells can migrate through the bloodstream to populate numerous 
tissues, including the BM; where they exhibit a differentiation capacity indicative of 
stem cells (Nagoshi et al., 2008). In contrast, lineage tracing studies showed that cells 
from the primary vascular plexus give rise to perivascular cells that exhibit MSC-like 
properties (Crisan et al., 2008; Feng et al., 2011; Vodyanik et al., 2010).  Cells identified 
in tissue studies exhibited MSC defining markers or functional features (Jin et al., 2013; 
Christodoulou et al., 2013; Baksh et al., 2007; Chen et al., 2014). MSC in different 
tissues may originate from different sources which could lead to difference in their 
function (Nagoshi et al., 2008; Crisan et al., 2008; Feng et al., 2011). 
 
1.4.2. MSC in the bone marrow niche  
While MSC populations from different tissues exhibit some similar functional properties 
in vitro (Christodoulou et al., 2013; Baksh et al., 2007), it appears as though they may 
originally perform tissue-specific functions. For instance, in the BM, MSC contribute to 
the haematopoietic stem cell (HSC) niche and are key regulators of haematopoiesis 
(Méndez-Ferrer et al., 2010; Ahn et al., 2010; Omatsu et al., 2010) and trafficking of 
other BM-derived cells into the circulation (Sugiyama et al., 2006; Chow et al., 2011; 
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Méndez-Ferrer et al., 2010). Depletion of MSC or MSC-like progenitors caused an 
increase in HSC mobilisation (Méndez-Ferrer et al., 2010) and augmented the 
expression of early myeloid selector genes by HSC, reducing their overall number in 
the BM (Omatsu et al., 2010). This indicates that the presence of MSC in the HSC 
niche is essential for inducing HSC proliferation and maintenance in an undifferentiated 
state (Omatsu et al., 2010). Indeed, stimulation of β-catenin in MSC has been shown 
to promote HSC self-renewal in vivo suggesting that this signalling pathway is involved 
(Ahn et al., 2010).  
 
MSC can also “hold” HSC in the perivascular niche through CXCL12-CXCR4 
dependent interactions, preventing them from exiting the BM into the bloodstream, akin 
to the mechanism previously reported for leukocytes (Méndez-Ferrer et al., 2010; 
Sugiyama et al., 2006; Beck et al., 2014). Importantly, the expression of CXCL12 by 
MSC can be regulated by BM-resident CD169+ macrophages (Chow et al., 2011). 
Depleting these BM macrophages reduced CXCL12 expression on MSC and in turn 
enhanced HSC egress into the bloodstream (Chow et al., 2011). Thus, MSC play an 
integral role in maintaining HSC within the BM niche through soluble mediators, but 
also complex multi-cellular cross-talk with HSC and tissue-resident macrophages. 
 
Evidence suggests that MSC may also regulate the trafficking of monocytes and B-
cells from the bone marrow (Shi et al., 2011; Chow et al., 2011). During systemic 
infection, BMMSC up-regulated macrophage chemoattractant protein 1 (MCP1) in 
response to toll-like receptor (TLR) activation, promoting the egress of CCR2+ 
monocytes into the bloodstream (Shi et al., 2011). This mobilisation of monocytes also 
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promoted HSC egress away from the stem cell niche (Shi et al., 2011; Chow et al., 
2011) encouraging their maturation into leukocytes. This tightly regulated process 
required crosstalk between MSC, monocytes, and HSC to coordinate an appropriate 
immune response. BMMSC also down-regulated expression of CXCR4 by B-cells, 
which may have promoted their exit from the BM (Corcione et al., 2006). Whether, 
MSC in vivo influence maturation of other leukocyte populations remains to be 
determined, although in vitro evidence suggests that they are capable of inhibiting 
differentiation of several leukocyte subsets (Djouad et al., 2007; Ghannam et al., 
2010). A main function of tissue-resident BMMSC is to endogenously regulate the 
proliferation and maturation of HSC, and therefore indirectly influence leukocyte 
generation. Additionally, MSC may also regulate leukocyte egress in response to 
infection and/or inflammatory cues.  
 
1.5. Immunomodulatory effects of MSC 
MSC also possess potent immunomodulatory capabilities and can regulate the 
survival, function and fate of different leukocyte populations (Figure 1-2) [reviewed by 
(Munir and McGettrick, 2015)]. MSC-mediated immunomodulation occurs through two 
mechanisms: release of soluble factors and cell-cell contact-dependent interactions. 
The majority of studies investigating the immunomodulatory capacity of MSC have 
been carried out on BMMSC (Le Blanc and Mougiakakos, 2012). However, recent 
evidence has shown that MSC from other tissues, namely clinical waste tissues such 
as dental pulp, umbilical cord and adipose tissue also exhibit immunomodulatory 
properties to varying degrees (Trivanović et al., 2013).  
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Figure 1-2: Immunomodulatory effects of MSC. MSC alter the function and fate of 
several leukocyte populations through the secretion of soluble mediators. MSC can 
directly suppress neutrophil apoptosis and respiratory burst by reducing reactive 
oxygen species production. MSC suppress the proliferation and differentiation of PBL 
and dendritic cells and they can promote monocyte polarisation toward an anti-
inflammatory (M2) phenotype. MSC can also modify the EC response to pro-
inflammatory cytokines [taken from (Munir and McGettrick, 2015)].  
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These effects are mediated by soluble factors such as indoleamine 2, 3-dioxygenase 
(IDO), transforming growth factor beta (TGFβ), interleukin-6 (IL-6) and prostaglandin 
E2 (PGE2) (Trivanović et al., 2013). Cell-cell contact with target immune cells has also 
been shown to play an important role in mediating several of the immunomodulatory 
effects, as discussed below. However, it is currently unknown whether these effects 
observed with culture expanded MSC represent their true endogenous function.  
 
1.5.1. Effects on innate immunity 
MSC are able to modulate the movement, activity, and survival of neutrophils. 
Conditioned medium from LPS-stimulated MSC promoted neutrophil chemotaxis and 
migration across blank filters. Furthermore, direct co-culture with early passage (p3-5) 
BMMSC was found to augment the activation of neutrophils (Brandau et al., 2014). At 
p4, BMMSC inhibited apoptosis of resting and IL-8 stimulated neutrophils and 
dampened N-Formylmethionine-leucyl-phenylalanine (fMLP) induced respiratory burst 
in an IL-6 dependent manner (Raffaghello et al., 2008).  Lipopolysaccharide (LPS)-
stimulation of tissue-resident glandular MSC enhanced their chemokine expression 
and conditioned medium from the MSC promoted neutrophil migration in vitro, in an IL-
8 and macrophage migration inhibitory factor-dependent manner (Brandau et al., 
2010). Migrated neutrophils in the co-cultures became activated and had a significantly 
longer life span (Brandau et al., 2010). This suggests that tissue-resident MSC may 
directly modulate the recruitment and activity of neutrophils responding to inflammatory 
insults or microbial challenge.  
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In another report, gastric cancer-derived MSC induced neutrophil activation via IL-6, 
downstream signal transducers and activators of transcription protein 3 (STAT3) and 
ERK1/2 signalling was also found to be involved. Activated neutrophils were further 
protected from spontaneous apoptosis (Zhu et al., 2014). Similarly, umbilical cord 
WJMSC were found to suppress adult neutrophil apoptosis in a dose-dependent 
manner (Zhang et al., 2015). Therefore, MSC from different tissue sources may 
promote neutrophil activation and survival in an IL-6 dependent manner. In certain 
contexts, direct cell-cell contact between MSC and neutrophils maximised the 
response (Zhu et al., 2014). However, the reasons for this remain unknown and 
requires further investigations. In contrast, an in vivo study showed that intravenous 
infusion of BMMSC in a mouse sepsis model inhibited neutrophil migration into tissues 
and as a result limited multi-organ damage associated with sepsis (Németh et al., 
2009). In vitro experiments showed that LPS or TNFα-stimulation of BMMSC induced 
IL-10 production by macrophages which in turn reduced neutrophil recruitment 
(Németh et al., 2009). Therefore, while MSC may dampen neutrophil recruitment, they 
could promote their survival and/or activation.  
 
MSC are also capable of suppressing effector functions of natural killer (NK) cells (Le 
Blanc and Mougiakakos, 2012). Secretion of IFNγ by IL-2 (Aggarwal and Pittenger, 
2005; Spaggiari et al., 2008) or IL-15 (Sotiropoulou et al., 2006) stimulated NK cells 
was found to be suppressed by human BMMSC. BMMSC induced suppression was 
partially mediated by direct cell contact and PGE2 (Spaggiari et al., 2008; Sotiropoulou 
et al., 2006). BMMSC also suppressed cytotoxic effects of cytokine-stimulated NK cells 
in vitro via the synergistic actions of IDO and PGE2 (Spaggiari et al., 2008). This 
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suggests that MSC can suppress the activity of several leukocyte populations using 
both soluble mediator and cell-cell contact dependent pathways.  
 
MSC have also been shown to skew monocyte differentiation towards an anti-
inflammatory M2 phenotype (Kim and Hematti, 2009; Maggini et al., 2010). IDO and 
PGE2 and direct cell-cell contact have also been implicated in BMMSC induced 
monocyte polarisation to IL-10 producing M2 macrophages (Kim and Hematti, 2009; 
Maggini et al., 2010; François et al., 2012). In a murine sepsis model, M2 macrophage-
derived IL-10 reduced neutrophil infiltration in vivo following infusion of BMMSC 
(Németh et al., 2009). In addition, human BMMSC suppressed differentiation of CD14+ 
monocytes into dendritic cells in vitro (through GM-CSF, IL-4 and LPS) when cultured 
on opposite sides of a porous filter (Jiang et al., 2005). Thus MSC may have the 
capacity to dampen inflammatory processes and promote resolution through its direct 
actions on several different leukocyte populations.  
1.5.2. Effects on adaptive immunity  
The ability of murine and human MSC to modulate the proliferation and cytotoxic 
activity of T-cells has been extensively studied [reviewed by (Ma et al., 2014)]. These 
assays are now widely used to test the potency of culture expanded MSC. MSC from 
BM, umbilical cord WJ and adipose tissue (AD) promoted T-cell survival in vitro and 
maintained them in a quiescent state by suppressing their proliferation (Ribeiro et al., 
2013; Selmani et al., 2008). BMMSC also inhibited their production of pro-inflammatory 
cytokines to dampen their inflammatory effects (e.g. IFNγ) (Aggarwal and Pittenger, 
2005). In this context, MSC-induced suppression was mediated by soluble factors 
(namely TGFβ, IDO and PGE2) (Li et al., 2014a) and cell contact (Benvenuto et al., 
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2007). These soluble factors acted synergistically to suppress T-cell proliferation and 
the effect was maximal when the MSC were in direct contact with target T-cells (Gu et 
al., 2013). Additionally, BMMSC augmented the expansion of Treg cells in a HLA-G 
dependent manner which could be enhanced by addition of IL-10 (Selmani et al., 
2008). Therefore, as well as directly regulating the proliferation and activity of cytotoxic 
T-cells, MSC may also indirectly modify their effects by promoting the proliferation of 
local Treg populations.  
 
In contrast, the ability of MSC to regulate other cell types of the adaptive immune 
system has not been clearly defined. Human BMMSC were found to preserve naive B-
cells in a resting state, suppressing their proliferation, differentiation and antibody 
production (Corcione et al., 2006). Murine BMMSC also inhibited proliferation of 
splenic B-cells from the follicular and marginal zone in vitro (Schena et al., 2010). 
Furthermore, direct contact between MSC and B-cells caused a reduction in the 
expression of chemokine receptors (CXCR5 and CCR7) on B-cells and dendritic cells 
(DC) (English et al., 2008) which are essential for trafficking through lymphoid organs 
(Corcione et al., 2006). Additionally, MSC may promote immunological tolerance in 
vivo, since co-culture with DC on opposite sides of a porous filter reduced expression 
of CD80/CD86 and HLA on the DC. This impaired their ability to stimulate T-cell 
expansion (Ramasamy et al., 2007; Beyth et al., 2005; Jiang et al., 2005), although the 
mechanism(s) involved in mediating this effect were not demonstrated. The majority of 
effects on adaptive immune responses appear to be mediated by MSC-derived soluble 
factors. However, in certain contexts direct cell-cell contact has been shown to 
enhance the effect. The exact mechanism by which cell contact augments the 
suppressive effects of MSC on T-cells is unknown but may involve the PD-1 
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(programmed cell death protein 1) pathway (Schena et al., 2010; Augello et al., 2005). 
Indeed, blocking PD-1 in BMMSC co-cultures with T-cells reversed their suppressive 
effect on proliferation, indicating that this pathway plays a role in MSC-mediated 
suppression (Augello et al., 2005). MSC can also indirectly modify immune cells 
through their interactions with EC to regulate leukocyte recruitment. As this is a major 
MSC function and the main focus of this thesis, it is discussed in detail in Section 1.7.2.  
 
1.6. Phenotypic and functional differences between MSC from different tissue 
sources 
MSC from adult and neonatal tissues fulfil the ISCT criteria, however differences in 
their proliferative capacity, differentiation potential and surface marker expression have 
been reported (Christodoulou et al., 2013; Baksh et al., 2007; Jin et al., 2013; Kern et 
al., 2006). Several studies revealed that neonatal MSC such as placenta, umbilical 
cord tissue or blood-derived MSC had a greater proliferative and clonal expansion 
potential than adult BMMSC and ADMSC (Li et al., 2014b; Baksh et al., 2007; Jin et 
al., 2013; Christodoulou et al., 2013). Neonatal MSC exhibited lower expression of 
senescence associated genes than adult MSC (Jin et al., 2013; Li et al., 2014b). 
WJMSC also displayed a greater osteogenic differentiation potential than BMMSC in 
vitro (Li et al., 2014b; Baksh et al., 2007) and adult ADMSC showed a greater 
proliferative and differentiation potential than BMMSC (Li et al., 2014b). 
 
Differences in the proliferation rate of distinct MSC populations reported in these 
studies could be due to differences in the levels of other stromal cells contaminating 
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the MSC culture. Within distinct tissues there may be different proportions of 
multipotent MSC to lineage committed progenitors (Post et al., 2008). BMMSC cultures 
may contain more of these lineage committed stromal cell contaminants than umbilical 
cord-derived MSC. This would reflect differences in tissue composition at distinct 
anatomical sites and the differences in their proliferative and differentiation capacities.  
 
In addition to phenotypic differences, MSC from several anatomical sites were found 
to modulate immune cell function to varying degrees (Li et al., 2014b). WJMSC exerted 
a greater suppression on Phytohaemagglutinin (PHA)-induced T-cell proliferation than 
placental-derived MSC, BMMSC and ADMSC during co-culture (Li et al., 2014b). A 
previous study also showed that BMMSC exhibited less potent suppressive effects 
than placental-derived MSC in vitro, in a similar model (Chang et al., 2006). 
Additionally, co-culture of human umbilical cord blood-derived MSC with rodent 
macrophages significantly reduced secretion of pro-inflammatory cytokines (IL-1α, IL-
8 and IL-6) to a greater extent than BMMSC and ADMSC (Jin et al., 2013). While 
BMMSC have a weaker suppressive effect than neonatal MSC populations, they have 
been shown to inhibit lymphocyte proliferation to a similar level as ADMSC (Roemeling-
van Rhijn et al., 2013; Puissant et al., 2005). A conflicting report however showed that 
three distinct neonatal MSC populations (from the amnion, placenta and WJ) exerted 
similar levels of suppression on proliferation of alloreactive T-cells as BMMSC 
(Manochantr et al., 2013). Discrepancies between studies could be due to differences 
in the methodologies used to isolate and culture the MSC. Therefore, while MSC from 
different sources mediate the same suppressive effects on different leukocytes 
subsets, the degree to which they mediate these effects and the mechanism by which 
they exert their effects may vary. 
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Collectively, the above suggests that MSC from neonatal tissues may be more potent 
than adult BMMSC and ADMSC in terms of their proliferative and immunomodulatory 
capacity (on T-cell proliferation). One explanation for this could be that MSC from 
neonatal tissues have undergone fewer population doublings prior to isolation than 
adult MSC. Indeed, culture expanded adult MSC have been reported to go through 
fewer population doublings in culture than neonatal MSC before undergoing replicative 
senescence (Ribeiro et al., 2013). A recent study showed that senescent BMMSC had 
a reduced capacity to suppress PHA-induced T-cell proliferation when compared to 
dividing BMMSC (Sepúlveda et al., 2014). In a murine model of LPS-induced sepsis, 
senescent BMMSC failed to protect mice from sepsis-associated lethality (Sepúlveda 
et al., 2014). Further work is needed to assess whether senescence is associated with 
a loss of MSC-mediated immunosuppression. It is also possible that functional 
differences between MSC populations are due to differences in developmental origin 
of different MSC populations, a phenomenon previously observed in different smooth 
muscle cell populations (Sinha et al., 2014). 
 
1.7. MSC crosstalk with EC and other tissue-resident stromal cells during 
homeostasis and inflammation 
MSC from different tissue sources are able to suppress immune cell proliferation and 
behaviour.  However, little is known about whether tissue-resident MSC can influence 
the function of other tissue-resident cells in their vicinity, such as EC and whether there 
are tissue-specific differences. MSC reside in the perivascular niche in close proximity 
with EC lining the vasculature (blood and lymphatic) and other tissue-resident (stromal) 
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cells. Comparatively speaking we understand little about the interactions of MSC with 
these populations and their functional consequences.  
 
1.7.1. MSC interactions with stromal cells 
Interactions between MSC and other stromal cells has mainly focused on the 
reparative properties of both cell types. Recent studies suggest that MSC may interact 
with other mesenchymal stromal cells within tissues during repair and bone 
remodelling to enhance their reparative functions (Tang et al., 2009; Abdel Aziz et al., 
2007; Semedo et al., 2009; Wu et al., 2015; Li et al., 2008). BMMSC reportedly migrate 
towards damaged bone in response to TGFβ released from osteoclasts at bone 
resorption sites (Tang et al., 2009). BMMSC were thought to differentiate into 
osteoblasts and then promote remodelling of the bone (Tang et al., 2009). In rodent 
models of tissue damage, injection of BMMSC or BMMSC-conditioned medium 
reduced fibrosis of affected organs, namely the kidneys, heart, liver and skin (Abdel 
Aziz et al., 2007; Semedo et al., 2009; Wu et al., 2015; Li et al., 2008). Soluble factors 
generated by the MSC (after infusion or in the conditioned media) may stimulate tissue-
resident stromal cells to differentiate into specific cell types required to replenish the 
tissue. While MSC may limit tissue fibrosis and promote repair, the direct interactions 
between MSC and other tissue-resident stromal cell populations has not been 
explored; therefore, little is known about this potential function of MSC. Endogenous 
Gil1+ MSC on the other hand were found to contribute to tissue fibrosis after organ 
damage in vivo suggesting that the source of MSC, the tissue context and the type of 
fibrosis influence the effect of MSC (Kramann et al., 2015). Further research is needed 
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to determine whether MSC and stromal cells influence each other to regulate the tissue 
microenvironment and therefore the local response during inflammation. 
 
1.7.2. MSC interactions with EC 
The effects of MSC on the behaviour of EC can be considered in three contexts: 
angiogenesis, vascular permeability and leukocyte recruitment. Interactions between 
BMMSC and EC have been described in these contexts while the effects of other MSC 
populations (e.g. WJMSC) on EC function has not yet been explored.   
 
1.7.2.1. Regulation of angiogenesis 
Under resting conditions, human and rodent BMMSC have been reported to release 
factors (e.g. Vascular endothelial growth factor α and platelet-derived growth factor-
BB) known to enhance the proliferation and migration of EC (Rahbarghazi et al., 2012; 
Chen et al., 2008; Dhar et al., 2010). The production of these agents indicates that 
MSC have the potential to promote angiogenesis. In a murine model of wound repair, 
BMMSC (injected intradermally) increased EC and macrophage numbers at the site of 
the wound (Chen et al., 2008; Wu et al., 2007). Furthermore, this appeared to be an 
MSC-specific effect as, proliferation and migration of both human and murine EC in 
vitro was increased in the presence of conditioned medium from BMMSC but not 
dermal fibroblasts (Chen et al., 2008). These studies suggested that MSC promoted 
wound healing by inducing angiogenesis. Furthermore, the tube forming capacity of 
EC was also augmented by BMMSC conditioned medium, indicating that MSC 
secreted pro-angiogenic factors (Wu et al., 2007). The capacity of MSC to mediate 
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tube-formation in vitro has been extensively studied [reviewed by (Nassiri and 
Rahbarghazi, 2014)]. Co-injection of MSC with B16 melanoma cells increased tumour 
size and vessel area in vivo, indicating that they may also promote tumour 
angiogenesis (Suzuki et al., 2011). A conflicting study found that MSC suppressed 
network formation through production of reactive oxygen species when in direct 
contact with rat lung microvascular EC in a matrigel model (Otsu et al., 2009). Of note, 
other key stimulators of angiogenesis, such as shear stress and oxygen tension, were 
not modelled in these studies. Collectively, these studies suggest that in response to 
tissue damage, MSC may mediate their reparative effects, at least in part, through 
crosstalk with EC, by promoting angiogenesis.  
 
1.7.2.2. Regulation of blood vascular permeability 
Recent evidence suggests that perivascular MSC also communicate with EC to 
regulate vascular permeability and maintain vessel integrity in resting and acute 
inflammatory conditions (Pati et al., 2011; Zhao et al., 2009; Pati et al., 2010; Zhao et 
al., 2010). Co-culture with MSC increased the stability of junctional molecules (e.g. VE-
Cadherin and β-catenin) by inhibiting their turnover at the plasma membrane of EC, 
reducing endothelial permeability to FITC-dextran (Pati et al., 2010). This effect was 
reproduced when EC were treated with conditioned medium from EC and MSC co-
cultures, but not mono-cultures, implicating soluble mediators as the main drivers (Pati 
et al., 2010). In LPS driven infection, infusion of BMMSC reduced pulmonary 
microvessel permeability and increased endothelial barrier function in vivo, thus 
reducing murine lung vascular permeability (Zhao et al., 2009). Similar observations 
were made using a rat model of haemorrhagic shock (Pati et al., 2011), indicating that 
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therapeutic administration of MSC may have beneficial effects for individuals with 
severe vascular damage. Tightening of the endothelial barrier may also regulate 
leukocyte infiltration into tissues. This could have important implications in chronic 
inflammatory disorders where aberrant infiltration of leukocytes from the blood plays a 
key role in the progression of the disease. 
 
1.7.2.3. MSC regulation of leukocyte recruitment to inflamed EC 
A small number of studies described below indicate that perivascular MSC 
communicate directly with neighbouring endothelium to indirectly regulate leukocyte 
recruitment during inflammation. However, none have questioned whether the capacity 
to regulate this process varies between MSC from different sources and therefore 
whether it’s likely to be tissue-specific.  
 
Intravenous infusion of murine BMMSC increased the number of circulating 
neutrophils, whilst simultaneously decreasing circulating monocytes in a murine model 
of sepsis (Németh et al., 2009). This suggests that MSC may actively inhibit neutrophil 
recruitment while simultaneously promoting monocyte recruitment. Although, the 
increase in levels of circulating neutrophils may be due to an increase in neutrophil 
production from the BM. A subsequent study showed that pre-treating pulmonary EC 
with conditioned medium from human EC and BMMSC co-cultures reduced their ability 
to support adhesion and migration of U937 cells (monocytic leukaemia cell line) in 
response to TNFα in vitro (Pati et al., 2011). The reduction in migration was caused by 
tightening of endothelial adherens junctions (VE-cadherin and β-catenin) and a 
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reduction in expression of the adhesion molecule ICAM1 and VCAM1 (Pati et al., 
2011). Furthermore, a recent report showed that in a murine model of ischemia-
reperfusion injury, systemic infusion of murine BMMSC reduced neutrophil recruitment 
to the injured jejunum (Kavanagh et al., 2015). Thus, MSC in vitro and in vivo showed 
the capacity to reduce leukocyte recruitment through their interactions with EC.  
 
In our laboratory, we have shown using an in vitro multi-cellular flow-based adhesion 
assay that BMMSC communicate with neighbouring vascular EC to limit leukocyte 
recruitment induced by pro-inflammatory cytokines (TNFα and IL-1β) (Luu et al., 2013). 
Specifically, BMMSC co-cultured in direct contact with EC (mimicking systemic infusion 
of MSC) reduced the numbers of both neutrophils and PBL adhering to and migrating 
through EC in response to cytokines, after 24h co-culture (Luu et al., 2013). A two-way 
conversation between BMMSC and EC was essential for mediating these effects since 
co-culture, but not MSC mono-culture, conditioned medium mimicked the effects of 
direct co-culture. This indicates that the effect was mediated by soluble factors 
generated only during the co-culture.  
 
IL-6 secretion was significantly upregulated in BMMSC co-culture compared to EC or 
MSC mono-cultures (Luu et al., 2013). Knockdown of IL-6 in BMMSC reduced IL-6 
production in co-culture indicating that IL-6 was primarily generated by the MSC (Luu 
et al., 2013). Knockdown or blocking of IL-6 or soluble IL-6 receptor (sIL-6R) reversed 
the suppressive effects of BMMSC on neutrophil adhesion and migration to TNFα-
stimulated EC and PBL recruitment to TNFα and IFNγ-stimulated EC (Luu et al., 2013). 
Thus, IL-6 signalling through sIL-6R was essential for suppressing leukocyte 
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recruitment in co-culture. TGFβ was shown to increase IL-6 production by MSC in co-
culture and neutralisation of TGFβ partially reversed the suppression on neutrophil 
adhesion and migration (Luu et al., 2013). Therefore, IL-6 and TGFβ appear to be 
involved in MSC-mediated suppression of recruitment with TGFβ appearing to act 
upstream of IL-6 (Luu et al., 2013).  
 
We observed that expression of ICAM1, VCAM1 and E-selectin at the genomic level 
was unaffected by co-culture despite the reduction in leukocyte recruitment observed 
(Luu et al., 2013). However, protein expression of ICAM1 on the surface of TNFα-
stimulated EC was reduced in co-culture (Luu et al., 2013). ICAM1 and VCAM1 protein 
expression was significantly reduced in co-culture after treatment of EC with TNFα and 
IFNγ (Luu et al., 2013). Co-culture with BMMSC also inhibited the secretion of 
chemokines (CXCL8 and CXCL10) responsible for stabilising leukocyte adhesion, and 
driving onward migration (Luu et al., 2013). Therefore, the suppression of ICAM1 and 
VCAM1 and chemokine expression on EC may in part explain the reduction in 
leukocyte adhesion and migration observed during BMMSC co-culture. 
 
BMMSC and EC were also co-cultured on opposite sides of a porous filter to model 
the crosstalk that might occur within a tissue (Luu et al., 2013; Munir et al., 2015; 
McGettrick et al., 2009). Again, it was observed that BMMSC were able to suppress 
neutrophil and PBL recruitment from flow (Luu et al., 2013). This may suggest that 
MSC are endogenous regulators of leukocyte recruitment that mediate their effects 
through interactions with vascular EC.  
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Several studies utilising in vitro flow-based adhesion models have previously shown 
that, in addition to MSC, stromal cells from a variety of tissues (e.g. fibroblasts and 
podocytes) can modify leukocyte recruitment induced by inflammatory cytokines 
(Kuravi et al., 2014; Lally et al., 2005; Luu et al., 2013; McGettrick et al., 2009). 
Collectively, the abovementioned studies of stromal cells showed that they use 
conserved mechanisms to regulate recruitment, involving IL-6 and TGFβ as regulators 
(Kuravi et al., 2014; Luu et al., 2013; McGettrick et al., 2009). IL-6 in conjunction with 
TGFβ was found to suppress neutrophil and PBL adhesion and migration through EC 
co-cultures with BMMSC or dermal fibroblasts in vitro (Luu et al., 2013; McGettrick et 
al., 2009). Indeed, in murine models of inflammation, IL-6 and TGFβ have previously 
been shown to reduce the inflammatory infiltrate by suppressing leukocyte recruitment 
(Ulich et al., 1991; Tilg et al., 1997).  
 
Studies so far suggest that MSC crosstalk with EC to reduce vascular permeability and 
inhibit the recruitment of leukocytes in response to pro-inflammatory cytokines. 
Therefore, MSC could be used to treat chronic inflammatory conditions as they would 
suppress the aberrant influx of leukocytes into the tissue. Studies to date have not 
addressed whether MSC from different tissue sources have the same capacity to 
mediate the same effects as BMMSC or whether it is a tissue-specific function. Indeed 
other stromal populations, including EC and fibroblasts, display distinct spatial 
identities (Aird, 2012) that govern their behaviour. This allows them to establish tissue-
specific ‘address-codes’ that actively regulate the recruitment of leukocytes to inflamed 
sites [reviewed by (Parsonage et al., 2005)]. Furthermore, the requirement for cell-cell 
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contact between MSC and EC also needs to be examined as it could impact their 
therapeutic potential. If MSC require contact or close proximity with EC to undergo 
crosstalk then direct injection into the tissue would be required. Alternatively, if MSC 
are able to exert their effects from a distance then systemic infusion could be used. 
These issues need to be addressed before MSC can be used therapeutically to 
suppress leukocyte infiltration in patients with chronic inflammation. 
 
1.8. IL-6 signalling during inflammation 
As noted above, IL-6 is implicated in several immunomodulatory effects of MSC. IL-6 
is an abundant pleiotropic cytokine that has context-specific functions during 
inflammation. IL-6 acts in a pro-inflammatory manner by inhibiting differentiation of 
CD4+ T-cells into Treg cells, promoting monocyte recruitment and inhibiting apoptosis 
of T-cells [reviewed by (Scheller et al., 2011)]. However, as described above, IL-6 may 
also mediate anti-inflammatory effects such as suppression of leukocyte recruitment 
during inflammation. The IL-6 receptor complex is composed of a type I 
transmembrane glycoprotein receptor (IL-6R; CD126) and a type I transmembrane 
signal transducer (IL-6ST; gp130) (Barnes et al., 2011). Most cell types, including EC 
and fibroblasts do not express IL-6R on their surface and rely upon soluble IL-6R (sIL-
6R) for trans-signalling in order to respond to IL-6 (Barnes et al., 2011). sIL-6R is 
generated by two distinct mechanisms; proteolytic cleavage of IL-6R on the surface of 
cells that express it (e.g. neutrophils and macrophages and some T-cell subsets) by 
matrix metalloproteinases (ADAM 17 or 10) or through expression of an IL-6R splice 
variant that lacks the transmembrane and cytosolic domains (e.g. by neutrophils and 
macrophages) (Müllberg et al., 1993; Horiuchi et al., 1994; Lust et al., 1992) . The sIL-
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6R binds to free IL-6 and the complex then interacts with IL-6ST, which is ubiquitously 
expressed on all cell types (Scheller et al., 2011). This interaction induces the 
activation of the transcription factor STAT3 through which the majority of the effects of 
IL-6 are thought to be mediated (Barnes et al., 2011).  
 
IL-6 may influence the sequence of events in acute inflammation through effects 
involving neutrophils, monocytes and EC. At the site of inflammation, chemokines such 
as IL-8 induced activated neutrophils to shed IL-6R which then signalled through EC 
via IL-6ST (Scheller et al., 2011; Barnes et al., 2011). IL-6 trans-signalling then 
inhibited production of IL-8 but promoted secretion of MCP1, inducing a transition from 
neutrophil to monocyte recruitment. This is thought to be a key step in the inflammatory 
process as it may prevent further tissue damage by reactive oxygen species and 
proteases secreted by the infiltrating neutrophils (Jones, 2005; Kaplanski et al., 2003; 
Hurst et al., 2001; McLoughlin et al., 2004). These studies show that IL-6 acts in a pro-
inflammatory manner by shifting the inflammatory response from neutrophils to 
monocytes. 
 
However, we have previously shown that IL-6 acts in an anti-inflammatory manner by 
suppressing lymphocyte adhesion to cytokine-stimulated EC (McGettrick et al., 2009). 
In this context IL-6 may reduce the expression of adhesion molecules by EC, thus 
reducing their capacity to support recruitment. Indeed, we showed that EC co-culture 
with BMMSC where IL-6 secretion was increased, recruitment of neutrophil and PBL 
was suppressed (Luu et al., 2013). The increase in expression of ICAM1 and VCAM1 
on cytokine-stimulated EC was inhibited by BMMSC co-culture suggesting that IL-6 
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signalling through the EC reduced their expression (Luu et al., 2013). Therefore, IL-6 
can act in a pro- or anti-inflammatory manner depending on the cell type it acts on and 
the context (e.g. healthy vs. chronically inflamed tissue) (McGettrick et al., 2009).  
 
1.9. Effect of inflammatory environment on MSC phenotype and function 
Inflamed tissue is a complex microenvironment that contains an array of soluble factors 
(such as pro- and anti-inflammatory cytokines). These agents can modify the actions 
of tissue-resident leukocytes, EC, and mesenchymal stromal cells, physiologically to 
remove the inflammatory insult and promote resolution. It has been suggested that 
tissue-resident MSC also respond to changes in their local microenvironment during 
inflammation (Prasanna et al., 2010; Waterman et al., 2010). Additionally, the 
inflammatory milieu may alter the phenotype of MSC, and for instance, in chronic 
conditions this may modify their immunomodulatory capacity. 
 
1.9.1. MSC response to inflammatory mediators 
Cytokines found in the inflammatory microenvironment can alter the phenotype and 
function of MSC. Pre-treatment of BMMSC, WJMSC and ADMSC with TNFα and IFNγ 
for 18h altered the expression of TLR on the MSC surface and increased secretion of 
cytokines (e.g. IL-6) and chemokines (e.g. IL-8, CCL5) compared to unstimulated MSC 
(Raicevic et al., 2011). Murine BMMSC treated with IFNγ combined with either TNFα, 
IL-1α or IL-1β for 24h exhibited greater expression of adhesion molecules such as 
ICAM1, VCAM1 and chemokines e.g. CXCL9 compared to untreated MSC (Ren et al., 
2008, 2010). Interestingly, treatment with individual cytokines had no significant effect 
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(Ren et al., 2008, 2010) suggesting that MSC-mediated responses are tightly regulated 
and require the presence of several key agents for their induction. The cytokine-
stimulated increase in adhesion molecule expression observed might be important for 
facilitating contact between tissue-resident MSC and infiltrating leukocytes. Binding of 
leukocytes to the MSC surface could potentially enhance the capacity of the MSC to 
exert their immunosuppressive effects.  
 
IFNγ stimulation of BMMSC and WJMSC for 72h induced expression of the anti-
inflammatory agent IDO relative to non-primed MSC (Prasanna et al., 2010). IDO has 
previously been identified as a key mediator of human MSC-induced suppression of 
T-cell proliferation (Prasanna et al., 2010). In several studies, cytokine-stimulation 
augmented the immunomodulatory effects of MSC compared to untreated MSC 
(Prasanna et al., 2010; Deuse et al., 2011; Yoo et al., 2009). Pre-treatment of BMMSC 
and placental or umbilical cord-derived MSC with IFNγ for 48h increased their 
suppressive effect on T-cell proliferation and mixed lymphocyte reaction compared to 
naïve MSC (Jones et al., 2007; Prasanna et al., 2010). Furthermore, TNFα priming of 
BMMSC and WJMSC (for 72h) was found to increase their ability to suppress PHA-
induced IL-2 secretion by T-cells (Prasanna et al., 2010). In these studies, priming 
MSC appeared to augment their anti-inflammatory effects. However, enhancing the 
effector functions of MSC also has the potential for damaging consequences. For 
instance, co-infusion of murine BMMSC which have been primed with TNFα and IFNγ 
(for 12h) with a C26 colon cancer cell line significantly increased tumour growth when 
compared to injection with non-primed MSC (Liu et al., 2011). This was taken to 
suggest that the pro-angiogenic properties of MSC had promoted tumour growth in this 
model. Collectively, the above studies suggest that MSC are able to respond to 
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cytokines in the inflammatory milieu, thus enhancing their effector functions, primarily 
their immunosuppressive capacity. However, cytokine priming is not essential for 
MSC-mediated suppression of T-cell proliferation and secretion of pro-inflammatory 
cytokines, as initial studies showed that non-primed MSC are potent regulators of 
immune cell function (François et al., 2012; Maggini et al., 2010; Raffaghello et al., 
2008; Kim and Hematti, 2009). In addition, it is uncertain whether the in vitro effects of 
cytokine priming MSC truly represent the responses of MSC to the inflammatory 
environment in vivo. 
 
Recently studies have suggested that MSC are able to polarise towards a pro-
inflammatory MSC1 phenotype or an anti-inflammatory MSC2 phenotype through the 
engagement of different TLR. Poly (I:C)-stimulated TLR3 activation on MSC was 
initially shown to enhance the immunosuppressive effects of BMMSC through the 
release of anti-inflammatory agents such as IDO and IL-10 (Waterman et al., 2010). In 
contrast, LPS ligation of TLR4 abrogated BMMSC-mediated suppression of T-cell 
proliferation and enhanced the production of pro-inflammatory cytokines (e.g. TNFα) 
and collagen deposition (Waterman et al., 2010). This was supported by in vivo 
experiments which showed that systemic infusion of TLR3-primed MSC into mice with 
lung injury ameliorated symptoms, whilst infusion of TLR4-primed MSC exacerbated 
the lung injury when compared to naive MSC (Waterman et al., 2010). However, in 
other reports, MSC infusion reduced lung oedema and leukocyte infiltration in murine 
models of sepsis where high levels of LPS (TLR4 ligand) were present (Tyndall and 
Pistoia, 2009; Zhao et al., 2009).  
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Subsequent in vitro studies have also produced conflicting results where secretion of 
IDO or PGE2 and T-cell proliferation were variously enhanced, reduced, or unchanged 
by TLR3 and 4-stimulated BMMSC (Opitz et al., 2009; Liotta et al., 2008; Raicevic et 
al., 2011). As we have recently reviewed, discrepancies between studies may reflect 
differences in experimental conditions (treatment concentrations and duration), source 
of MSC and the numbers used in each assay (Munir and McGettrick, 2015). However, 
these studies strongly indicate that MSC are highly plastic cells that can act as 
inflammatory sensors that respond to changes in levels of cytokines, danger signals 
and bacterial components in the tissue microenvironment.  
 
1.9.2. The potential effects of a chronic inflammatory environment on MSC behaviour 
While MSC exert a number of acute responses to inflammatory agents, whether effects 
persist or change during chronic inflammation is currently uncertain. Other 
mesenchymal stromal cell populations, namely fibroblasts and secretory smooth 
muscle cells, have previously been shown to undergo a transformation from an 
immunosuppressive, regulatory state to a pro-inflammatory state in chronic 
inflammatory diseases (i.e. rheumatoid arthritis, RA and atherosclerosis respectively) 
[reviewed by (McGettrick et al., 2012)]. Therefore, it is possible that MSC undergo 
phenotypic changes (possibly to a pro-inflammatory state) in response to chronic 
inflammation.  
 
An ex vivo study showed that human BMMSC isolated from RA patients showed 
impaired capacity to support haematopoiesis when co-cultured with CD34+ 
37 
 
haematopoietic progenitors (Papadaki et al., 2002). Furthermore, MSC from patients 
with either systemic lupus erythematosus (SLE) or RA exhibited reduced proliferation 
capacity and telomere length compared to BMMSC taken from healthy donors 
(Kastrinaki et al., 2008; Nie et al., 2010). BMMSC isolated from patients with multiple 
sclerosis (MS) or systemic sclerosis (SS) on the other hand did not exhibit any 
differences in their proliferation and differentiation capacity compared to healthy 
controls (Mallam et al., 2010; Papadaki et al., 2005; Larghero et al., 2008). 
Interestingly, MSC from patients with SLE, RA and SS maintained the capacity to 
suppress T-cell proliferation (Kastrinaki et al., 2008; Nie et al., 2010; Larghero et al., 
2008). BMMSC from healthy donors cultured in medium containing 20% synovial fluid 
from osteoarthritis patients, increased the expression of IL-6 and IDO genes compared 
to those cultured with synovial fluid from post-mortem donors without joint inflammation 
(Leijs et al., 2012). Proteomic analysis of RA BMMSC revealed changes in expression 
of cell cycle regulators namely a decrease in cyclin-D (which regulates transition from 
G1 to S-phase) when compared to healthy age and gender-matched BMMSC 
(Kastrinaki et al., 2008). During chronic inflammation, BMMSC appear to undergo rapid 
proliferation followed by premature senescence as shortening of telomeres was 
observed (Kastrinaki et al., 2008). The implications of the above changes in the 
phenotype of MSC or their immunomodulatory actions in response to chronic 
inflammation are not fully understood. Furthermore, since these studies were all 
carried out using BMMSC, whether MSC from other sources respond to the 
inflammatory microenvironment in the same manner remains to be explored. 
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1.10. Effect of differentiation on MSC immunomodulation 
In response to injury, tissue-resident or therapeutically administered MSC respond to 
environmental cues and may undergo differentiation in order to replenish the cells lost 
(Tang et al., 2009). Whether differentiation under these conditions influences their 
immunomodulatory capacity, is a matter of current research interest. From a 
therapeutic perspective, loss of MSC immunomodulation upon differentiation could 
limit the use of MSC in treatment of inflammatory disorders.  
 
Recent studies have compared the capacities of undifferentiated MSC and MSC-
derived osteoblasts or chondrocytes to suppress T-cell proliferation and function 
(Niemeyer et al., 2007; Montespan et al., 2014; Lohan et al., 2014). Human BMMSC 
and ADMSC were found to have a similar osteogenic differentiation capacity and MSC-
derived osteoblasts from both sources suppressed the proliferation of allogeneic T-
cells to the same extent as matched undifferentiated MSC (Montespan et al., 2014; 
Niemeyer et al., 2007). BMMSC and ADMSC-derived osteoblasts also retained 
expression of HLA-G (a potent immunosuppressive molecule involved in suppression 
of T-cell proliferation) (Montespan et al., 2014). Furthermore, MSC from both sources 
continued to lack expression of major histocompatibility complex class II molecules 
after osteogenic differentiation (Niemeyer et al., 2007). Therefore, as well as retaining 
their immunosuppressive potential, MSC also maintained their immune privileged 
status after osteogenic differentiation.  
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In addition, chondrogenic differentiation of human BMMSC did not alter their capacity 
to suppress proliferation of collage type II induced T-cells from peripheral blood and 
synovial fluid of RA patients (Lohan et al., 2014). BMMSC and derived chondrocytes 
also suppressed activation of T-cells (as measured by CD69 and CD25 surface 
expression) and reduced secretion of pro-inflammatory cytokines including TNFα and 
IFNγ while simultaneously inducing expression of the anti-inflammatory cytokines, IL-
4 and IL-10 in vitro (Lohan et al., 2014). These data suggest that osteogenic and 
chondrogenic differentiation of MSC in vivo in response to tissue damage may not alter 
their endogenous immunosuppressive potential. In contrast, a recent study showed 
that murine MSC-derived chondrocytes lost their ability to suppress mitogen induced 
T-cell proliferation in vitro and loss of suppression was associated with a decrease in 
nitric oxide and PGE2 levels (Ryan et al., 2014). Conflicting findings may reflect 
differences in the assays used and MSC isolated.  
 
Importantly, only the effects on T-cell proliferation have been analysed in the studies 
to date. It may be the case that while this effect is unaltered by differentiation, other 
effects on immune responses such as leukocyte recruitment are influenced by 
differentiation. In addition, the effect of adipogenic differentiation of MSC has not been 
explored and is of particular interest in this thesis. 
 
1.11. Role of ectopic fat in chronic inflammation 
Ectopic fat refers to lipid accumulated in non-adipose tissue, such as the pancreas, 
skeletal muscle and the liver (Liu et al., 2014). Ectopic fat deposits are associated with 
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a number of disorders including Duchenne muscular dystrophy (Uezumi et al., 2010), 
myocardial infarction (Goldfarb and Roth, 2009) and RA (Arend et al., 2013; Clements 
et al., 2009; Schweitzer et al., 1993). Accumulation of ectopic fat has also been 
implicated in metabolic disorders, namely atherosclerosis, dyslipidaemia and diabetes 
mellitus type II (Goodpaster and Wolf, 2004; Liu et al., 2014). Interestingly, patients 
with fatty liver and pancreas exhibited elevated levels of inflammatory cytokines, 
suggesting a link between ectopic fat and chronic inflammation (Haukeland et al., 
2006; Smits and van Geenen, 2011).  
 
1.11.1. Role of inflammatory cytokines in ectopic fat deposition 
The main function of adipose tissue-derived mature adipocytes is to accumulate 
triglycerides as an energy store [reviewed by (Goossens, 2008)]. Initially, ectopic fat 
formation was thought to be due to ineffective lipid storage by adipose tissue. Indeed, 
obese patients had enlarged, dysfunctional adipocytes that were unable to support 
storage of excess lipid. This increased the uptake of lipid by other non-adipose tissues 
and increased ectopic fat deposition at these sites (Goossens, 2008).  However, this 
concept was challenged by observations that non-obese patients with metabolic 
disorders also showed ectopic fat deposition (Liu et al., 2014; Lim and Meigs, 2014). 
Lipodystrophy is a disorder characterised by abnormal production and distribution of 
fat within the body (Garg and Agarwal, 2009). Mutations in genes involved in fat 
storage and differentiation of pre-adipocytes (such as peroxisome proliferator activated 
receptorγ, PPARγ) and lipid synthesis (1-acylglycerol-3-phosphate-O-acyltransferase 
2 and Berardinelli-Seip congenital lipodystrophy) in adipocytes contribute to 
lipodystrophy (Garg and Agarwal, 2009). Impaired capacity to store lipid, increases the 
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levels of circulating lipids and promotes uptake by non-adipose tissues. Lipodystrophy 
was associated with elevated levels of TNFα within the adipose tissue (Sevastianova 
et al., 2008).  Thus, ectopic fat deposition is caused by an impairment of adipocytes to 
effectively uptake and store lipid.  
 
Treatment of 3T3-L1 pre-adipocytes (cell line) with the inflammatory cytokines IL-6 and 
TNFα and the acute phase protein, serum amyloid A during adipogenic differentiation 
in vitro inhibited their capacity to differentiate into mature adipocytes (Gustafson and 
Smith, 2006; Filippin-Monteiro et al., 2012). This was caused by a reduction in the 
expression of adipogenic transcription factors, PPARγ and CCAAT enhancer binding 
protein (C/EBPα), in pre-adipocytes (Gustafson and Smith, 2006; Filippin-Monteiro et 
al., 2012). In addition, inflammation has previously been shown to stimulate lysis of 
adipocytes to increase levels of circulating free fatty acids which can then promote lipid 
accumulation in ectopic sites (Salles et al., 2012). Indeed, knockout of TNFα in mice 
on a high fat diet significantly increased the mass of fat pads compared to wild-type 
mice. Importantly, knockout mice showed reduced accumulation of triglycerides in 
ectopic sites (liver and skeletal muscle) and lower levels of circulating adipokines 
(Salles et al., 2012). These results suggest that pro-inflammatory cytokines impair lipid 
uptake and storage by adipose tissue, thus increasing storage at ectopic sites.  
 
1.11.2. Potential contribution of MSC to ectopic fat formation 
The development of ectopic fat could also be the result of inappropriate adipogenic 
differentiation of tissue-resident MSC in affected tissues. In a murine model of 
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Duchenne muscular dystrophy (induced by double knockout of dystrophin and 
utrophin), non-myogenic MSC (nmMSC) isolated from skeletal muscle exhibited 
enhanced adipogenic and osteogenic differentiation potential in vitro compared to wild-
type nmMSC (Sohn et al., 2013, 2015). In vivo, culture expanded nmMSC were found 
to differentiate into fatty acid-binding protein positive (FABP4+) adipocytes 2 weeks 
after transplantation into the skeletal muscle of dystrophin and utrophin knockout mice 
(Sohn et al., 2013). Therefore, ectopic fat observed in this model may be attributed to 
abnormal differentiation of tissue-resident nmMSC (Sohn et al., 2013, 2015).  
 
In a murine model of muscle degeneration (induced by glycerol injection), 
destabilisation of the muscle fibres was associated with an increase in the number of 
adipocytes. After 2 weeks there was a significant increase in fat deposits and fibrotic 
tissue in the injured muscle (Uezumi et al., 2010). Platelet-derived growth factor 
receptor α (PDGFRα) expressing mesenchymal progenitor cells isolated from murine 
skeletal muscle interstitium were the only cell type within the muscle capable of 
undergoing adipogenic differentiation in vitro and in vivo (Uezumi et al., 2010). Ectopic 
fat formation in this model was suggested to be due to adipogenic differentiation of 
PDGFRα+ progenitor cells. However, as MSC are not the only cell type that expresses 
PDGFRα, it is also possible that other PDGFRα expressing cells may contribute to 
ectopic fat deposition in the glycerol-induced muscle degeneration model. 
 
In a different model of muscle injury (induced by infusion of cardiotoxin) ectopic fat 
deposition was not observed indicating that fat accumulation was stimulus-specific 
(Uezumi et al., 2010). Interestingly, transplantation of PDGFRα+ cells from the glycerol-
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induced model referred to above, into mice with cardiotoxin-induced injury did not 
undergo adipogenic differentiation. In contrast, PDGFRα+ cells from cardiotoxin-
induced injury injected into muscle with glycerol-induced injury differentiated into 
PPARγ and C/EBPα expressing adipocytes (Uezumi et al., 2010). This suggests that 
adipogenic differentiation of PDGFRα+ cells in vivo is dependent upon the tissue 
microenvironment. Co-culture of PDGFRα+ cells with myofibres inhibited their 
adipogenic differentiation in vitro. Therefore, the loss of myofibres during muscle 
degeneration might promote ectopic adipocyte accumulation in the skeletal muscle 
(Uezumi et al., 2010).  
 
Collectively, the foregoing suggests that under certain (potentially inflammatory, e.g. 
RA) conditions, ectopic fat deposition may arise from MSC causing them to change 
their phenotype, losing their ability to suppress the inflammatory response and perhaps 
taking on a stimulatory state and perpetuating inflammation. This might occur during 
'classic' differentiation e.g., into adipocytes, or conversion into a non-specific state in 
chronically insulted tissue. The effect of adipocyte differentiation on the capacity of 
MSC to regulate immune processes such as leukocyte recruitment has not been 
examined and is a topic of this thesis. 
 
1.11.3. MSC in ectopic bone deposition 
As well as ectopic fat, aberrant bone formation or calcification has also been described 
in fibrodysplasia ossificans progressiva (Culbert et al., 2014), the vasculature of 
chronic kidney disease (Mizobuchi et al., 2009), and the adipose tissue after intra-
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abdominal surgery (Zamolyi et al., 2006). Ectopic bone deposition may also be due to 
abnormal differentiation of MSC, as direct injection of murine BMMSC into the infarcted 
heart of mice induced formation of encapsulated structures. These structures 
contained calcifications and ossifications within scar tissue at the infarct site (Breitbach 
et al., 2007). 
 
1.12. Hypothesis and aims 
MSC and other tissue-resident stromal cell populations are able to engage in crosstalk 
with vascular EC and regulate the recruitment of circulating neutrophils and 
lymphocytes in response to pro-inflammatory cytokines (Kuravi et al., 2014; Luu et al., 
2013; Lally et al., 2005; McGettrick et al., 2009). In particular, BMMSC are able to 
suppress TNFα and IL-1β-mediated leukocyte recruitment. Recently it has been shown 
that MSC from different anatomical sites have varying capacity to regulate other 
immune responses (Li et al., 2014b). Therefore, MSC from different tissues may exhibit 
different effects on leukocyte recruitment. Furthermore, recently it has been suggested 
that MSC may contribute to ectopic fat development, a key event in the progression of 
dyslipidaemia and other metabolic disorders (Uezumi et al., 2010; Sohn et al., 2015; 
Breitbach et al., 2007) also associated with sites of chronic inflammation. Therefore, 
we hypothesise that (i) MSC can modify the endothelial response to cytokines and thus 
act as endogenous tissue-resident regulators of leukocyte recruitment; (ii) that this 
ability may differ between MSC from different tissue sources; (iii) tissue-specific 
differences in MSC behaviour may have an impact on their therapeutic potential and 
(iv) that adipogenic differentiation may play a role in the loss of control of leukocyte 
recruitment observed in chronic inflammation.  
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To test these hypotheses, the aims of this project were: 
1. To develop methods to isolate MSC from different tissues, characterise their 
behaviour in culture and assess whether they fulfil the MSC criteria.  
2. To compare the ability of MSC from different tissues to regulate the recruitment 
of neutrophils by inflamed EC; including the effects of passage, requirement 
for close proximity between MSC and EC and the release of soluble mediators.  
3. To assess the effect of adipogenic differentiation on the ability of MSC to 
regulate leukocyte recruitment. 
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2. Materials and Methods  
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2.1. Isolation and culture of human umbilical vein endothelial cells 
Human umbilical cords were collected from the Human Biomaterials Resource Centre 
(HBRC; University of Birmingham) from full term births after caesarean section, with 
informed consent. Human umbilical vein endothelial cells (HUVEC) were isolated as 
previously described (Cooke et al., 1993; Munir et al., 2015). Briefly, the umbilical vein 
was cannulated at each end and rinsed with Dulbecco’s Phosphate Buffered Saline 
(PBS; Sigma-Aldrich, Poole, UK). The vein was then filled with 1mg/ml collagenase 
type Ia from Clostridium histolyticum and incubated at 37oC for 20min. The umbilical 
cord was subsequently massaged to ensure detachment of HUVEC. The vein was 
flushed out with PBS, the cell suspension was collected and centrifuged at 400g for 
5min. Cells were resuspended in complete culture medium consisting of M199 basal 
medium (Gibco, Paisley, UK) supplemented with 20% foetal calf serum (FCS), 35μg/ml 
Gentamicin, 10ng/ml epidermal growth factor, 1μg/ml hydrocortisone (all from Sigma) 
and 2.5μg/ml Amphotericin B (Life Technologies, Paisley, UK) and seeded into T25 
flasks (SLS, Nottingham, UK). HUVEC were used at passage 1 (p1) for all assays. 
Commercial primary blood microvascular EC (BEC; PromoCell, Heidelberg, Germany) 
were obtained at p0 and expanded by three passages in culture. BEC were cultured in 
medium supplied by PromoCell (EC Growth Medium MV, PromoCell) and seeded onto 
T25 tissue culture flasks (SLS) until they reached 100% confluence at which point the 
cells were passaged at a ratio of 1:3 as described in Section 2.4. BEC were used at 
p4 for all assays. 
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2.2. Isolation and culture of human MSC 
2.2.1. Culture of BMMSC 
Commercial primary human BMMSC (Lonza Ltd, Basel, Switzerland) were obtained at 
p2 and expanded by three passages in culture. BMMSC were cultured in MSC growth 
medium supplied by Lonza (MSCGMTM BulletKit, Lonza Ltd) on T75 tissue culture 
flasks (SLS) until they reached 70-80% confluence at which point the cells were 
passaged at a ratio of 1:3 as described in Section 2.4. BMMSC were used at p5 for all 
adhesion assays unless otherwise stated.  
 
2.2.2. Isolation and culture of WJMSC 
WJMSC were isolated from umbilical cords (in accordance with ethics stipulated by the 
HBRC) as previously described (Munir et al., 2015), by resecting the blood vessels and 
cutting the remaining tissue into 2-3mm3 fragments. Two methods were used to isolate 
MSC. The fragments were placed in a T25 tissue culture flask for two weeks, after 
which they were removed and outgrowth cells were cultured. Alternatively, the 
fragments were suspended in an enzymatic cocktail of 1mg/ml Collagenase type II 
from Clostridium histolyticum and 1mg/ml Hyaluronidase in PBS (all from Sigma) and 
incubated at 37oC on a rotator for 3h or 5h. The viscous cell suspension obtained after 
digestion was diluted 1:5 in PBS and passed through a 70μm filter (BD Falcon, Oxford, 
UK). The suspension was centrifuged at 400g for 5min and the pellet was resuspended 
in complete culture medium composed of low glucose (LG) DMEM with stable L-
glutamine or Ham’s F12 DMEM (all from Biosera, ZI du Bousquet, France) 
supplemented with 10% FCS, 100U/ml penicillin and 100μg/ml streptomycin (all from 
Sigma) or MSCGM.  
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2.2.3. Isolation and culture of TBMSC 
Trabecular bone explants were taken from osteoarthritis patients after joint 
replacement and kindly provided by Dr Andrew Filer, Dr Mark Pearson and Dr A 
Thomas from the Royal Orthopaedic Hospital (Birmingham). The bone fragments were 
dissected into smaller fragments and placed in T25 flasks with complete LG DMEM 
growth media and incubated at 37oC in 5% CO2. Once the TBMSC migrated away from 
the explants and adhered to the flask, the tissue fragments were removed. 
Alternatively, the explants were suspended in an enzymatic cocktail of 1mg/ml 
collagenase type II from Clostridium histolyticum for 3h at 37oC and then centrifuged 
at 400g for 5min. The cells were resuspended in complete LG DMEM media and 
seeded onto a tissue culture flask. Enzymatic digestion did not yield sufficient numbers 
of cells for culture, therefore explant culture was used to isolate TBMSC for all work 
described.  
 
Both WJMSC and TBMSC were allowed to reach 70-80% confluence and were then 
passaged at a ratio of 1:3 (described in Section 2.4.). The cells were expanded and 
characterised based on surface marker expression and differentiation potential at p3. 
The cells were also used at p3 for all subsequent adhesion assays. 
 
2.2.4. Differentiation of human MSC 
Adipogenic and osteogenic differentiation was induced by culturing MSC in Adipogenic 
Induction or Osteogenic Differentiation Medium (Lonza) according to the 
manufacturer’s instructions for 21 or 14 days respectively.  
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2.3. Isolation and culture of human pre-adipocytes and mature adipocytes 
Human subcutaneous adipose tissue was collected from the HBRC with informed 
consent from healthy patients that had undergone open abdominal surgery. The tissue 
was cut into small fragments and suspended in DMEM/F-12 medium (Biosera) 
supplemented with 25mM HEPES and 2mg/ml collagenase type II (all from Sigma) at 
37oC for 1h on a rotator. The digest was passed through a 70µm pore filter and then 
centrifuged at 400g for 5min. Floating mature adipocytes were harvested, resuspended 
in DMEM/F-12 medium and placed in culture for 24h. Due to their short life in culture 
(McNelis et al., 2013), mature adipocytes were used 48h after cell isolation for 
subsequent assays. Pelleted pre-adipocytes were resuspended in DMEM/F-12 media 
supplemented with 10% FCS, 100U/ml penicillin and 100μg/ml streptomycin (all from 
Sigma) and transferred to a T75 culture flask as previously described (McNelis et al., 
2013). Pre-adipocytes were used at p1 for all functional assays.  
 
2.3.1. Adipogenic differentiation of human pre-adipocytes 
Pre-adipocytes were differentiated into mature adipocytes at p1 for some functional 
assays. The cells were detached from culture flasks (described in Section 2.4.) and 
seeded onto the outer surface of 0.4µm 6-well Transwell filters (BD Pharmingen, 
Cowley, UK) at a density of 5x105 cells/filter in complete DMEM/F-12 medium. After 
24h, the medium was replaced with adipogenic differentiation media composed of 
DMEM/F-12, 166nM recombinant insulin, 0.2nM triiodothyronine (T3), 50µg/ml 3-
isobutyl-1-methylxanthine (IBMX), 33µM Biotin, 17µM pantothenic acid, 2µM 
Rosiglitazone (PPAR agonist), 0.01mg/ml transferrin and 100nM cortisol (all from 
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Sigma) for 5 days as previously described (McNelis et al., 2013). The medium was 
then replaced with differentiation media without IBMX and Rosiglitazone for a further 
16-23 days after which functional assays were performed.  
 
2.4. Detachment of cells from tissue culture flasks  
Human EC, MSC and adipocytes were detached by aspirating cell culture medium 
from flasks and adding sufficient 0.02% Ethylenediaminetetraacetic acid (EDTA; 
Sigma) to coat the flask. EDTA was aspirated after 2min and a sufficient volume of 
2.5mg/ml trypsin (Sigma) was added to coat the growth surface of the flask and the 
cells were incubated at 37°C until the cells began to detach from the surface. The flask 
was tapped to completely dislodge the cells and the trypsin was inactivated by adding 
8ml complete culture medium (dependent on the cell type). The cell suspension was 
centrifuged at 400g for 5min and either added to culture flasks for further expansion or 
seeded for adhesion assays. For seeding in adhesion assays, after trypsinisation cells 
were resuspended in 1ml culture media and 20µl of suspension was transferred to a 
cellometer counting slide and counted using a cellometer Auto T4 cell counter 
(Nexcelom; Salisbury Green, UK). Cells were subsequently diluted to the desired 
concentration in cell culture medium and seeded. 
 
2.4.1. Freezing and thawing MSC 
All MSC (p5 BMMSC, p3 WJMSC and TBMSC) were detached from T75 culture flasks 
after reaching 70-80% confluence as described above. After centrifugation, the 
supernatant was aspirated and the pellet was resuspended in 3ml ice-cold serum free 
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Cryo-SFM (PromoCell). 1ml aliquots of cell suspension were transferred to 1.5ml 
cryovials (Greiner Bio-One, Stonehouse, UK) and placed into freezing containers 
which were stored at -80°C overnight. Cryovials were then transferred to a liquid 
nitrogen Dewar for long term storage. Each aliquot contained enough cells to seed a 
T25.  
 
Prior to thawing MSC, the appropriate cell culture medium was heated to 37°C. Cells 
were rapidly thawed by gently warming the cryovial between hands and then 
resuspending in 8ml warm culture medium. Cells were centrifuged at 400g for 5min 
and supernatant was aspirated. The pellet was resuspended in 5ml appropriate MSC 
culture medium and seeded onto a T25 flask.  
 
2.5. Isolation of neutrophils and peripheral blood lymphocytes 
Venous blood was obtained from healthy donors and placed in tubes containing EDTA 
(anti-coagulant; Sarstedt, Nümbrecht, Germany) after informed consent. The blood 
was separated on a gradient of 2.5ml Histopaque 1077 layered over 2.5ml Histopaque 
1119 (Sigma). Blood was layered onto the gradient and centrifuged at 1120g for 40min. 
Neutrophils were harvested at the interface between Histopaque 1077 and 1119 above 
the erythrocyte layer and washed twice in a solution of 0.15% bovine serum albumin 
in PBS containing 1mM calcium chloride and 0.5mM magnesium chloride (PBSA; 
Sigma) by centrifuging at 400g for 5min. Neutrophils were counted using either a 
cellometer Auto T4 cell counter or a Z™ Series Coulter counter (Beckman Coulter, 
High Wycombe, UK) and resuspended in PBSA at the desired concentration.  
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To isolate PBL, the whole blood layered onto a Histopaque gradient was centrifuged 
at 1120g for 30min. The peripheral blood mononuclear cell (PBMC) layer was 
harvested (from above the 1077 layer) and washed twice in PBSA by centrifuging at 
400g for 5min. The PBMC were resuspended in 10ml PBSA and placed in a T25 flask 
and incubated at 37oC in 5% CO2 for 30min to plate out monocytes and platelets. Non-
adherent PBL were collected and centrifuged at 400g for 5min.  The cells were 
resuspended in PBSA, counted (as described above) and the concentration was 
adjusted to 2x106 cells/ml. 
 
2.6. Proliferation kinetics of MSC in different culture media 
WJMSC were detached from the flask using trypsin/EDTA, counted using a 
haemocytometer and then seeded at 1,300 cells/cm2 in T75 flasks and cultured in 
MSCGM, LG DMEM or Ham’s F12 DMEM complete culture media for 5 days.  Parallel 
BMMSC cultures were set up in MSCGM medium as a control. Images were taken of 
the flask using an inverted phase contrast microscope (Olympus, South-End on Sea, 
UK) from 5 random fields after 5 days. The cell number in each field was counted and 
averaged. The number of population doublings (PD) and the doubling time (PDT) were 
calculated as previously described (Christodoulou et al., 2013) using the equations: 
PD = (1/log102)×log10(Nt/No) and PDT = 𝑡 × [log102 (log10 Nt − log10 No)], where No 
is the number of cells counted at time zero; Nt is the number of cells at each time point; 
and t is the number of hours between each time point.  
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2.7. Flow cytometry 
2.7.1. Characterisation of MSC phenotype 
Cultured BMMSC, WJMSC and TBMSC were characterised based on the expression 
of the surface markers CD44, CD73, CD90, CD105, CD146, CD271, CD14, CD34 and 
CD45. Cells were detached from the flask using 0.02% EDTA and Accutase (Life 
Technologies, Paisley, UK) and centrifuged at 400g for 5min. MSC were washed in 
PBSA solution and transferred to polypropylene tubes (BD Bioscience, Oxford, UK). 
Cells were incubated with antibodies against CD44-APC, CD73-FITC, CD90-BV421, 
CD105-PerCP-Cy5.5, CD271-AF647 (all from BD Bioscience), CD146-AF647 
(Biolegends; London, UK) and CD14-PE (Immunotools, Friesoythe, Germany) CD34- 
CD45-PE (BD Bioscience) diluted at 1:50 for 20min at 2-4oC. Control cells were stained 
with fluorophore- and isotype-matched control antibodies. MSC were washed twice in 
PBSA by centrifuging at 400g for 5min. Pellets were resuspended in 200µl PBSA and 
analysed on a Cyan ADP flow cytometer (Beckman Coulter Inc., Pasadena, USA) and 
at least 5,000 live events were acquired per sample. Summit 4.3 software was used to 
analyse the data offline (Beckman Coulter). Data was expressed as the percentage 
positive cells expressing each marker above the level of the isotype control.  
 
2.7.2. Detection of intracellular IL-6 and TGFβ signalling by flow cytometry 
EC and BMMSC mono-cultures or co-cultures were detached from surfaces using 
EDTA and Accutase (Gibco; as described in Section 2.4. with Accutase replacing 
Trypsin) at different time points after seeding the EC (15min, 30min, 1h, 4h, 6h and 
24h). Cells were centrifuged at 400g for 5min and resuspended in 100µl PBSA. 
According to the manufacturer’s instructions, Fix buffer I (BD Bioscience) was pre-
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heated to 37oC and added to the cell suspension at a 1:1 volume. Cells were incubated 
at 37oC for 10min and then centrifuged at 400g for 5min. The cells were then washed 
twice in PBSA and the supernatant was aspirated. The pellets were vortexed and the 
cells were permeabilised by slowly adding ice cold perm buffer III (BD Bioscience). EC 
and BMMSC were incubated on ice for 30min and then centrifuged at 400g for 5min. 
Cells were washed twice in PBSA and resuspended in 300µl PBSA. 5µl anti-Smad2/3 
or 20µl anti-STAT3 antibody (BD Bioscience) were added to the cells and incubated at 
room temperature for 30min. Control cells were stained with fluorophore- and isotype-
matched control antibodies. The anti-Smad2/3 antibody was validated by treating 
PBMC and EC with 10ng/ml recombinant TGFβ for 30min and staining for Smad2/3. 
To validate the anti-STAT3 antibody, polymorphonuclear leukocytes (PMN) and 
BMMSC were treated with 100ng/ml IL-6 for 15min and stained for STAT3. 
 
2.8. Assessment of multilineage differentiation of MSC 
After inducing differentiation down the osteogenic or adipogenic lineages for 14 or 21 
days respectively, the cells (cultured in 6-well plates) were fixed in 10% neutral 
buffered formalin (composed of 100ml 40% formaldehyde, 4g sodium phosphate 
monobasic monohydrate, 6.5g sodium phosphate dibasic anhydrous [all from Sigma] 
and made up to 1L with distilled water) for 30min at room temperature and washed in 
distilled water. For staining lipid droplets in MSC-derived adipocytes, the cells were 
treated with 60% isopropanol and stained with 0.3% Oil Red O (Sigma) dissolved in 
isopropanol for 30min. The cells were washed and counterstained with heamotoxylin 
solution (Sigma). For staining calcium deposits in MSC-derived osteoblasts, fixed cells 
were stained with Alizarin Red dye (Sigma) dissolved in distilled water for 45 minutes. 
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Cells were then washed. Images of differentiated MSC were taken using an EVOS FL 
Imaging System (Thermo Scientific, Loughborough, UK). 
 
2.9. Flow-based adhesion assays 
2.9.1. Co-culture of HUVEC and MSC in channel slides 
HUVEC were detached from culture flasks using trypsin/EDTA and seeded into pre-
coated microchannel slides (VI0.4, Ibidi GmbH, Martinsried, Germany) at a density that 
would generate a confluent monolayer as previously described (Luu et al., 2013). After 
24h adherent BMMSC, WJMSC and TBMSC were dissociated using trypsin/EDTA and 
labelled with 5μM Cell Tracker Green (Life Technologies) for 30min in serum free 
MSCGM at 37oC. MSC were centrifuged at 400g for 5min and then resuspended in 
MSCGM with 10% FCS for a further 30min at 37oC and then counted using the 
Cellometer and adjusted to 1.5x105 cell/ml. 30µl of suspension was added to chosen 
channels (enough to fill the growth area of the channel) and incubated for 1h at 37oC 
in 5% CO2 to allow the cells to adhere (Luu et al., 2013; Munir et al., 2015). Non-
adherent MSC were washed off with MSCGM and the microchannel slide was cultured 
for 24h. EC alone or co-cultures were treated with 100, 10 or 1U/ml TNFα (R&D 
Systems, Abingdon, UK) for 4h. Phase contrast and fluorescent images were taken of 
5 random fields at 10X magnification. The number of EC per field were counted in the 
phase contrast images and the number of adherent MSC were counted in the 
corresponding fluorescent images. The ratio of MSC:EC was then calculated. 
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2.9.2. Establishing HUVEC and MSC co-cultures on Transwell filter 
MSC and EC were co-cultured on opposite side of a porous Transwell filter as 
previously described (Luu et al., 2013; McGettrick et al., 2009). In short, BMMSC, 
WJMSC and TBMSC or MSC-derived adipocytes were detached from culture flasks 
using trypsin/EDTA, counted and resuspended in MSCGM. MSC were seeded on the 
outer surface of a 6-well 0.4µm Transwell filter at a density of 5x105 cells/filter (BD 
Pharmingen) and incubated at 37°C and 5% CO2 for 1h. The filters were subsequently 
inverted and transferred to a 6-well tissue culture plate (VWR) and cultured in the 5ml  
MSCGM for a further 24 hours (McGettrick et al., 2009). EC were detached and seeded 
onto the inner surface of the filter at a density that would yield a confluent monolayer 
within 24h (McGettrick et al., 2010b). Parallel EC mono-cultures were also established. 
All filters were cultured in MSCGM for 24h prior to running the flow-adhesion assay. 
Culture supernatants were harvested and centrifuged at 800g for 10min to remove cell 
debris. The supernatant was taken and stored at -80°C. The cells were stimulated with 
100U/ml TNFα for 4h (to assess neutrophil recruitment) or 100U/ml TNFα and 10ng/ml 
Interferonγ (IFNγ; Peprotech Inc., London, UK) for 24h (to assess PBL recruitment) in 
fresh culture medium.  
 
Alternatively, co-cultures were established by seeding MSC onto the bottom of a 6-well 
plate for 24h and seeding EC on a filter which was placed in the well. Parallel 
endothelial mono-cultures and direct co-cultures were set up as controls. To 
investigate the bioactivity of culture conditioned media, fresh EC mono-cultures were 
seeded onto filters and after 1h were treated with conditioned media from 24h MSC or 
MSC-derived adipocyte mono-cultures or co-cultures for 24h. EC were then stimulated 
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with 100U/ml TNFα in the same media for a further 4h before performing the adhesion 
assay.  
 
In some experiments, a neutralising antibody against either IL-6 (5µg/ml; clone 6708), 
transforming growth factorβ1 (10µg/ml; clone 9016) or a function blocking antibody 
against the IL-6R (5µg/ml; clone 17506; all from R&D Systems) was added when MSC 
or MSC-derived adipocyte co-cultures were established and was present for the 
duration of the co-culture and cytokine-stimulation.  
 
2.9.3. The recruitment of leukocytes to EC from flow  
In the channel slide model, female Luer connectors were placed in the inlet and outlet 
holes of the microchannel slide creating a flow chamber (Figure 2-1A). In the filter 
model, EC mono-culture or co-culture filters were placed on a glass coverslip and cut 
out using a scalpel. The filter was then covered by a parafilm gasket that had a 
20x4mm slot cut out over the filter region (Figure 2-1B).  
 
The coverslip was positioned inside a custom made Perspex chamber consisting of 
two parallel plates. The top plate had an inlet and outlet hole cut out over the filter 
region (not covered by the plastic gasket) which created the flow channel over the EC 
monolayer (Figure 2-1B). Microchannel slides or filter chambers were connected to a 
perfusion system and placed on the stage of an inverted phase contrast/fluorescent 
video microscope in a Perspex chamber at 37oC.  
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A. Microchannel slide model 
 
 
 
 
B. Filter model 
 
 
 
Figure 2-1: Schematic of the microchannel slide and filter flow chambers. (A) 
Schematic representation of the microchannel slide flow chamber indicating the growth 
area of the channel where the EC were seeded. The luer connecters that generated 
the inlet and the outlet port of the slide are shown. The dimensions of the channels 
were 0.44mm height, 17mm length and 3.8mm width. The growth area of the channel 
is 0.6 cm2. (B) Schematic representation of the filter flow chamber where EC and MSC 
were co-cultured on opposite sides of a Transwell filter. Image B was adapted from 
(McGettrick et al., 2010a). 
  
 
Inlet 
Outlet 
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The perfusion system was composed of a “wash reservoir” containing PBSA and a 
“sample reservoir” containing leukocytes connected to a valve. An inlet tube coming 
from the microvalve was connected to the flow chamber enabling perfusion of PBSA 
or leukocytes over the EC (Figure 2-2). An outlet tube was connected to the flow 
chamber leading to a syringe pump which controlled the perfusion rate. 
 
In the channel slide and filter models, neutrophils or PBL were diluted to a 
concentration 1x106 or 2x106 cells/ml respectively and perfused over the EC for 4min 
at a wall shear stress of either 0.05Pa (microchannel slides) or 0.1Pa (filters) as 
previously described (Luu et al., 2013; Munir et al., 2015; McGettrick et al., 2009).  This 
was followed by a 2min washout in cell free PBSA. 10 sec video recordings were made 
of 5 random fields along the centre of the flow chamber after 2min. PBSA was then 
flowed through the chamber for a further 5min and then 5 random fields were taken 
again after 9min post-perfusion. 
 
2.9.4. Analysis of leukocyte adhesion and behaviour 
Leukocyte behaviour was assessed using image analysis software (ImagePro 6.0, 
Data cell Ltd., Finchampstead, UK). At 2min and 9min post-perfusion, the number of 
adherent leukocytes/field were counted and classed as either rolling (phase-bright, 
sphere-shaped cell rolling along the endothelium much slower than free-flowing cells), 
stationary (typically exhibiting altered morphology and slowly migrating on the surface) 
or transmigrated (phase dark, spread cells that have migrated under the endothelium). 
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Figure 2-2: Schematic of the perfusion system. The microchannel slide or filter 
chamber was mounted onto the microscope stage and an inlet and outlet port was 
connected to either end of the channel. PBSA was flowed over the EC from the wash 
reservoir, connected to the electronic valve. The valve was turned on and a bolus of 
leukocytes were perfused over the EC for 4min. Then the valve was turned off and 
wash buffer was perfused for the remainder of the assay. The syringe pump was 
connected to the outlet of the flow chamber, regulating the flow rate of the perfused 
wash buffer or leukocyte suspension. Images were taken of 5 random fields using a 
phase contrast microscope. The image was adapted from (McGettrick et al., 2010a).  
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The number of adherent leukocytes after 2min post-perfusion was averaged per field 
and converted to number/mm2/106 perfused based on the microscope field dimensions 
and the volume flow rate. Neutrophil behaviour was analysed at 9min post-perfusion 
and expressed as the percentage of adherent cells that were rolling, stationary or 
migrated.  
 
2.10. Leukocyte recruitment by 3D collagen gels incorporating EC and MSC 
BMMSC, WJMSC or BMMSC-derived adipocytes or osteoblasts were detached using 
trypsin/EDTA as described in Section 2.4. The cells were counted using a Cellometer 
and resuspended in an appropriate volume of ice cold FCS for seeding 25x103 cells/gel 
in 80µl. Collagen gels were generated by adding 3.32ml rat tail collagen (2.15mg/ml; 
First Link Ltd, West Midlands, UK) to a 10ml round bottomed tube (Appleton Woods 
Birmingham, UK).  Subsequently, 680µl 10x concentrated M199 media (Sigma) was 
added to the tube and mixed by inversion. The pH of the gel was neutralised by slowly 
adding 1N NaOH (Sigma) until the colour changed from orange to pale pink as 
previously described (Jeffery et al., 2013). All reagents and tubes were kept ice cold 
to delay the gels from setting.  
 
To 8 wells of a 12-well plate 420µl collagen gel mixture was added. 80µl FCS (for EC 
mono-culture gels) or 80µl MSC or adipocyte or osteoblast cell suspension (for co-
culture gels) was immediately added to each gel and mixed thoroughly to ensure even 
distribution of cells. The plate was incubated at 37°C and 5% CO2 for 5-10min to allow 
the gels to set. 1ml MSCGM was added to gels and incubated at 37°C and 5% CO2 for 
24h. EC were detached from culture flasks using trypsin/EDTA and seeded on the gel 
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surface at a density that would yield a confluent monolayer within 24h. After 24h, gels 
were stimulated with TNFα for 4h to allow assessment of neutrophil migration (Figure 
2-3).   
 
Purified neutrophils were isolated as described in Section 2.5., counted and 
resuspended in PBSA at 5x105 cells/ml (Figure 2-3). The gels were washed twice in 
PBSA and 1ml neutrophil suspension was added to each gel and incubated at 37°C 
and 5% CO2 for 20min. Gels were washed three times in PBSA to remove non-
adherent neutrophils. The plate was placed on the stage of an inverted phase contrast 
video microscope with a computer operated motorised focus in a Perspex chamber at 
37oC. Digital z-stack images were taken at 2µm intervals through the thickness of the 
gel in 4 random fields using a digital camera controlled by ImagePro software. The gels 
were then placed back in the incubator for 2h. Then the gels were washed again, and 
Z-stack images were taken. In co-culture gels, z-stack images were also taken at 3µm 
intervals in 4 random fields to determine the location and number of MSC or adipocytes 
within the gel. The total number of neutrophils adherent on the EC surface and 
throughout the gel were counted on saved images using ImagePro software offline. 
Adherent neutrophils at the EC surface were labelled either surface adherent (phase 
bright) or transmigrated (phase dark; migrated just under the EC monolayer) (Figure 
2-3 and 2-4). Using z-stack images at 20min and 2h, the numbers of neutrophils that 
penetrated the gel in each 50µm interval were also recorded (Figure 2-3 and 2-4). The 
neutrophil count was averaged over the 4 fields and converted to the total number/gel 
based on the known microscope field dimensions and the size of the well. The count 
was once again adjusted based on the field and well dimensions to determine the total 
MSC or adipocyte or osteoblast number/gel.  
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Figure 2-3: Schematic of the 3D collagen gel model incorporating MSC and EC. 
A collagen gel based assay was setup to create a 3D stromal microenvironment in 
order to assess the effects of MSC and MSC-derived adipocytes and osteoblasts on 
neutrophil migration through EC and stroma. MSC or MSC-derived adipocytes and 
osteoblasts were seeded into a collagen gel matrix. After 24h, EC were seeded onto 
the gel surface. After a further 24h, gels were stimulated with TNFα for 4h. Neutrophils 
(5x105) were added to the gels and incubated at 37oC and 5% CO2 for 20min. Non-
adherent neutrophils were then washed off and neutrophil migration was assessed by 
taking z-stack imaging through the gel matrix. Cells were classified as surface adherent 
(phase bright on the EC surface), transmigrated (phase dark under the EC monolayer) 
or penetrated into the gel.     
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Figure 2-4: Morphology of neutrophils and EC on the surface and within the 3D 
collagen gel matrix. Representative images of HUVEC and neutrophils (surface 
adherent, transmigrated and gel penetrated) on collagen gel matrix after stimulation 
with TNFα for 4h. Images are representative of n=6 independent experiments. 
Images were taken at 20X magnification.   
Surface adherent neutrophils 
(phase bright) 
EC 
EC 
Transmigrated neutrophil 
(phase dark) 
Neutrophils that have 
penetrated the gel 
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Total adhesion was expressed as a percentage of the total number of neutrophils 
added to each gel. Surface adherent, transmigrating and gel penetrated neutrophils 
were calculated as a percentage of the total adherent. The average depth of neutrophil 
penetration was calculated by multiplying the midpoint depth of each 50µm interval by 
the average number of neutrophils found each interval, adding the numbers for each 
interval, and then dividing this value by the total number of neutrophils that penetrated 
into the gel. as previously described (Jeffery et al., 2013).  
 
2.11. Quantification of protein in culture supernatants 
2.11.1. ELISA 
Sandwich enzyme-linked immunosorbent assay (ELISA) kits were used to quantify 
human IL-6, sIL-6R and CD105 levels (R&D Systems) in supernatants from 
microchannel slides and filters. Mono-cultures supernatants were harvested from 24h 
EC or MSC cultures on filters or microchannel slides while co-cultures supernatants 
were harvested after a further 24h culture. All supernatants were collected prior to 
cytokine stimulation. The kits were used according to the manufacturer’s instructions. 
The absorbance was measured at 450nm and 540nm using a Bio-tek Synergy™ HT 
Multi-Detection Microplate Reader (Bio-Tek, Swindon, UK). The concentration of 
protein was calculated based on interpolation using a standard curve of calibrants 
supplied with the kits.  
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2.11.2. Membrane-based sandwich cytokine array 
A Human XL Cytokine Array Kit (R&D Systems) was used to screen for cytokines 
present in supernatants (same supernatants as tested in Section 2.11.1.) according to 
the manufacturer’s instructions. A panel of 102 cytokines were analysed (Table 2-1). 
Data were analysed after 5min exposure of the membrane to X-ray film. The film was 
then scanned and the average pixel density (termed integrated density) for each 
analyte was quantified using ImageJ software. This analysis was semi-quantitative. 
 
2.12. Gene expression analysis 
2.12.1. RNA extraction and cDNA conversion 
EC and BMMSC or BMMSC-derived adipocytes mono- and co-cultures were seeded 
onto filters and co-cultured for 24h (as described in Section 2.9.2.). The cells were 
either harvested after 24h or stimulated with TNFα for 2h before being harvested. Cells 
were detached separately from either side of filters or from wells using trypsin/EDTA 
and then centrifuged at 400g for 5min (Section 2.4.). Total RNA was extracted using 
an RNAeasy mini kit (Qiagen, Manchester, UK) according to the manufacturer’s 
protocol. The RNA concentration was quantified using a Nanodrop (Thermo Scientific). 
500µg RNA from each sample was then converted to cDNA using a Promega kit 
(Promega, Southampton, UK) according to the manufacturer’s instructions.   
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Adiponectin IFN-γ Lipocalin-2/NGAL 
Aggrecan IGFBP-2 CCL2/MCP-1 
Angiogenin IGFBP-3 CCL7/MCP-3 
Angiopoietin-1 IL-1α/IL-1F1 M-CSF 
Angiopoietin-2 IL-1 beta/IL-1F2 MIF 
BAFF/BLyS/TNFSF13B IL-1ra/IL-1F3 CXCL9/MIG 
BDNF IL-2 CCL3/CCL4 MIP-1α/β 
CD14 IL-3 CCL20/MIP-3α 
CD30 IL-4 CCL19/MIP-3β 
CD40 Ligand/TNFSF5 IL-5 MMP-9 
Chitinase 3-like IL-6 Myeloperoxidase 
Complement Component C5/C5a IL-8 Osteopontin (OPN) 
Complement Factor D IL-10 PDGF-AA 
C-Reactive Protein IL-11 PDGF-AB/BB 
Cripto-1 IL-12 p70 Pentraxin 3/TSF-14 
Cystatin C IL-13 CXCL4/PF4 
Dkk-1 IL-15 RAGE 
DPPIV/CD26 IL-16 CCL5/RANTES 
EGF IL-17A RBP4 
CXCL5/ENA-78 IL-18 BPa Relaxin-2 
Endoglin/CD105 IL-19 Resistin 
EMMPRIN IL-22 CXCL12/SDF-1α 
Fas Ligand IL-23 Serpin E1/PAI-1 
FGF basic IL-24 SHBG 
KGF/FGF-7 IL-27 ST2/IL1 R4 
FGF-19 IL-31 CCL17/TARC 
Flt-3 Ligand IL-32α/β/γ TFF3 
G-CSF IL-33 TfR 
GDF-15 IL-34 TGF-α 
GM-CSF CXCL10/IP-10 Thrombospondin-1 
CXCL1/GROα CXCL11/I-TAC TNF-α 
Growth Hormone Kallikrein 3/PSA uPAR 
HGF Leptin VEGF 
ICAM-1/CD54 LIF Vitamin D BP 
 
Table 2-1: List of cytokines analysed in the human XL cytokine array kit. 
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2.12.2. Quantitative PCR 
A 384-well plate (Sigma) was setup to analyse genes from each culture condition. To 
each well 0.5µl cDNA, 0.5µl gene specific primers (Applied Biosystems, Warrington, 
UK), 4µl Universal PCR mastermix (Life Technologies) and 5µl DNAse free water were 
added. Each sample was run in triplicate and three samples from separate 
experiments were generated for each culture condition. FAM-labelled primers for 
measuring IL-6, IL-6R, IL-6ST, TGFβ1-3, decorin, SOCS3, IDO1, IDO2, ICAM1, 
VCAM1, E-selectin, FABP4, C/EBPα, PPARγ and 18S (as a housekeeping gene) were 
used. All primers tested were purchased as Taqman Gene Expression Assays (Applied 
Biosystems; Table 2-2). The qPCR was run on a 7900HT Real Time PCR machine for 
40 cycles and analysed using SDS 2.2 Software (Applied Biosystems). The threshold 
cycle (CT) for each gene of interest was averaged between the three sample repeats 
(only if the CT values were within one cycle of each other) and subtracted from the 
average CT value for the housekeeping gene, 18S (delta CT). The relative expression 
of each gene was then calculated using the formula, 2-dCT.  
   
2.13. Statistical analysis 
Data are expressed as mean ± SEM and the n number refers to the number of 
independent experiments performed per treatment. A different EC and leukocyte donor 
were used for each experiment. A different WJMSC and TBMSC were used for each 
experiment unless otherwise stated, while only 2-3 BMMSC donors were used for each 
series of experiments. Multi-variant data when paired were analysed using analysis of 
variance (ANOVA), followed by Bonferroni or Dunnett post-hoc test. Paired t-test was 
used when multiple parameters were grouped together even though not all conditions 
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were tested in every experiment, but EC mono-culture controls were performed on 
each occasion. p<0.05 was considered statistically significant.  
 
 
Primer Assay ID 
IL-6 Hs00985639_m1 
IL-6R Hs01075666_m1 
IL-6ST Hs00174360_m1 
SOCS3 Hs02330328_s1  
TGFβ1 Hs00998133_m1 
TGFβ2 Hs00234244_m1 
TGFβ3 Hs01086000_m1 
Decorin Hs00754870_s1 
ICAM1 Hs00164932_m1 
VCAM1 Hs01003372_m1 
E-selectin Hs00950401_m1 
PPARγ Hs01115513_m1 
CEBPα Hs00269972_s1 
FABP4 Hs01086177_m1 
IDO1 Hs00984148_m1 
IDO2 Hs01589373_m1 
IL-10 Hs00961622_m1 
 
Table 2-2: List of primers used for qPCR. 
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3. Isolation and characterisation 
of MSC from different tissue 
sources 
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3.1. Introduction 
MSC can be isolated from most human tissues and while BMMSC remain the most 
widely studied and accessible source, recently MSC isolated from umbilical cords and 
trabecular bone have gained considerable interest. This is because these tissues 
generate a greater yield of highly proliferative MSC that have similar 
immunosuppressive properties as BMMSC (Mafi et al., 2011; Baksh et al., 2007). 
Despite intense research, a specific MSC phenotype has not yet been defined. 
Therefore, the ISCT have recommended minimal criteria for classifying MSC based on 
their expression of an array of cell surface markers and their capacity to differentiate 
into adipocytes, osteoblasts and chondrocytes (Dominici et al., 2006). While these 
criteria can be applied to MSC from all tissue sources, it is often the case that between 
MSC populations there are differences in MSC marker expression and in their 
differentiation capacity (Russell et al., 2010).  Recently, CD146 and CD271 have been 
identified as markers exclusively expressed by MSC with greater clonogenic potential 
and immunomodulatory capacity (Maijenburg et al., 2012; Kuci et al., 2010). However, 
there are currently no functional markers that can be used to enrich for MSC. 
Interestingly, while MSC from different sources show phenotypic differences, they all 
exert similar functional effects such as the ability to suppress T-cell proliferation 
(Russell et al., 2010; Christodoulou et al., 2013). This suggests that these phenotypic 
differences have no functional effects on the cells. 
 
MSC are typically isolated from solid tissue by either culturing tissue explants or 
enzymatic digestion of tissue fragments. In this chapter we optimised the isolation and 
culture of MSC from human umbilical cord WJ, a readily available source of MSC. We 
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then compared the morphology, surface marker profile and adipogenic and 
osteoblastic differentiation potential of WJMSC isolated by the optimal method, to MSC 
isolated in house from TB by explant culture and to commercially-available, pre-defined 
BMMSC. This was the first step in examining whether phenotypic differences existed 
between MSC populations, which might be linked to functional differences in their 
immunomodulatory capacity. 
 
3.2. Results 
3.2.1. Comparison of different methods for isolating WJMSC 
The morphology of MSC isolated from solid tissues can serve as a good indicator of 
the viability of the cells after isolation as MSC exhibit altered morphology when 
exposed to stressful culture conditions (McCormick et al., 2006). Therefore, we 
examined the morphology of WJMSC isolated by explant culture or enzymatic 
digestion after 14 days in culture. Cells isolated by explant culture were very 
heterogeneous and the majority of cells were small and irregularly shaped (Figure 3-
1A). Only a few cells within the culture exhibited a spindle-like, fibroblastic morphology, 
characteristic of MSC (Figure 3-1A). In contrast, WJMSC isolated by enzymatic 
digestion contained a greater proportion of cells with the typical fibroblastic morphology 
suggesting that MSC isolated by this method were more viable than those isolated by 
explant culture (Figure 3-1A). As the enzymatic digestion method yielded a greater 
proportion of cells with MSC-like morphology than the explant culture method, this 
method was used for all subsequent work. 
  
74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-1: Comparison of the morphology of WJMSC isolated by explant culture 
and enzymatic digestion. MSC (passage 0)  were isolated from umbilical cord 
Wharton’s jelly by cutting the tissue into small fragments and placing them into culture 
flasks to allow MSC to migrate from the tissue and adhere to the plastic (Explant 
culture). Alternatively, tissue fragments were incubated with an enzymatic cocktail for 
5h and the cell suspension obtained was then seeded onto culture flasks (Enzymatic 
digestion). (A) Representative phase contrast images of WJMSC isolated using the 
explant culture and enzymatic digestion methods respectively, 14 days post-isolation. 
(B) Representative phase contrast images of WJMSC morphology 14 days after 
enzymatic digestion for 3h or 5h. (C) Representative images of the two distinct 
morphologies; flattened vs. spindle shaped observed 14 days after enzymatic digestion 
for 5h. These images are representative of n= 2 experiments. All images were taken 
at p0 at 20X magnification. Scale bars represent 10µm.  
Explant culture Enzymatic digestion 
3h digestion 5h digestion 
Flattened morphology Spindle-like morphology 
A 
B 
C 
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Next, we tested the optimum time period to digest the umbilical cord tissue to yield the 
maximum number of WJMSC. Umbilical cord tissue digestion was performed for 3h or 
5h and the morphology was examined 14 days post-isolation. WJMSC obtained after 
5h tissue digestion yielded a greater proportion of cells with characteristic fibroblastic 
morphology than after 3h digestion (Figure 3-1B). WJMSC isolated after 3h digestion 
were more flattened and thin than typical MSC (Figure 3-1B). In addition, the cell 
suspension obtained after 3h digestion was significantly more viscous than after 5h 
and was harder to filter (to remove larger tissue fragments). Thus, 5h enzyme 
incubation was chosen as the optimum length of time to digest the tissue.  
 
WJMSC cultures obtained by enzymatic digestion contained cell types with two distinct 
morphologies. Cells with a flattened, egg-shaped morphology and typical spindle-like 
morphology were observed (Figure 3-1C). Initially, there were a greater number of 
MSC with the flattened morphology during early culture and fewer spindle shaped 
MSC. The spindle-like MSC subsequently dominated the culture and continued to 
propagate with passage and the cells with flattened morphology were not observed 
after the first passage.  
 
3.2.2. Proliferation kinetics of BMMSC and WJMSC 
Subsequently, we assessed the proliferation of WJMSC cultured in different types of 
cell culture media and compared to BMMSC cultured in MSCGM in order to identify 
the optimum media for WJMSC expansion. The proliferation kinetics (number of 
population doublings, PD and the population doubling time, PDT) were determined 
after culturing WJMSC in MSCGM, LG DMEM and DMEM F12 as these media have 
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previously been used to culture WJMSC (Conconi, 2011). There was no significant 
difference in the number of PD undergone by p3 WJMSC cultured in the different media 
(Figure 3-2B). However, WJMSC in all culture media underwent a significantly greater 
number of PD than p5 BMMSC cultured in MSCGM (Figure 3-2A). p3 WJMSC cultured 
in MSCGM and LG DMEM underwent approximately 2.5 PD and 1.8PD in DMEM F12 
compared to 1.0 PD by BMMSC after 5 days in culture  (Figure 3-2A and B).  
 
Mean PDT was found to be significantly higher in BMMSC (Figure 3-2C) than WJMSC 
cultured in all media (Figure 3-2D). BMMSC doubled after ~60h at p5, while WJMSC 
cultured in MSCGM and LG DMEM doubled in under 25h (Figure 3-2C). PDT of 
WJMSC cultured in DMEM F12 was significantly higher (~33h) than MSC cultured in 
MSCGM or LG DMEM (Figure 3-2D). Interestingly, WJMSC had faster proliferation 
kinetics than BMMSC in all media tested. However, after comparing the different 
media, LG DMEM was selected as the culture media for WJMSC expansion as the 
proliferation kinetics were faster than MSC cultured in DMEM F12. Furthermore, LG 
DMEM had the same effect on WJMSC proliferation as MSCGM but the media was 
significantly cheaper. The proliferation kinetics of TBMSC were not examined as they 
proliferated too slowly for such analysis to be performed, taking up to 30 days to reach 
confluence. TBMSC were cultured in LG DMEM for comparison to WJMSC. 
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Figure 3-2: Proliferation kinetics of BMMSC and WJMSC in different culture 
media. (A,B) The number of population doublings and (C,D) the population 
doubling time of (A,C) p5 BMMSC and p3 WJMSC cultured in MSCGM and (B,D) 
p3 WJMSC cultured in MSCGM, LG DMEM and DMEM F12 were analysed after 5 
days in culture. Data are mean ± SEM from n= 3 experiments. In A and C, unpaired 
t-test showed a significant difference in the number of PD and PDT between 
BMMSC and WJMSC; ## = p<0.01. In B, ANOVA showed a significant effect of 
culture media on the number of PD undergone by WJMSC. In D, ANOVA showed 
a significant effect of culture media on the PDT of WJMSC, p<0.01. ** = p<0.01 by 
Bonferroni post-test. A different BMMSC and WJMSC donor was used per 
experiment.  
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3.2.3. Comparison of the phenotype of different MSC populations: 
We next assessed whether the isolated MSC fulfil the ISCT criteria. WJMSC (isolated 
by digestion) and TBMSC (isolated by explant) at p3 exhibited the same fibroblastic 
morphology as p5 BMMSC (Figure 3-3). The expression of the MSC marker panel on 
p3 WJMSC and TBMSC was then tested and compared to p5 BMMSC. The expression 
of MSC markers CD44, CD73, CD90, CD105, CD146, and CD271 was analysed by 
flow cytometry. Expression of negative markers CD14, CD20, CD34 and CD45 were 
also examined. All 3 MSC types, showed high expression of CD44, CD73, CD90 and 
CD105 (Figure 3-4). Interestingly, only BMMSC and WJMSC expressed CD146 while 
all 3 MSC populations expressed CD271 (Figure 3-4). Minimal contamination by 
endothelial and haematopoietic progenitors (based on CD14, CD20, CD34 and CD45) 
was observed in all cultures (Figure 3-4). The expression of the marker panel was 
measured on p5, p7 and p9 BMMSC and p3, p5 and p7 WJMSC to examine whether 
prolonged culture altered their expression profile. Expression on TBMSC was only 
assessed at p3 as they could not be expanded further. It was observed that 90-100% 
BMMSC and WJMSC retained CD44, CD73 and CD90 expression over passage 
(Figure 3-5). A significant reduction (40-50%) in the number of CD105 expressing cells 
was observed with passage. ~90% WJMSC expressed CD146 at p3 but this 
diminished significantly with passage and was almost completely lost by p5 (Figure 3-
5). Similarly, the expression of CD271 was higher on p3 WJMSC (55%) than BMMSC 
(30%) and TBMSC (25%) and significantly reduced with passage (Figure 3-5). 
Collectively, these data indicate that WJMSC and TBMSC fulfil the criteria for MSC 
marker expression and that WJMSC show greater level of CD146 and CD271 
expression.  
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Figure 3-3: The morphology of BMMSC, WJMSC and TBMSC. Representative 
phase contrast images of (A) p5 BMMSC, (B) p3 WJMSC and (C) p3 TBMSC. Images 
are representative of N= 5-7 MSC donors. Images were taken at (A) 20X or (B,C) 10X 
magnification. Scale bar represents 10µm.  
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Figure 3-4: Expression of MSC markers by BMMSC, WJMSC and TBMSC. 
Representative histogram plots of CD44, CD73, CD90, CD105, CD146, CD271 and 
negative markers (CD14/CD20/CD34/CD45 combined) expression on p5 BMMSC, p3 
WJMSC and p3 TBMSC compared to isotype control treated MSC. Images are 
representative of n= 3 experiments. A different BMMSC, WJMSC and TBMSC donor 
was used per experiment. 
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Figure 3-5: Expression of MSC markers by BMMSC, WJMSC and TBMSC at 
different passages. The percentage of cells expressing CD44, CD73, CD90, CD105, 
CD146 and CD271 by p5 BMMSC, p3 WJMSC and p3 TBMSC was analysed 
compared to isotype control treated MSC. Data are mean ± SEM from n= 3 
independent experiments. ANOVA showed a significant effect of passage on 
expression of CD105, CD271 and CD146, p<0.05. * = p<0.05 and ** = p<0.01 
compared to p5 BMMSC or p3 WJMSC by Bonferroni post-test. ND = not determined. 
3 different WJMSC and TBMSC donors and 2 different BMMSC donors were used in 
this set of experiments. 
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3.2.4. Comparison of the differentiation potential of the different MSC populations 
The capacity of all MSC populations to differentiate into adipocytes and osteoblasts 
was also examined, as this was stipulated by the ISCT to be a functional requirement 
for an MSC. p5 BMMSC, p3 WJMSC and p3 TBMSC exhibited the capacity to 
differentiate into adipocytes, confirmed by Oil Red O staining of their lipid droplets 
(Figure 3-6). However, WJMSC contained fewer lipid droplets than BMMSC and 
TBMSC (Figure 3-6). BMMSC-derived adipocytes contained larger lipid vacuoles than 
TBMSC or WJMSC (Figure 3-6). Differentiation in adipocyte induction media was 
carried out for 21 days as lipid droplets in the WJMSC could only be detected at this 
point. In contrast, lipid droplets were detectable in BMMSC and TBMSC cultures after 
7-10 days in culture, indicating that these MSC populations had a greater propensity 
to differentiate down the adipogenic lineage.  
 
Osteogenic differentiation was carried out for 14 days and assessed by Alizarin Red 
staining of mineralised calcium deposits produced by the cells. All MSC types 
generated large calcium deposits after 14 days differentiation indicating that they could 
all differentiate down the osteogenic lineage (Figure 3-6). TBMSC contained more 
calcium deposits that were larger in size than BMMSC or WJMSC (Figure 3-6). 
WJMSC and BMMSC had capacity to differentiate down the osteogenic lineage. 
Chondogenic differentiation potential of MSC from the different sources was not 
examined in this thesis.  
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Figure 3-6: Differentiation of BMMSC, WJMSC and TBMSC towards adipocytes 
or osteoblasts. Representative phase-contrast images of p5 BMMSC, p3 WJMSC 
and p3 TBMSC and MSC-derived adipocytes and osteoblasts are shown. Lipid 
droplets in the adipocytes were stained with Oil Red O. Calcium deposits shown in in 
the osteoblast culture were stained with Alizarin Red. Images are representative of n= 
3 independent experiments. Images were taken at 20X magnification (except for 
adipogenically differentiated and WJMSC which were taken at 4X). Scale bar 
represents 10µm. A different BMMSC, WJMSC and TBMSC donor was used per 
experiment. 
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3.3. Discussion 
In this chapter, we developed new, optimal isolation and culture conditions for WJMSC. 
We subsequently characterised BMMSC, WJMSC and TBMSC based on expression 
of MSC markers and differentiation potential. Commercially available BMMSC at p5, 
p3 WJMSC isolated by enzymatic digestion and p3 TBMSC isolated by explant culture 
expressed the full panel of MSC markers and lacked expression of negative markers. 
BMMSC and WJMSC retained expression of these markers over further passage 
suggesting that they didn’t spontaneously differentiate during culture. Analysis of 
marker expression by later passage TBMSC could not be performed as the cells could 
not be expanded beyond p3. BMMSC, WJMSC and TBMSC exhibited osteoblastic and 
adipogenic differentiation potential albeit to varying degrees based on staining and 
appearance of the differentiated cells. Therefore, MSC isolated from WJ and TB met 
the ISCT criteria with the exception of chondrogenic differentiation potential of the MSC 
which was not assessed. 
 
One issue with defining MSC by this criteria is that it is very generic. In fact, other 
stromal cell populations such as human dermal fibroblasts also express CD44, CD73, 
CD90 and CD105 (Alt et al., 2011; Halfon et al., 2011) and are capable of differentiating 
into adipocytes and osteoblasts when cultured in appropriate media (Haniffa et al., 
2007). This indicates that this criterion is not specific to MSC alone and will need to be 
used in conjunction with functional studies to determine whether isolated cells are in 
fact MSC. There are currently no MSC-specific cell surface markers or functional 
markers that can be used to distinguish MSC from other tissue-resident stromal 
populations that potentially contaminate MSC cultures.  
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WJMSC isolated by enzymatic digestion initially exhibited two distinct morphologies; 
flattened and spindle-like. It has previously been reported that three subpopulations of 
BMMSC arise in culture soon after isolation; small, spherical rapidly dividing cells, 
spindle-shaped fibroblastic cells and flattened cuboidal cells that had a low proliferation 
capacity (Sekiya et al., 2002; Battula et al., 2009; Mets and Verdonk, 1981). The 
flattened BMMSC were identified as mature MSC that showed early signs of 
commitment to the osteoblastic lineage and as such had a reduced proliferation and 
differentiation potential compared to fibroblastic MSC (Colter et al., 2000, 2001). Here, 
WJMSC showed similar heterogeneity in culture at p0, but the flattened WJMSC did 
not survive in culture as their proliferation rate appeared to be much slower than the 
fibroblastic MSC. Consequently, the flattened MSC population were not observed after 
p0 and a uniform population of fibroblastic MSC was obtained by p3.  
 
MSC from different tissue sources have been shown to be phenotypically and 
functionally similar, although they may exhibit differences in their capacity to proliferate 
and differentiate. For instance, umbilical cord-derived MSC had a greater proliferative 
and clonogenic capacity than BMMSC and ADMSC despite exhibiting similar surface 
marker expression and differentiation capabilities (Jin et al., 2013; Christodoulou et al., 
2013; Baksh et al., 2007). We also observed that WJMSC proliferated significantly 
faster than BMMSC based on the number of PD and PDT of both MSC populations.  
 
Although trilineage differentiation is a key phenotypic feature of MSC, we observed 
that BMMSC, WJMSC and TBMSC exhibited differences in their capacity to 
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differentiate into adipocytes and osteoblasts. BMMSC and TBMSC differentiated into 
adipocytes with larger lipid droplets than WJMSC. In contrast, TBMSC showed a 
greater degree of calcium deposition than BMMSC and WJMSC after differentiation 
into osteoblasts, as confirmed by staining. This suggests that there are phenotypic 
differences between MSC from different tissue sources.  
 
Passaging MSC may also affect their phenotype as changes in cell morphology, size, 
surface marker expression (CD44, CD105, CD146 and CD271) and differentiation 
potential have previously been reported [reviewed by (Eggenhofer et al., 2014)]. 
Indeed, we observed that expression of CD105, CD146 and CD271 significantly 
diminished with passage, particularly for WJMSC. As CD271 and CD146 are markers 
of MSC that exhibit greater colony forming unit capacity and suppression of mitogen 
induced T-cell proliferation (Maijenburg et al., 2012; Kuci et al., 2010), the decrease in 
expression over passage suggest that BMMSC and WJMSC may lose their growth 
potential and immunomodulatory capacity with passage. In addition, previous studies 
showed that BMMSC and ADMSC underwent growth arrest at earlier passage (p11-
12) than umbilical cord-derived MSC (beyond p18) and had a significantly lower growth 
rate (Jin et al., 2013; Christodoulou et al., 2013). Additionally, BMMSC had a 
decreased adipogenic differentiation potential and an increase in osteogenic 
differentiation capacity with passage (p5-10) (Wagner et al., 2008). In contrast, 
WJMSC retained their ability to differentiate down the characteristic mesodermal 
lineages (adipocyte, osteoblast and chondrocyte) as far as p15 (Chen et al., 2014). 
These studies suggest that the MSC phenotype is altered in culture, with WJMSC 
retaining their phenotypic characteristics for longer than BMMSC.  Based on our 
findings and those of other groups, WJMSC may be a better source than BMMSC for 
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therapy as they grow faster and express higher levels of CD146 and CD271. However, 
given that we observed that WJMSC displayed a poor differentiation capacity 
compared to the BMMSC and TBMSC, this will greatly limit their therapeutic potential. 
It also raises the question whether WJMSC are in fact “true” MSC if they exhibit 
reduced capacity to differentiate down the adipogenic and osteogenic lineages.   
 
In conclusion, we observed that MSC from different sources exhibit differences in their 
growth potential, surface marker expression and differentiation capacity. Indeed, 
WJMSC had a greater growth potential, retention of MSC marker expression over 
passage and osteoblastic differentiation potential than BMMSC and TBMSC. Whether 
these phenotypic differences in MSC populations observed translated into functional 
differences in their capacity to regulate neutrophil recruitment in response to 
inflammation was assessed in the following chapter.  
  
88 
 
 
 
 
 
 
 
 
 
 
 
4. Capacity of MSC from different 
sources to regulate neutrophil 
recruitment to vascular EC 
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4.1. Introduction 
Numerous in vitro and in vivo studies have demonstrated that MSC from different 
anatomical sites are capable of directly modifying leukocyte proliferation and effector 
functions [reviewed by (Le Blanc and Mougiakakos, 2012; Munir and McGettrick, 
2015)]. However, these studies have not considered the possibility that MSC may also 
directly influence the recruitment of the inflammatory infiltrate. Previously we have 
shown that cross-talk between BMMSC and EC reduced the endothelial response to 
cytokines, suppressing leukocyte adhesion and migration (Luu et al., 2013). This 
evidence suggests that MSC may be endogenous regulators of recruitment, limiting 
entry of leukocytes into inflamed tissues. Whether MSC from different sources have 
the same capacity to regulate recruitment or whether this is a tissue-specific feature of 
BMMSC was the main focus of this chapter. 
 
Recent evidence suggests that the MSC niche varies at different anatomical sites, 
likely due to differences in the levels of locally released factors (e.g. cytokines) and 
interactions with neighbouring stromal cells. Differences in the tissue 
microenvironment may lead to functional differences between MSC populations 
(Magatti et al., 2008; Wolbank et al., 2007; Chen et al., 2011; Chang et al., 2006). 
However, isolation and ex vivo expansion of MSC has been shown to adversely affect 
their immunomodulatory responses, therefore any tissue-specific differences may be 
lost during culture expansion (Li et al., 2012; Giuliani et al., 2011; Yu et al., 2014; 
Bortolotti et al., 2015). Indeed, several studies have reported that MSC from different 
tissues that were expanded in culture exerted similar suppressive effects on leukocyte 
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responses, e.g. T-cell proliferation (Roemeling-van Rhijn et al., 2013; Puissant et al., 
2005; Chang et al., 2006; Trivanović et al., 2013).   
 
MSC from different tissues sources may also induce their immunosuppressive effects 
to different extents (Prasanna et al., 2010). For instance, WJMSC express different 
levels of immunosuppressive factors (hepatocyte growth factor, IDO and PGE2) than 
BMMSC (Prasanna et al., 2010; Deuse et al., 2011) which may lead to differences in 
their capacity to regulate immune cell responses. While most studies implicate soluble 
mediators as the main drivers for immunosuppression, recently it has been suggested 
that direct cell-cell contact may be required for inducing or enhancing MSC effector 
functions directly on leukocyte functions (Brandau et al., 2014; Spaggiari et al., 2008; 
Sotiropoulou et al., 2006). While the effects of MSC on leukocyte effector functions 
have been extensively explored, there is little experimental evidence on the 
mechanism by which MSC crosstalk with EC regulates leukocyte recruitment. Whether 
MSC from different tissues utilise distinct mechanisms (direct contact vs. soluble 
mediators) to regulate neutrophil recruitment was assessed in this chapter.  We 
compared the capacity of MSC from different tissues namely BMMSC, WJMSC and 
TBMSC to regulate the recruitment of neutrophils to cytokine-stimulated EC. Two 
distinct in vitro models (a direct co-culture model with MSC incorporated in the EC 
monolayer and a Transwell filter model with the different cell types cultured on opposite 
sides of the porous filter) were used to study the effects of MSC from different tissue 
sources on the capacity of EC to support neutrophil recruitment during inflammation.  
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4.2. Results 
4.2.1. Ability of MSC from different sources to incorporate into endothelium 
We previously showed that direct co-culture of BMMSC and EC at a ratio of 1:25 in a 
microchannel slide flow-based adhesion assay suppressed neutrophil adhesion and 
migration (Luu et al., 2013). Utilising the same model we tested the ability of BMMSC, 
WJMSC and TBMSC to adhere to EC by adding the same density of MSC and 
observing how many bound and incorporated into the EC monolayer. All MSC 
populations adhered to the EC and lost their characteristic fibroblastic morphology 
(Figure 4-1A).  Importantly, the integrity of the EC monolayer was not compromised by 
the addition of MSC as there were no gaps around the area where the MSC had 
attached (Figure 4-1A). Interestingly, significantly more TBMSC adhered to the EC 
than WJMSC and BMMSC respectively (Figure 4-1B). 
 
4.2.2. Effects of MSC from different sources cultured in direct contact with EC on 
neutrophil recruitment  
Subsequently, we tested the effect of different MSC on neutrophil recruitment to EC 
using the microchannel slide model (as described in Section 2.9.) in response to low 
and high grade inflammation. The cells were stimulated with either 1U/ml (low grade 
inflammation) or 100U/ml (high grade inflammation) TNFα for 4h. At 100U/ml TNFα, 
neutrophil adhesion was higher compared to 1U/ml TNFα in EC mono-cultures (Figure 
4-2). Co-culture with all MSC populations reduced neutrophil adhesion compared to 
EC mono-cultures at both concentrations of TNFα, but the suppression was only 
statistically significant after stimulation with 100U/ml TNFα (Figure 4-2).   
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Figure 4-1: Adhesion of different MSC types to EC in microchannel slides. 
Fluorescently labelled MSC (BMMSC, WJMSC and TBMSC) were added to a 
confluent monolayer of HUVEC in a microchannel slide and left to adhere for 1h. Non-
adherent MSC were washed off and remaining cells were cultured for 24h. Images 
were taken after a flow based adhesion assay was performed. (A) Representative 
phase-contrast images and corresponding fluorescent images of EC mono-cultures 
and MSC co-cultures. Images were taken at 20X magnification. (B) The ratio of 
adherent MSC:EC for the 3 MSC populations. Data are mean ± SEM from n= 3 
experiments. ANOVA showed a significant effect of MSC source on MSC:EC ratio, 
p<0.05. * = p<0.05 and $ = p=0.053 by Bonferroni post-test. A different EC and 
BMMSC, WJMSC and TBMSC donor was used in each experiment. 
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Figure 4-2: Effect of MSC co-culture on neutrophil adhesion to inflamed EC 
in microchannel slides. EC mono-cultures and MSC co-cultures were stimulated 
with either (A) 1U/ml or (B) 100U/ml TNFα for 4h and neutrophil adhesion was 
analysed. Data are mean ± SEM from n= 5 experiments. In B, ANOVA showed a 
significant effect of culture conditions on neutrophil adhesion, p<0.01. * = p<0.05 
and ** = p<0.01 compared to EC mono-cultures by Dunnett post-test. A different 
EC and neutrophil donor was used per experiment. 3 different BMMSC and 5 
different WJMSC and TBMSC donors were used in this set of experiments. 
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In response to low dose TNFα, a higher percentage of adherent neutrophils were 
rolling and stationary and less migrated compared to high dose TNFα at 2min and 9min 
post-perfusion, however, it was not statistically significant (Figure 4-3). At both 
concentrations of TNFα, neutrophil migration tended to be higher at 9min post-
perfusion than 2min in EC mono-cultures (Figure 4-3). However, at both time points 
co-culture with MSC did not significantly alter neutrophil behaviour compared to the 
EC mono-cultures (Figure 4-3). As the suppressive effect of MSC on neutrophil 
adhesion was greater at 100U/ml TNFα this concentration was selected for all 
subsequent experiments. Furthermore, as migration was higher at 9min post-
perfusion, all subsequent behavioural analysis was performed at this time point.  
 
4.2.3. Effects of culturing MSC from different sources on opposite side of filters to EC 
on neutrophil recruitment  
Next, we cultured MSC (from all 3 sources) and EC on opposite sides of a porous filter 
and assessed neutrophil recruitment using the flow based adhesion assay (described 
in Section 2.9.2.). To find the optimum ratio of MSC to EC to obtain maximum 
suppression of neutrophil recruitment, 1x105, 3x105 or 5x105 WJMSC were seeded 
onto filters and co-cultured with EC for 24h. Co-culture with WJMSC was found to 
significantly reduce neutrophil adhesion in a dose-dependent manner relative to the 
EC control (Figure 4-4A). However, once again co-culture had no significant effect on 
neutrophil behaviour compared to the EC control (Figure 4-4B). As the greatest 
suppressive effect was obtained with 5x105 MSC, this density was used for the 
remainder of the study. 
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Figure 4-3: Effect of MSC co-culture on the behaviour of adherent neutrophils in 
microchannel slides. EC mono-cultures and MSC co-cultures were stimulated with 
either (A,B) 1U/ml or (C,D) 100U/ml TNFα for 4h. The behaviour of adherent 
neutrophils was analysed at (A,C) 2min and (B,D) 9min post-perfusion. Neutrophil 
behaviour was expressed as the percentage of adherent neutrophils that were rolling, 
stationary and migrated. Data are mean ± SEM from n= 5 experiments. ANOVA 
showed no significant effect of MSC co-culture on neutrophil behaviour. A different EC 
and neutrophil donor was used per experiment. 3 different BMMSC and 5 different 
WJMSC and TBMSC donors were used in this set of experiments. 
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Figure 4-4: Effect of the number of WJMSC seeded onto filters on neutrophil 
recruitment to TNFα treated EC in a filter flow based adhesion assay. WJMSC 
were seeded at different numbers (1x105, 3x105 or 5x105) onto filters and co-cultured 
with EC for 24h. Parallel EC mono-cultures were also set up. Cultures were stimulated 
with 100U/ml TNFα for 4h and neutrophil (A) adhesion and (B) behaviour were 
analysed. Neutrophil behaviour was expressed as the percentage of adherent 
neutrophils that were rolling, stationary and migrated. Data are mean ± SEM from n= 
5 experiments. In A, ANOVA showed a significant effect of culture conditions on 
neutrophil adhesion. * = p<0.05 and ** = p<0.01 compared to EC mono-cultures by 
Dunnett post-test. In B, ANOVA showed no significant effect of culture conditions on 
neutrophil behaviour. A different EC, neutrophil and WJMSC donor was used per 
experiment.  
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Subsequently we compared the suppressive effect of BMMSC, WJMSC and TBMSC 
on neutrophil recruitment using the filter-based adhesion assay. Similar to the 
microchannel model, co-culture with all 3 MSC populations significantly suppressed 
neutrophil adhesion to EC to a similar extent, compared to EC mono-cultures in 
response to TNFα (Figure 4-5A). Furthermore, co-culture had no significant effect on 
the behaviour of the adherent neutrophils (Figure 4-5B). All subsequent adhesion 
assays were performed using the filter flow based model. 
 
4.2.4. Effect of MSC co-culture conditioned media on neutrophil recruitment 
Next, we examined whether the effects of co-culture were mediated by secreted 
soluble factors. To test this, EC mono-cultures were treated with conditioned media 
from BMMSC, WJMSC or TBMSC mono-cultures or co-cultures for 24h prior to TNFα-
stimulation for a further 4h in the same culture media. Conditioned media from co-
cultures with all MSC populations mimicked the suppressive effects of direct MSC co-
culture (Figure 4-6). In contrast, mono-culture conditioned media from all MSC 
populations was effectively inert (Figure 4-6). In addition, neutrophil behaviour was not 
significantly affected by any conditioned media tested (Figure 4-7). However, a 
significant reduction in the percentage of stationary neutrophils was observed when 
EC were treated with TBMSC mono-culture or co-culture conditioned media (Figure 4-
7). Therefore, the immunosuppressive effects of MSC may be attributed to bioactive 
agent(s) secreted during co-culture with EC, but not secreted by MSC cultured alone. 
However, as the effect of EC mono-culture conditioned media was not tested, it cannot 
be ruled out that the suppressive effects of co-culture conditioned media are due to 
factors secreted by the EC alone.    
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Figure 4-5: Effect of co-culture of EC with different MSC populations on 
neutrophil adhesion. BMMSC, WJMSC and TBMSC (5x105) were co-cultured with 
EC on opposite sides of filters for 24h prior to stimulation with 100U/ml TNFα for 4h. 
Neutrophil (A) adhesion and (B) behaviour were then assessed. Neutrophil behaviour 
was expressed as the percentage of adherent neutrophils that were rolling, stationary 
and migrated. Data are mean ± SEM from n= 5 experiments. Assays performed with 
WJMSC co-cultures were carried out on separate days, but EC mono-culture controls 
were performed on each occasion. Therefore, comparisons to controls were performed 
using independent paired t-tests. * = p<0.05 and ** = p<0.01 compared to EC mono-
cultures. In B, ANOVA showed no significant effect of culture conditions on neutrophil 
behaviour. A different EC and neutrophil donor was used per experiment. 3 different 
BMMSC and 5 different WJMSC and TBMSC donors were used in this set of 
experiments. 
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Figure 4-6: Effect of conditioned media from MSC cultured alone or with EC on 
neutrophil adhesion from flow. Conditioned media was harvested from (A) BMMSC, 
(B) WJMSC or (C) TBMSC cultured alone or with EC for 24h. EC mono-cultures were 
treated with conditioned media for 24h before stimulation with 100U/ml TNFα for 4h in 
the same culture media. Neutrophil adhesion was analysed. Data are mean ± SEM 
from n= 3 experiments. Assays performed with MSC mono-cultures and co-culture 
conditioned media were carried out on separate days, but EC mono-culture controls 
were performed on each occasion. Therefore, comparisons to controls were performed 
using independent paired t-test. * = p<0.05 compared to EC mono-cultures. A different 
EC and neutrophil donor was used per experiment. 2 different BMMSC and 3 different 
WJMSC and TBMSC donors were used in this set of experiments. 
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Figure 4-7: Effect of conditioned media from MSC cultured alone or with EC on 
neutrophil behaviour. Conditioned media was harvested from (A) BMMSC, (B) 
WJMSC or (C) TBMSC cultured alone or with EC for 24h. EC mono-cultures were 
treated with conditioned media for 24h before stimulation with 100U/ml TNFα for 4h in 
the same culture media. Neutrophil behaviour was analysed and expressed as the 
percentage of adherent neutrophils that were rolling, stationary and migrated. Data are 
mean ± SEM from n= 3 experiments. Assays performed with MSC mono-culture and 
co-culture conditioned media were carried out on separate days, but EC mono-culture 
controls were performed on each occasion. In A and B, ANOVA showed no significant 
effect of MSC conditioned media on neutrophil behaviour. In C, ANOVA showed a 
significant effect of TBMSC co-culture on neutrophil behaviour, p<0.05. * = p<0.05 
compared to EC mono-cultures by Bonferroni post-test. A different EC and neutrophil 
donor was used per experiment. 2 different BMMSC and 3 different WJMSC and 
TBMSC donors were used in this set of experiments.     
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4.2.5. Effect of proximity between MSC and EC on neutrophil recruitment  
Next, we examined whether close proximity between MSC and EC was required for 
limiting neutrophil adhesion. MSC were seeded onto a 6-well plate while EC were 
cultured above on a Transwell filter (in the same well) for 24h at a distance of 0.9mm. 
The suppressive effect of BMMSC on neutrophil adhesion was only slightly reduced 
when separated from EC compared to co-cultures on opposite sides of the filter, 
although the suppression was no longer statistically significant (Figure 4-8A). In 
contrast, separation of WJMSC or TBMSC from EC reduced their capacity to suppress 
neutrophil adhesion (Figure 4-8B and C). The behaviour of adherent neutrophils was 
not significantly altered by separation of EC from all MSC populations (Figure 4-9). 
Therefore, MSC from different sources differ in their requirement for proximity to EC to 
generate the bioactive agent(s) that mediate their functional effects on recruitment. 
 
4.2.6. Role of IL-6 and TGFβ in the suppression of neutrophil recruitment by MSC from 
different sources 
IL-6 secretion was previously found to be upregulated in BMMSC co-cultures with EC 
when both cell types were in direct contact in microslide channels (Luu et al., 2013). 
Indeed, the immunosuppressive effects of BMMSC were found to be mediated by IL-6 
and TGFβ (Luu et al., 2013). We hypothesised that IL-6 may be a common bioactive 
agent mediating suppression by all MSC populations. To examine this, we quantified 
IL-6 levels in supernatants from 24h EC, BMMSC, WJMSC and TBMSC mono-cultures 
and co-cultures. IL-6 secretion was significantly increased in co-culture with all MSC 
populations when MSC were incorporated into the EC monolayer (Figure 4-10A) or on 
the opposite sides of a Transwell filter (Figure 4-10B) compared to EC mono-culture.  
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Figure 4-8: Effect of varying closeness of contact between EC and MSC during 
co-culture on suppression of neutrophil adhesion. Co-cultures were formed by 
seeding (A) BMMSC, (B) WJMSC or (C) TBMSC on the opposite side of Transwell 
filters to EC (Close proximity) or by seeding MSC on the 6-well plate below and EC 
above on a filter (Separate). Cultures were treated with 100U/ml TNFα for 4h and 
neutrophil adhesion was analysed. Data are mean ± SEM from n= 3-13 experiments. 
Close proximity and Separate culture assays were carried out on separate days, but 
EC mono-culture controls were performed on each occasion. Therefore, comparisons 
to controls were performed using independent paired t-test. ** = p<0.01 compared to 
EC mono-cultures. A different EC and neutrophil donor was used per experiment. 2 
different BMMSC and at least 3 different WJMSC and TBMSC donors were used in 
this set of experiments.  
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Figure 4-9: Effect of varying closeness of contact between EC and MSC during 
co-culture on neutrophil behaviour. Co-cultures were formed by seeding (A) 
BMMSC, (B) WJMSC or (C) TBMSC on the opposite side of Transwell filters to EC 
(Close proximity) or by seeding MSC on the 6-well plate below and EC above on a 
filter (Separate). Cultures were treated with 100U/ml TNFα for 4h. Neutrophil behaviour 
was analysed and expressed as the percentage of adherent neutrophils that were 
rolling, stationary and migrated. Data are mean ± SEM from n= 3-13 experiments. 
Close proximity and separate culture assays were carried out on separate days, but 
EC mono-culture controls were performed on each occasion. Paired t-test showed no 
significant effect of MSC conditioned media treatment on neutrophil behaviour. A 
different EC and neutrophil donor was used per experiment. 2 different BMMSC and 
at least 3 different WJMSC and TBMSC donors were used in this set of experiments.  
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Figure 4-10: Levels of IL-6 in EC and MSC mono-culture and co-culture 
supernatants cultured in varying degrees of closeness. IL-6 was measured in 
supernatants from mono-cultures and co-cultures of EC and all MSC populations from 
(A) microchannel slides, (B) filters and (C) co-cultures formed on opposite sides of the 
filter (Close proximity) or in the absence of contact (Separate). Data are mean ± SEM 
from n= 3 independent experiments. In B, WJMSC mono-culture supernatants were 
tested on a separate day to the other conditions, but EC mono-culture controls were 
performed on each occasion. In A, B and C, ANOVA showed a significant effect of 
culture conditions on IL-6 secretion, p<0.01. * = p<0.05 and ** = p<0.01 compared to 
EC mono-cultures by Dunnett post-test. 
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In addition, the levels generated during co-culture tended to be greater than the sum 
of the EC and MSC mono-cultures (Figure 4-10A and B). Separating EC from BMMSC, 
WJMSC and TBMSC significantly reduced IL-6 secretion compared with co-cultures 
on opposite sides of a filter (Figure 4-10C). Therefore, IL-6 may be a common soluble 
mediator in EC co-cultures with all MSC populations. To assess whether IL-6 and 
TGFβ played a role in suppression of neutrophil adhesion by MSC from different 
sources, BMMSC or WJMSC were cultured with EC, in the presence or absence of 
antibodies targeting soluble IL-6, IL-6R or TGFβ for the duration of the co-culture and 
cytokine treatment. In this series of experiments, p4 WJMSC were used as there were 
too few p3 WJMSC available. Additionally, TBMSC were not examined as there were 
too few cells available to perform these assays. BMMSC and WJMSC were found to 
significantly suppress neutrophil recruitment compared to EC alone (Figure 4-11). 
Inhibition of IL-6 (by neutralising IL-6 or blocking IL-6R) or TGFβ signalling during co-
culture abrogated suppression of neutrophil adhesion by BMMSC or WJMSC (Figure 
4-11). Blocking IL-6 or TGFβ signalling had no significant effect on the behaviour of 
adherent neutrophils (Figure 4-12). Co-culture of EC with WJMSC significantly 
increased neutrophil transmigration, but this effect was not significantly altered by 
inhibiting IL-6 or TGFβ signalling (Figure 4-12B). Increased neutrophil migration in p4 
WJMSC co-cultures was concomitant with a significant reduction in the percentage of 
rolling and stationary neutrophils (Figure 4-12B). This suggests that co-culture with 
later passage WJMSC may promote migration. Collectively, these data indicate that 
IL-6 and TGFβ are drivers of BMMSC and WJMSC-mediated suppression of neutrophil 
recruitment.  
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Figure 4-11: Effect of blocking actions of IL-6 or TGFβ on the capacity of MSC in 
co-culture to suppress neutrophil adhesion. (A) BMMSC or (B) WJMSC co-cultures 
were treated with neutralising antibodies against IL-6 or TGFβ, or a function blocking 
antibody against IL-6R for the duration of the co-culture and cytokine treatment. 
Neutrophil adhesion was assessed. Data are mean ± SEM from n= 4 experiments. 
ANOVA showed a significant effect of culture conditions on neutrophil adhesion, 
p<0.01. ** = p<0.01 compared to EC mono-cultures by Dunnett post-test. A different 
EC and neutrophil donor was used per experiment. 3 different BMMSC and 4 different 
WJMSC donors were used in this set of experiments. 
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Figure 4-12: Effect of blocking actions of IL-6 or TGFβ in MSC co-cultures on 
neutrophil behaviour. (A) BMMSC or (B) WJMSC co-cultures were treated with 
neutralising antibodies against IL-6 or TGFβ, or a function blocking antibody against 
IL-6R for the duration of the co-culture and cytokine treatment. Neutrophil behaviour 
was analysed and expressed as the percentage of adherent neutrophils that were 
rolling, stationary and migrated. Data are mean ± SEM, n= 4 experiments. In A, ANOVA 
showed no significant effect of culture conditions on neutrophil behaviour. In B, ANOVA 
showed a significant effect of culture conditions on neutrophil behaviour, p<0.01. * = 
p<0.05 and ** = p<0.01 compared to EC mono-cultures by Bonferroni post-test. A 
different EC and neutrophil donor was used per experiment. 3 different BMMSC and 4 
different WJMSC donors were used in this set of experiments. 
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4.2.7. Effects of passage on MSC-mediated suppression of neutrophil recruitment 
To determine whether passaging MSC altered their ability to suppress neutrophil 
recruitment, the effect of EC co-culture with p5, p7 and p9 BMMSC or p3, p5 and p7 
WJMSC was tested. TBMSC were not examined as they could not be expanded 
beyond p3. p5 BMMSC were found to significantly suppress neutrophil adhesion and 
this effect was diminished at p7 and p9 (Figure 4-13A). WJMSC retained their ability 
to significantly suppress neutrophil adhesion up to p7 (Figure 4-13B). Increasing 
passage of BMMSC to p7 and p9 did not significantly alter the behaviour of neutrophils 
adherent to co-cultures (Figure 4-14A). In contrast, increasing passage of WJMSC 
tended to reduce the percentage of rolling and stationary neutrophils and increase the 
percentage migrated compared to EC mono-cultures (Figure 4-14B). However, the 
change in neutrophil behaviour was only significant at p7 WJMSC co-culture (Figure 
4-14B). Next, we measured IL-6 generated by BMMSC and WJMSC co-cultures over 
passage to assess whether the loss of immunosuppression by MSC at later passage 
(Figure 4-13) was due to a reduction in IL-6 secretion in co-culture. However, co-
cultures at all passages of BMMSC and WJMSC produced similar levels of IL-6 (Figure 
4-15). Furthermore, the levels of IL-6 in co-culture were significantly higher than the 
individual mono-cultures (Figure 4-15). This suggests that while IL-6 may have been 
bioactive in co-culture, it was not the sole mediator responsible for the 
immunosuppression by these MSC populations.  
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Figure 4-13: Effect of BMMSC and WJMSC passage on their ability to suppress 
neutrophil adhesion. EC were co-cultured with (A) BMMSC or (B) WJMSC at different 
passage, on opposite sides of a filter for 24h prior to stimulation with TNFα for 4h. 
Parallel EC mono-cultures were set up and neutrophil adhesion was assessed. Data 
are mean ± SEM from n= 3-5 experiments. Assays at each passage were carried out 
on separate days, but EC mono-culture controls were performed on each occasion. 
Therefore, comparisons to controls were performed using an unpaired t-test. * = 
p<0.05 and ** = p<0.01 compared to EC mono-cultures. A different EC and neutrophil 
donor was used per experiment. At least 2 different BMMSC and 3 different WJMSC 
donors were used in this set of experiments. 
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Figure 4-14: Effect of BMMSC and WJMSC passage on the behaviour of 
neutrophils adherent to EC co-cultured with MSC.  EC were co-cultured with (A) 
BMMSC or (B) WJMSC at different passage, on opposite sides of a filter for 24h prior 
to stimulation with TNFα for 4h. Parallel EC mono-cultures were set up and the 
behaviour of adherent neutrophils was assessed. Neutrophil behaviour was expressed 
as the percentage of adherent neutrophils that were rolling, stationary and migrated. 
Data are mean ± SEM from n= 3-5 experiments. Assays at each passage were carried 
out on separate days, but EC mono-culture controls were performed on each occasion. 
Therefore, in B, comparisons to controls were performed using independent paired t-
tests. * = p<0.05 and ** = p<0.01 compared to EC mono-cultures. A different EC and 
neutrophil donor was used per experiment. At least 2 different BMMSC and 3 different 
WJMSC donors were used in this set of experiments. 
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Figure 4-15: Effect of MSC passage on the levels of IL-6 in EC and MSC mono-
culture and co-culture supernatants. IL-6 was measured in supernatants from 
mono-cultures or co-cultures of EC with (A) BMMSC, or (B) WJMSC at different 
passage. Data are mean ± SEM from n= 3 experiments. In A and B, ANOVA showed 
a significant effect of culture conditions on IL-6 secretion, p<0.01. ** = p≤0.01 
compared to EC mono-cultures by Dunnett post-test. 
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4.2.8. Assessment of downstream IL-6 and TGFβ signalling during co-culture 
To identify whether EC and/or MSC in the co-culture responded to soluble IL-6 and 
TGFβ, we set out to measure internal phosphorylated STAT3 (pSTAT3; downstream 
of IL-6) and phosphorylated Smad2/3 (pSmad2/3; downstream of TGFβ) in the 
BMMSC and EC during co-culture by flow cytometry. Initially, we validated the anti-
pSmad2/3 antibody by treating PBMC with recombinant TGFβ and then antibody 
staining the cells (as described in Section 2.7.2.). Treatment of PBMC with 
recombinant TGFβ1 increased the levels of pSmad2/3 (Figure 4-16A-B) confirming that 
the antibody could detect intracellular TGFβ signalling. 
 
We next assessed the expression of pSmad2/3 by EC after treatment with recombinant 
TGFβ1 to determine whether EC are able to respond to TGFβ and upregulate 
intracellular pSmad2/3. Expression of pSmad2/3 was upregulated by TGFβ treated EC 
compared to untreated EC (Figure 4-16C-D) indicating that the cells express the 
corresponding receptors and are able to signal through pSmad2/3.  
 
To validate the pSTAT3 antibody, PMN were treated with recombinant IL-6 and stained 
with anti-pSTAT3. While this cell type is known to respond to IL-6 and increase 
phosphorylation of STAT3, in our hands treatment with IL-6 did not increase the levels 
of pSTAT3 above the isotype control (Figure 4-16E-F). As IL-6 induced STAT3 
phosphorylation and degradation occurs rapidly, identifying the exact time at which this 
process occurs is very difficult. We attempted to measure pSTAT3 in IL-6 treated PMN 
at several earlier time points but once again pSTAT3 could not be detected (n=1). 
Consequently, pSTAT3 was not measured in co-cultures. 
113 
 
- +
0
5
10
15
B. PBMC
**
TGF1
M
F
I 
p
S
m
a
d
2
/3
- +
0
10
20
30
40
50
D. EC
TGF1
M
F
I 
p
S
m
a
d
2
/3
- +
0
2
4
6
8
F. PMN
IL-6
M
F
I 
p
S
T
A
T
3
A. PBMC
E. PMN
C. EC
 
Figure 4-16: Analysis of phosphorylated Smad2/3 or STAT3 in leukocytes or EC 
treated with TGFβ and IL-6. (A-D) PBMC or EC were treated with recombinant TGFβ1 
for 30min and stained with anti-pSmad2/3. In C and D, untreated EC mono-cultures 
were set up as a control. (A,C) Representative histogram plots of pSmad2/3 stained 
PBMC or EC compared to isotype control. (B,D) Median fluorescence intensity (MFI) 
for pSmad2/3 in TGFβ treated PBMC or EC after subtracting the isotype MFI. (E,F) 
PMN were treated with IL-6 for 15min and stained with anti-pSTAT3. (E) 
Representative histogram plot of pSTAT3 stained PMN. (F) MFI for pSTAT3 in IL-6 
treated PMN after subtracting the isotype MFI. Data are mean ± SEM from n= 3 
experiments. In B, paired t-test showed a significant effect of TGFβ-stimulation of 
Smad2/3 expression by PBMC; ** = p<0.01. In D and F, paired t-test showed no 
significant effect of treatment on expression. A different PBMC, EC and PMN donor 
was used per experiment.  
114 
 
We subsequently assessed whether pSmad2/3 was upregulated in EC during co-
culture and how early in the co-culture this signalling occurred. pSmad2/3 expression 
in EC co-cultures was measured at 4h, 6h and 24h and compared to EC mono-
cultures. Levels of pSmad2/3 was comparable in the EC mono-cultures and co-
cultures at each time point (Figure 4-17A-B). Furthermore, expression of pSmad2/3 in 
all cultures did not change over time (Figure 4-17A-B).  
 
We then assessed pSmad2/3 levels in EC at earlier time points (15min, 30min, 60min 
and 240min) during co-culture, in case we missed its upregulation. A steady increase 
in pSmad2/3 levels was observed between 15min and 60min which was then reduced 
at 240min, although the effect was not significant (Figure 4-17C-D). Furthermore, the 
median fluorescence intensity (MFI) values for pSmad2/3 were very low compared to 
TGFβ treated EC mono-cultures (Figure 4-16D) indicating that TGFβ downstream 
signalling in EC was not significantly upregulated at any point during co-culture. 
Analysis of pSmad2/3 in BMMSC mono-cultures and co-cultures at 4h, 6h and 24h 
also showed that co-culture had no effect on pSmad2/3 levels in BMMSC compared 
to mono-cultures (Figure 4-18). The MFI values for pSmad2/3 were very low and were 
comparable to the isotype control (Figure 4-18). pSmad2/3 levels in BMMSC at earlier 
time points during co-culture were not assessed as there were not enough cells 
available to perform these analyses. Collectively, these data suggest that co-culture 
does not affect intracellular TGFβ signalling in either EC or BMMSC in co-culture 
compared to mono-cultures.   
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Figure 4-17: Analysis of pSmad2/3 in EC during co-culture with BMMSC. EC were 
seeded onto filters with BMMSC for (A,B) 4h, 6h and 24h or (C,D) 15min, 30min, 60min 
and 240min, then detached and stained for pSmad2/3. In A and B, parallel EC mono-
cultures were also set up. (A,C) Representative histogram plots of pSmad2/3 stained 
EC at each time point compared to isotype control. (B,D) MFI for pSmad2/3 in EC after 
different lengths of time in co-culture after subtracting the isotype MFI. Data are mean 
± SEM from n=3 experiments. A different EC and BMMSC donor was used per 
experiment. 
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Figure 4-18: Analysis of pSmad2/3 in BMMSC during co-culture with EC. EC were 
seeded onto filters with BMMSC for 4h, 6h and 24h, BMMSC were then detached and 
stained for pSmad2/3. Parallel BMMSC mono-cultures were also set up. (A) 
Representative histogram plots of pSmad2/3 stained BMMSC at each time point 
compared to isotype control. (B) MFI for pSmad2/3 in BMMSC after different lengths 
of time in co-culture after subtracting the isotype MFI. Data are mean ± SEM from n=3 
experiments. A different EC and BMMSC donor was used per experiment. 
  
117 
 
4.3. Discussion 
In this chapter we utilised two in vitro flow based adhesion models with varying degrees 
of proximity between the MSC and EC to compare the ability of MSC from different 
tissues to regulate leukocyte recruitment. We observed that BMMSC, WJMSC and 
TBMSC suppressed the EC response to cytokine stimulation and limited neutrophil 
adhesion. Whilst all MSC types exerted the same effect on neutrophil adhesion, we 
observed several differences between the populations. WJMSC retained their 
immunosuppressive effects with passage while the effects of BMMSC was diminished 
by passage.    
 
In addition, WJMSC and TBMSC required close proximity with the EC to induce 
suppression while BMMSC could exert their effects at a distance albeit to a lesser 
degree. Co-culture conditioned media from all MSC populations suppressed neutrophil 
adhesion and IL-6 was found to be a common bioactive agent. However, higher 
passage BMMSC co-cultures still secreted high levels of IL-6 despite losing their 
suppressive effects on neutrophil recruitment, indicating a role for other bioactive 
agent(s). We previously showed that TGFβ was also a key regulator in BMMSC-
mediated suppression of neutrophil recruitment (Luu et al., 2013). Here, neutralisation 
of IL-6 and TGFβ effectively inhibited suppression by BMMSC and WJMSC in co-
culture showing that concerted action of both mediators was required to suppress 
neutrophil recruitment for either MSC population.  
 
While all MSC populations had similar effects on neutrophil adhesion, in the filter model 
later passage WJMSC were found to promote neutrophil migration compared to 
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BMMSC and TBMSC. This effect of WJMSC in co-culture with EC has not been 
previously reported. While the mechanism mediating this effect was not examined in 
this thesis, we hypothesise that it may have been driven by chemokines released by 
the WJMSC which bound to the EC surface to promote neutrophil migration. To 
examine the role of chemokines in WJMSC co-cultures, expression of IL-8 should be 
measured as it is a key mediator that drives neutrophil migration (Imaizumi et al., 
1997).  
 
The behaviour of adherent neutrophils was unaffected by co-culture with BMMSC and 
TBMSC which disagrees with our previous study which showed that BMMSC 
suppressed migration when incorporated in the EC monolayer (Luu et al., 2013). The 
discrepancies in the findings may be due to differences in the potency of the TNFα 
used as they were both purchased from different suppliers. The TNFα batch used in 
this study was found to be more potent than the batch used in the previous study. 
Indeed, using the microslide channel model, the percentage neutrophil migration in this 
study was found to be 40-60% on EC alone compared to 30-35% in the previous report 
(Luu et al., 2013). High concentrations of TNFα (100U/ml) used in this study may have 
overcome the suppressive effects of MSC on migration.  
 
MSC can mediate their suppressive effects through the release of soluble factors such 
as IDO and PGE2, with efficacy enhanced by direct contact with target cells [reviewed 
by (Munir and McGettrick, 2015)]. To test whether the MSC-mediated suppression was 
through released agents, we cultured EC in MSC conditioned media for the same 
length of time as the standard co-culture. Mono-culture conditioned media from all 
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MSC populations were inert while their suppressive effects were transferable in the co-
culture conditioned media. These results suggest that, similar to other immune-
protective responses of MSC, suppression of neutrophil adhesion by MSC is mediated 
through soluble agent(s). However, in this case, the factor(s) were only generated 
when MSC from the different sources were co-cultured with EC. This is consistent with 
our previous study (Luu et al., 2013) with BMMSC alone. In another report, medium 
from pulmonary EC and BMMSC co-cultures, but not mono-cultures, reduced adhesion 
of U937 cells (a monocytic leukaemia cell line) to TNFα-treated pulmonary EC under 
static conditions (Pati et al., 2011). This suggests that crosstalk between MSC and EC 
is essential for mediating suppression of neutrophil recruitment during inflammation.  
 
As the soluble factors responsible for mediating suppression were only generated 
during co-culture with EC, we subsequently tested whether close proximity between 
the MSC and EC was required for inducing crosstalk. EC and MSC cultured on 
opposite sides of a filter were held ~10µm apart, but cell-cell interactions may have 
occurred via the tips of protruding pseudopods through 0.4µm pores in the filter. 
Separation of MSC from EC by ~900µm significantly impaired the suppressive effects 
of WJMSC and TBMSC to a greater extent than BMMSC. This may have been due to 
differences in the sensitivity of MSC from different tissue sources to factor(s) released 
by EC; with WJMSC and TBMSC having a lower sensitivity than BMMSC.  Of note, 
separation of the two cell types in these assays may not represent the in vivo situation 
as generally the distance between tissue-resident cells and local blood vessels are 
unlikely to be as far apart as the distance between MSC and EC in these assays. Thus, 
in vivo, WJMSC and TBMSC may only be able to secrete soluble factor(s) mediating 
suppression of neutrophil infiltration when in close proximity to vascular EC. 
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Interestingly, IL-6 secretion was significantly reduced in separated WJMSC and 
TBMSC co-cultures suggesting that the soluble mediator(s) required to induce their 
immunosuppressive effect were only generated to sufficient levels when cells were in 
close proximity.  
 
Consistent with our previous report (Luu et al., 2013), crosstalk between EC and 
BMMSC, WJMSC or TBMSC was required to produce the high levels of IL-6 present 
in co-culture conditioned media. While IL-6 is often described as an inflammatory 
cytokine, that inhibits expansion of Treg cell populations and activated T-cell apoptosis 
[reviewed by (Scheller et al., 2011)], recent studies have shown that it acts on EC in a 
context dependent manner (Lally et al., 2005; Kuravi et al., 2014; Luu et al., 2013; 
McGettrick et al., 2009). In published studies, IL-6 either alone or in conjunction with 
TGFβ modified inflammatory infiltrates by inhibiting recruitment (Ulich et al., 1991; 
McGettrick et al., 2009) or by switching recruitment from neutrophils to mononuclear 
leukocytes (Hurst et al., 2001; Kaplanski et al., 2003; Rose-John et al., 2007). 
Furthermore, in our laboratory, pre- treating cytokine-stimulated EC with recombinant 
IL-6 suppressed recruitment of PBL or neutrophils suggesting that it can also act in an 
anti-inflammatory manner (Butler et al., 2011; McGettrick et al., 2009). Thus, in the 
context of leukocyte recruitment during inflammation, IL-6 appears to act in an anti-
inflammatory manner.  
 
We have previously shown that TGFβ is also active in BMMSC-mediated suppression 
of neutrophil recruitment (Luu et al., 2013). Here, we observed that neutralising either 
IL-6 or TGFβ signalling abolished the suppression of neutrophil adhesion by BMMSC 
121 
 
and WJMSC. This suggests that IL-6 and TGFβ act in conjunction to mediate 
suppression with one factor likely regulating the signalling of the other, as loss of either 
factor abrogated the effect. These data suggest that MSC from different tissue sources 
utilised the same mechanism to mediate suppression of neutrophil adhesion. This was 
not restricted to leukocyte recruitment, as a previous study showed that BMMSC, 
WJMSC and ADMSC utilised the same mechanism to suppress proliferation of PHA-
induced allogeneic T-cell proliferation and secretion of TNFα and IFNγ (Yoo et al., 
2009). The effect was mediated by soluble agents that were found to be secreted to 
similar levels by all 3 MSC populations (Yoo et al., 2009).  
 
In vitro expansion can have adverse effects on the proliferation and differentiation 
potential of adult MSC, which have been found to lose their capacity by p5-7 (Lo Surdo 
and Bauer, 2012; Choudhery et al., 2014), compared to foetal and neonatal MSC which 
retain their potential for longer in culture (p12-18) (Giuliani et al., 2011). As well as their 
proliferation and differentiation capacity, previous studies have shown that the 
immunomodulatory effects of MSC were altered by passage with foetal and neonatal 
MSC retaining their suppressive effects (predominantly on T-cell proliferation) for 
longer in culture than BMMSC (Li et al., 2012; Giuliani et al., 2011; Yu et al., 2014; 
Zhuang et al., 2014). In agreement, we showed that BMMSC co-cultures lost their 
ability to inhibit neutrophil adhesion more rapidly with passage than WJMSC. We 
hypothesised that the loss of suppression was due to a decrease in IL-6 secretion 
during co-culture. However, we observed that IL-6 levels were consistently higher in 
co-culture than EC mono-cultures. Therefore, MSC-mediated suppression required the 
action of other soluble factor(s) that were presumably downregulated by passage. For 
instance TGFβ production in co-culture may be reduced by MSC passage which would 
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abrogate their immunosuppressive capacity. However, the effects of passage on TGFβ 
levels in co-culture were not measured.  
 
To test which cells IL-6 and TGFβ signalled through in the co-culture, we attempted to 
measure the levels of phosphorylated downstream signalling molecules for the two 
pathways (pSTAT3 and pSmad2/3 respectively). However, we were unable to detect 
changes in pSTAT3 in positive control samples. As IL-6-STAT3 signalling is a rapid 
process that occurs shortly after binding of IL-6 to its receptor, the time point used in 
these assays (after 30min stimulation with IL-6) may have been too late. Given the 
rapid kinetics of IL-6-STAT3 signalling, identifying when IL-6 is upregulated in co-
culture could provide insight into when its signalling occurs. In future studies IL-6 levels 
in conditioned media from EC and MSC mono-cultures and co-cultures should be 
measured at several time points during the co-culture (1h, 4h, 6h, 12h and 24h) to 
elucidate when IL-6 signalling may occur.  
 
The cell types in co-culture that responded to TGFβ could not be determined as co-
culture did not appear to alter levels of pSmad2/3 in EC or BMMSC. The levels of TGFβ 
protein should be quantified in conditioned media to determine the effects of co-culture 
on its signalling. However, TGFβ is only active after proteolytic cleavage (Taylor, 
2009), therefore, only levels of the active form should be measured in co-culture 
conditioned media, not the total levels of TGFβ present. However, levels of active 
TGFβ protein in culture supernatants cannot be accurately assessed. Quantitative 
ELISA kits for measuring TGFβ have an acid activation step which activates all latent 
TGFβ present in culture media. As FCS contains high levels of latent TGFβ, this also 
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becomes activated. As a result, the levels of active TGFβ induced by co-culture would 
be masked by the levels of FCS-derived TGFβ. In future studies co-cultures should be 
set up in serum free culture media and after ensuring that they retain their suppressive 
effects in the new culture environment, the levels of active TGFβ should be measured.  
  
Currently, the majority of studies looking at the therapeutic potential of MSC are testing 
BMMSC, however other groups have shown that proliferation capacity of BMMSC is 
reduced in culture (Lo Surdo and Bauer, 2012; Choudhery et al., 2014). Furthermore, 
isolation of BM aspirate is a highly invasive and painful procedure making it an 
undesirable source for long term use. Recently MSC have been isolated from clinical 
waste tissues such as umbilical cord that exert similar effects as BMMSC 
(Christodoulou et al., 2013; Baksh et al., 2007; Jin et al., 2013; Roemeling-van Rhijn 
et al., 2013). Therefore, we assessed whether umbilical cord-derived WJMSC or 
trabecular bone-derived TBMSC (taken from patients after hip replacement surgery) 
could induce the same suppressive effect on recruitment as BMMSC. We observed 
that MSC from clinical waste tissue could suppress neutrophil recruitment to the same 
extent as BMMSC.  
 
The models used in this chapter mimic the action of MSC in co-culture with EC in 
different contexts. The microslide channel model, incorporating MSC into the EC 
monolayer does not occur physiologically but may arise after systemic infusion of MSC 
as a therapeutic intervention. Our data suggests that systemic infusion of early 
passage WJMSC or TBMSC in patients with chronic inflammation may suppress the 
influx of circulating leukocytes to the same extent as BMMSC. The filter model, where 
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MSC and EC were separated by a porous membrane mimics direct injection of MSC 
into the tissue for therapy. This indicates that WJMSC and TBMSC were able to 
suppress neutrophil recruitment when in reduced contact with the EC. However, close 
proximity was critical as separation of these MSC populations from EC reduced their 
suppressive effects. This suggests that the optimum method for administration of 
WJMSC or TBMSC would be directly into the target tissue ensuring that the cells are 
injected into a highly vascularised site. Therefore, WJMSC and TBMSC are both 
attractive alternative MSC sources that can be used as a treatment for chronic 
inflammation by inhibiting the aberrant recruitment of circulating leukocytes. Our 
results also suggest that treatment with co-culture conditioned medium may be just as 
effective as direct MSC infusion for treatment of chronic inflammation.    
 
The filter model also mimics the interactions between EC and MSC in vivo as MSC are 
generally located in the perivascular niche in close proximity to EC (Méndez-Ferrer et 
al., 2010). Therefore, we showed that as well as their reparative functions, tissue-
resident MSC may also suppress the aberrant recruitment of neutrophils in response 
to cytokines in an attempt to dampen inflammation. Previous studies have shown that 
other tissue-resident stromal cells are also capable of inducing this effect (Kuravi et al., 
2014; McGettrick et al., 2009). Thus, we conclude that MSC in this context are a model 
of tissue stroma which is an inherently suppressive microenvironment that acts to limit 
leukocyte infiltration during inflammation. It has previously been reported that stromal 
cells (i.e. fibroblasts) from chronically inflamed sites lose their capacity to suppress 
leukocyte recruitment in response to changes in their local microenvironment 
[reviewed by (McGettrick et al., 2012)]. It would be interesting to test the effects of 
chronic inflammation on the capacity of MSC to regulate recruitment.  
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In conclusion, we have shown that MSC from three different sources are capable of 
suppressing neutrophil recruitment to inflamed endothelium in an IL-6 and TGFβ-
dependent manner. The effect of MSC co-culture could be achieved by co-culture 
conditioned media and was dependent upon proximity between MSC and EC and their 
effects were diminished with passage. Based on these data we propose that MSC act 
as endogenous regulators of the response of EC to cytokines which may limit 
recruitment of the inflammatory infiltrate.  
  
126 
 
 
 
 
 
 
 
 
 
5. Effect of differentiation on the 
capacity of MSC to regulate 
leukocyte recruitment  
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5.1. Introduction 
MSC differentiation in vivo is thought to be a normal physiological process in response 
to tissue damage. However, recent evidence suggest that MSC may aberrantly 
differentiate (namely into adipocytes and osteoblasts) in chronically inflamed tissue, 
potentially contributing to ectopic fat and bone commonly found at these sites (Uezumi 
et al., 2010; Breitbach et al., 2007). While the immune-protective functions of MSC 
have been extensively studied, the effect of differentiation on these responses have 
not been well characterised. We hypothesised that MSC lose their ability to suppress 
leukocyte recruitment after adipogenic differentiation which may contribute to chronic 
inflammation.  
 
Using the filter-based adhesion assay, we examined whether BMMSC-derived 
adipocytes regulate the recruitment of leukocytes from flow and the mechanism 
involved in mediating their effects. We then used a 3D collagen gel model to assess 
whether adipocyte co-culture with EC influences neutrophil migration into tissue. 3D 
collagen gel assays performed with microvascular blood EC (BEC) and gene 
expression analysis of adhesion markers by EC in co-culture with MSC and adipocytes 
were performed by my project student under my supervision. Finally, we examined 
whether subcutaneous fat-derived pre-adipocytes (pre-AD; before and after in vitro 
adipogenic differentiation) and mature adipocytes (AD) share similar characteristics as 
BMMSC-derived adiopocytes, in terms of their ability to modulate leukocyte 
recruitment from flow. 
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5.2. Results 
5.2.1. Effects of MSC or MSC-derived adipocyte culture on leukocyte recruitment 
Initially, MSC were differentiated for 21 days using adipogenic induction media, we 
then examined expression of adipocyte markers, PPARγ, C/EBPα and FABP4 in 
BMMSC and BMMSC-derived adipocyte mono-cultures to confirm that they were 
upregulated upon differentiation. Expression of all 3 markers were increased upon 
differentiation compared to undifferentiated BMMSC mono-cultures, although only the 
increase in FABP4 expression was statistically significant (Figure 5-1). Adipocyte 
marker expression by WJMSC and TBMSC was not analysed as there were insufficient 
cells to perform these analyses. Then we tested the effect of adipogenic differentiation 
on the ability of MSC from different sources to suppress neutrophil adhesion. 
Adipogenic differentiation of BMMSC, WJMSC and TBMSC reduced their ability to 
suppress neutrophil adhesion to TNFα-stimulated EC compared to undifferentiated 
MSC, although the loss of suppression was only significant with BMMSC (Figure 5-2). 
Differentiation appeared to have no significant effect on the behaviour of adherent 
neutrophils compared to MSC co-culture (Figure 5-3). BMMSC exhibited a greater 
adipogenic differentiation potential than WJMSC (Section 3.4.) and were therefore 
used in all subsequent assays. Subsequently, we assessed the effect of BMMSC-
derived adipocyte co-culture with EC on PBL recruitment after 24h TNFα and IFNγ-
stimulation. In contrast, to their effects on neutrophil recruitment, co-culture with 
BMMSC-derived adipocytes significantly suppressed PBL adhesion to the same extent 
as BMMSC (Figure 5-4A), but had no effect on their subsequent behaviour, when 
compared to EC mono-cultures (Figure 5-4B). Therefore, while adipogenic 
differentiation alters their capacity to regulate neutrophil recruitment, the effects of 
BMMSC on PBL recruitment were unaffected by differentiation.  
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Figure 5-1: Expression of adipocyte markers by BMMSC after adipogenic 
differentiation. BMMSC were cultured in the presence or absence of adipogenic 
induction media for 21 days. Gene expression for the adipocyte markers (A) PPARγ, 
(B) C/EBPα and (C) FABP4 were examined by qPCR. Data are mean ± SEM from n= 
3 independent experiments. In A and B, paired t-test showed no significant effect of 
differentiation on gene expression. In C, paired t-test showed a significant change in 
gene expression upon differentiation; p<0.05. 2 different BMMSC donors were used in 
this set of experiments. 
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Figure 5-2: Effect of adipogenic differentiation of MSC on neutrophil adhesion. 
BMMSC, WJMSC and TBMSC were cultured in adipogenic induction media for 21 
days, seeded onto Transwell filters and co-cultured with EC for 24h. Parallel MSC co-
cultures were also set up as a control. Cultures were stimulated with 100U/ml TNFα 
for 4h and neutrophil adhesion to (A) BMMSC, (B) WJMSC and (C) TBMSC 
undifferentiated and differentiated co-cultures was examined. Data are mean ± SEM 
from n= 3 independent experiments. In A and C, ANOVA showed a significant effect 
of culture conditions on neutrophil adhesion, p<0.01 and p<0.05 respectively. * = 
p<0.05 and ** = p<0.01 by Bonferroni post-test. In B, ANOVA showed no significant 
effect of culture conditions on neutrophil adhesion. A different EC and neutrophil donor 
was used per experiment. 2 different BMMSC and 3 different WJMSC and TBMSC 
donors were used in this set of experiments. 
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Figure 5-3: Effect of adipogenic differentiation of MSC on neutrophil behaviour. 
BMMSC, WJMSC and TBMSC were cultured in adipogenic induction media for 21 
days, seeded onto Transwell filters and co-cultured with EC for 24h. Parallel MSC co-
cultures were also set up as a control. Cultures were stimulated with 100U/ml TNFα 
for 4h and the behaviour of adherent neutrophils was examined in (A) BMMSC, (B) 
WJMSC and (C) TBMSC undifferentiated and differentiated co-cultures. Neutrophil 
behaviour was expressed as the percentage of adherent neutrophils that were rolling, 
stationary or migrated. Data are mean ± SEM from n= 3 independent experiments. 
ANOVA showed no significant effect of culture conditions on neutrophil behaviour. A 
different EC and neutrophil donor was used per experiment. 2 different BMMSC and 3 
different WJMSC and TBMSC donors were used in this set of experiments. 
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Figure 5-4: Effect of adipogenic differentiation of MSC on PBL recruitment. 
BMMSC were cultured in adipogenic induction media for 21 days, seeded onto 
Transwell filters and co-cultured with EC for 24h. Parallel MSC co-cultures were also 
set up as a control. Cultures were stimulated with 100U/ml TNFα and 10ng/ml IFNγ for 
24h. PBL (A) adhesion and (B) behaviour were analysed. PBL behaviour was 
expressed as the percentage of adherent neutrophils that were rolling, stationary or 
migrated. Data are mean ± SEM from n= 3 independent experiments. In A, ANOVA 
showed a significant effect of culture conditions on PBL adhesion, p<0.01. ** = p<0.01 
by Dunnett post-test compared to EC mono-cultures. In B, ANOVA showed no 
significant effect of culture conditions on PBL behaviour. A different EC and PBL donor 
was used per experiment and 2 different BMMSC were used in this set of experiments. 
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5.2.2. Effect of adipogenic differentiation on neutrophil recruitment in response to low-
grade inflammation 
While BMMSC-derived adipocytes lose their capacity to suppress neutrophil 
recruitment at high dose TNFα (100U/ml), they did not enhance neutrophil adhesion 
either. We hypothesised that at high dose TNFα, the maximum level of recruitment by 
EC may have been reached and so any pro-inflammatory effects would be masked. 
Therefore, BMMSC and differentiated adipocytes were co-cultured with EC and treated 
with lower doses of TNFα (0.1U/ml or 1U/ml). For both TNFα doses, low levels of 
neutrophil adhesion were observed on EC cultured alone or with BMMSC (Figure 5-
5A). MSC co-culture did not significantly suppress neutrophil adhesion and co-culture 
with BMMSC-derived adipocytes tended to increase neutrophil adhesion in response 
to low dose TNFα when compared to EC mono-cultures, although this effect was not 
significant (Figure 5-5A). In all conditions, the majority of adherent neutrophils were 
rolling or stationary, with a low percentage of cells undergoing transmigration (Figure 
5-5B and C). Co-culture had no significant effect on neutrophil behaviour (Figure 5-5B 
and C).  
 
5.2.3. Effect of adipocyte co-culture on the expression of IL-6 signalling molecules  
As we have previously shown that IL-6 was a key immunosuppressive mediator 
(Section 4.2.6.), we questioned whether secretion of IL-6 or its soluble receptors (sIL-
6R) were reduced in MSC-derived adipocyte co-cultures and therefore could explain 
the loss of immunosuppression observed.  Therefore, IL-6 and sIL-6R levels were 
measured in EC, BMMSC and BMMSC-derived adipocyte mono-culture and co-culture 
conditioned media after 24h. 
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Figure 5-5: Effect of adipogenic differentiation of MSC on neutrophil recruitment 
in response to low dose TNFα. BMMSC were cultured in adipogenic induction media 
for 21 days, seeded onto Transwell filters and co-cultured with EC for 24h. Parallel 
MSC co-cultures were also set up as a control. Cultures were stimulated with 0.1U/ml 
or 1U/ml TNFα 4h and neutrophil (A) adhesion and (B-C) behaviour were analysed. 
Neutrophil behaviour was expressed as the percentage of adherent neutrophils that 
were rolling, stationary or migrated. Data are mean ± SEM from n= 3 independent 
experiments. ANOVA showed no significant effect of culture condition on neutrophil 
adhesion or behaviour. A different EC, BMMSC and neutrophil donor was used per 
experiment.  
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In contrast to BMMSC mono-cultures, conditioned media from adipocyte mono-
cultures contained significantly higher levels of IL-6 than EC mono-cultures and co-
culture with EC did not significantly alter its production (Figure 5-6A). sIL-6R levels on 
the other hand did not significantly change in any of the culture conditions (Figure 5-
6B). Therefore, changes in IL-6 or sIL-6R secretion could not account for the loss of 
MSC-mediated suppression of neutrophil recruitment upon differentiation.  
 
The gene expression of components of the IL-6 signalling pathway (IL-6, IL-6R, IL-6ST 
[signal transducer] and SOCS3 [an IL-6 inducible gene]) were also analysed to 
determine whether any changes in their expression in EC, MSC or adipocytes occurred 
during co-culture. IL-6 gene expression was elevated in EC from BMMSC co-cultures 
compared to EC cultured alone, or with adipocytes although the effect was not 
significant (Figure 5-7A). The receptors for IL-6 (IL-6R and IL-6ST) and SOCS3 were 
up-regulated in EC in co-culture with either BMMSC or adipocytes at the mRNA level, 
compared to EC cultured alone although the effect was not statistically significant 
(Figure 5-7B, C and D). Furthermore. IL-6, IL-6R, IL-6ST and SOCS3 gene expression 
tended to be slightly increased in BMMSC upon co-culture compared to BMMSC 
mono-cultures, although the increase was not statistically significant (Figure 5-7E-H). 
In contrast, these genes tended to be expressed at much lower levels in adipocytes 
during co-culture compared to mono-culture, however, the difference in gene 
expression was not statistically significant (Figure 5-7I-L). IL-6 gene expression 
remained high in adipocytes during co-culture (Figure 5-7I) suggesting that these cells 
secreted IL-6 during co-culture with EC, as EC did not upregulate IL-6 expression in 
co-culture.    
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Figure 5-6: Levels of IL-6 and sIL-6R in EC, BMMSC and BMMSC-derived 
adipocyte mono-culture and co-culture supernatants. (A) IL-6 and (B) sIL-6R 
levels were measured in supernatants from 24h mono-cultures or co-cultures of EC, 
BMMSC and BMMSC-derived adipocytes on Transwell filters. Data are mean ± SEM 
from (A) n= 9 and (B) n= 4 independent experiments. In A, ANOVA showed a 
significant effect of culture conditions on IL-6 secretion, p<0.01. ** = p<0.01 compared 
to EC mono-cultures by Dunnett post-test. In B, ANOVA showed no significant effect 
of culture conditions on sIL-6R levels in supernatants. 
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Figure 5-7: Expression of IL-6 related genes by EC, MSC and adipocytes. BMMSC were cultured in adipogenic induction media 
for 21 days, seeded onto Transwell filters and co-cultured with EC for 24h. Parallel MSC co-cultures were also set up as a control. 
RNA from each cell type was isolated and the expression of (A,E,I) IL-6, (B,F,J) IL-6R, (C,G,K) IL-6ST and (D,H,I) SOCS3 were 
analysed by qPCR in parallel EC, BMMSC and adipocytes mono-cultures and co-cultures. Data are mean ± SEM from n= 3 
independent experiments.  Paired t-test showed no significant difference in gene expression for all conditions tested. A different EC 
donor was used per experiment and 2 different BMMSC donors were used in this set of experiments.
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5.2.4. Effect of adipocyte co-culture on the expression of TGFβ signalling molecules 
As we showed that the suppressive effects of BMMSC on neutrophil recruitment were 
mediated by the concerted action of IL-6 and TGFβ (Section 4.2.6.), we hypothesised 
that the loss of suppression upon differentiation may be due to a decrease in TGFβ 
expression in EC or adipocytes in co-culture. The expression of TGFβ1, TGFβ2 and 
TGFβ3 and decorin (a TGFβ1 binding protein) was assessed in EC, BMMSC and 
adipocyte mono-cultures and co-cultures. The expression of all 3 TGFβ isoforms and 
decorin were upregulated in EC co-cultured with BMMSC but not adipocytes, however, 
only the increase in TGFβ1 and TGFβ3 expression was significant (Figure 5-8A-D). 
Expression of all TGFβ isoforms were highest in BMMSC and adipocyte mono-cultures 
and tended to be reduced by co-culture, although the change in expression was not 
statistically significant (Figure 5-8E-G and I-K). Decorin was expressed at similar levels 
by BMMSC mono-cultures and co-cultures (Figure 5-8H). In contrast, expression of 
decorin by adipocytes tended to be downregulated during co-culture although the 
effects were not significant (Figure 5-8L). This suggests that during adipocyte co-
culture, while IL-6 secretion is still upregulated, TGFβ expression is suppressed and 
may not be present to mediate suppression of neutrophil recruitment along with IL-6.  
 
5.2.5. Effect of adipocyte co-culture on expression of adhesion molecules by EC  
We also analysed E-selectin and VCAM1 gene expression by TNFα-stimulated EC in 
co-culture, to assess whether MSC or MSC-derived adipocyte co-culture altered the 
expression of adhesion markers by EC. However, expression of E-selectin and VCAM1 
was highest in EC mono-cultures and tended to be reduced in BMMSC and adipocyte 
co-culture, although the decrease was not statistically significant (Figure 5-9). 
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Figure 5-8: Gene expression of TGFβ and decorin by EC, MSC and adipocytes. BMMSC were cultured in adipogenic induction 
media for 21 days, seeded onto Transwell filters and co-cultured with EC for 24h. Parallel MSC co-cultures were also set up as a 
control. RNA from each cell type was isolated and the expression of (A,E,I) TGFβ1, (B,F,J) TGFβ2, (C,G,K) TGFβ3 and (D,H,I) Decorin 
were analysed by qPCR. In parallel EC, BMMSC and adipocytes mono-cultures and co-cultures were also set up. Data are mean ± 
SEM from n= 3 independent experiments. In A and C, ANOVA showed a significant effect culture conditions on gene expression by 
EC, p<0.05. * = <0.05 compared to BMMSC co-culture by Bonferroni post-test.  In E-L, paired t-test showed no significant difference 
in gene expression for all conditions tested. A different EC donor was used per experiment and 2 different BMMSC donors were used 
in this set of experiments.
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Figure 5-9: Gene expression of adhesion markers by EC mono-cultures and co-
cultures after stimulation with TNFα. BMMSC were cultured in adipogenic induction 
media for 21 days, seeded onto Transwell filters and co-cultured with EC for 24h. 
Parallel MSC co-cultures were also set up as a control. All cultures were stimulated 
with TNFα for 2h. RNA from EC was isolated and the expression of (A) E-selectin and 
(B) VCAM1 were analysed by qPCR. Data are mean ± SEM from n= 3 independent 
experiments. ANOVA showed no significant difference in gene expression for all 
culture conditions tested.  A different EC donor was used per experiment and 2 
different BMMSC donors were used in this set of experiments. 
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This suggests that the loss of suppression with adipocytes was not due to an increase 
in adhesion molecule expression on EC. 
 
5.2.6. Roles of soluble factors in the loss of suppression by MSC-derived adipocytes 
As IL-6 secretion was high in adipocyte co-culture, we wanted to assess whether 
adipocyte co-culture conditioned media suppressed recruitment to the same extent as 
BMMSC co-culture. Unlike BMMSC co-culture conditioned media which significantly 
suppressed neutrophil adhesion, treatment of EC with conditioned media from 
adipocyte mono-cultures or co-cultures had no statistically significant effect on 
neutrophil adhesion compared to EC cultured alone (Figure 5-10A). Neutrophil 
behaviour was also not significantly altered by treatment with all conditioned media 
(Figure 5-10B). Therefore, adipocyte co-culture conditioned media, despite containing 
high levels of IL-6 was unable to suppress neutrophil recruitment.   
 
Next we examined the effect of neutralising IL-6 and TGFβ on neutrophil recruitment 
to BMMSC-derived adipocytes co-cultures to assess whether these factors play a role 
in the loss of suppression observed. Neutralisation of IL-6 alone or in combination with 
TGFβ in adipocyte co-cultures significantly suppressed neutrophil adhesion compared 
to EC mono-cultures (Figure 5-11A). In contrast, TGFβ neutralisation had no significant 
effect on neutrophil adhesion, which was to be expected given that its expression was 
reduced during adipocyte co-culture (Figure 5-8). Antibody treatment had no 
statistically significant effect on the behaviour of adherent neutrophils (Figure 5-11B). 
Therefore, loss of suppression by MSC upon differentiation was mediated by IL-6 but 
not TGFβ.  
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Figure 5-10: Effect of adipocyte conditioned media on neutrophil recruitment. 
Conditioned media were harvested from BMMSC and adipocytes cultured alone or with 
EC for 24h. EC mono-cultures were treated with conditioned media for 24h before 
stimulation with 100U/ml TNFα for 4h in the same culture media. Neutrophil (A) 
adhesion and (B) behaviour were analysed. Neutrophil behaviour was expressed as 
the percentage of adherent neutrophils that were rolling, stationary or migrated. Data 
are mean ± SEM from n= 5 experiments. In A, ANOVA showed a significant effect of 
culture conditions on neutrophil adhesion, p<0.01. ** = p<0.01 by Dunnett post-test 
compared to EC mono-cultures. In B, ANOVA showed no significant effect of culture 
conditions on neutrophil behaviour. A different EC and neutrophil donor was used per 
experiment and mono-culture and co-culture conditioned media from 3 different 
BMMSC donors were used in this set of experiments.  
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Figure 5-11: Effect of neutralisation of IL-6 and TGFβ in adipocyte co-culture on 
neutrophil recruitment. Adipocyte co-cultures were treated with neutralising 
antibodies against IL-6 or TGFβ alone or in combination for the duration of the co-
culture and 4h cytokine treatment. Neutrophil (A) adhesion and (B) behaviour were 
assessed. Neutrophil behaviour was expressed as the percentage of adherent 
neutrophils that were rolling, stationary or migrated. Data are mean ± SEM from n= 3 
independent experiments. In A, ANOVA showed a significant effect of culture 
conditions on neutrophil adhesion, p<0.01. * = p<0.05 and ** = p<0.01 by Dunnett post-
test compared to EC mono-cultures. In B, ANOVA showed no significant effect of 
culture condition on neutrophil behaviour. A different EC, BMMSC and neutrophil donor 
was used per experiment. 
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Subsequently, we used a cytokine expression array to detect the presence of 102 
cytokines in 4 different conditioned media from one experiment (EC mono-culture, 
BMMSC co-culture and adipocyte mono-cultures and co-cultures). Our aim was to use 
this unbiased screen to identify differences in cytokine secretion between MSC and 
adipocyte co-cultures that could be responsible for the loss of immunosuppression 
observed (Figure 5-12A). Of the screened cytokines, Angiogenin, Complement factor 
D and CD105 were higher in adipocyte co-culture than BMMSC co-culture conditioned 
media (Figure 5-12B). In addition, adipocyte co-culture was found to increase secretion 
of several other cytokines, including Angiogenin, Complement factor D and CD105, 
compared to EC and adipocyte mono-cultures (Figure 5-12C).  
 
As CD105 is an auxiliary TGFβ co-receptor, we hypothesised that increased shedding 
of CD105 in adipocyte co-cultures compared to MSC co-cultures reduced TGFβ 
signalling in co-culture, inhibiting the suppression of neutrophil recruitment. To validate 
the results of the array, we measured CD105 levels in EC, BMMSC and adipocyte 
mono-cultures and co-cultures by ELISA. BMMSC and adipocyte co-cultures had 
higher levels of CD105 compared to all mono-culture conditions, although it was only 
significant with BMMSC co-culture (Figure 5-13). Furthermore, the concentration of 
CD105 detected in all samples was very low (Figure 5-13). In contrast to the cytokine 
array data, we observed no statistically significant difference in the concentration of 
CD105 released during BMMSC or adipocyte co-culture with EC (Figure 5-13). 
Therefore, changes in CD105 do not account for the differences in immunosuppression 
observed between the two co-cultures.  
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Figure 5-12: Comparison of cytokine secretion in EC, BMMSC and BMMSC-
derived adipocyte mono-culture and co-culture supernatants. 24h EC mono-
culture, BMMSC co-culture, adipocyte mono-culture and co-culture conditioned media 
from one experiment were added to (A) membrane antibody arrays. The average pixel 
density for each cytokine was analysed. The integrated density of each analyte in (B) 
BMMSC vs. adipocyte co-cultures and (C) EC and adipocyte mono-cultures vs. 
adipocyte co-cultures were compared. In B and C, data are mean ± SEM from duplicate 
analytes in n= 1 experiment. 
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Figure 5-13: Levels of CD105 in BMMSC and adipocyte mono-culture and co-
culture supernatants. CD105 was measured in supernatants from 24h mono-cultures 
or co-cultures of EC, BMMSC and BMMSC-derived on Transwell filters. Data are mean 
± SEM from n= 6 independent experiments. ANOVA showed a significant effect of 
culture conditions on CD105 levels, p<0.01 ** = p<0.01 compared to EC mono-cultures 
by Dunnett post-test. 
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5.2.7. Effect of fatty acid treatment of MSC-derived adipocyte on leukocyte adhesion 
Next, we wanted to determine whether treatment of BMMSC-derived adipocytes with 
fatty acids (present in metabolic disorders) enhanced leukocyte adhesion by shifting 
the adipocytes into a pro-inflammatory state. BMMSC were differentiated on filters for 
21 days and then treated with oleic acid (OA) for 24h prior to co-culture with EC. 
Neutrophil and PBL adhesion was examined. In these assays fluorescently labelled 
leukocytes were perfused over the endothelium because the lipid droplets within the 
differentiated MSC-derived adipocytes obscured the image on the filter making it 
difficult to visualise the adherent leukocytes. Consequently, leukocyte behaviour was 
not analysed as it was too difficult to distinguish stationary and transmigrated 
leukocytes under fluorescence. OA treatment had no significant effect on neutrophil 
adhesion to untreated or TNFα treated adipocyte co-cultures when compared to 
matched EC controls (Figure 5-14A and B). Co-culture with BMMSC-derived 
adipocytes significantly suppressed PBL adhesion (Figure 5-14C). In contrast, treating 
adipocytes with OA reversed their ability to suppress PBL adhesion in response to 
cytokines (Figure 5-14C). The increase in PBL adhesion was statistically significant 
compared to untreated BMMSC-derived co-cultures. This suggests that OA treatment 
may cause adipocytes to become pro-inflammatory by abrogating their ability to 
suppress PBL recruitment. OA treatment tended to reduce the concentration of IL-6 
measured in adipocyte mono-culture and co-culture conditioned media, but the effect 
was not significant (Figure 5-15).  
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Figure 5-14: Effect of OA treatment of adipocytes on neutrophil and PBL 
adhesion. BMMSC were adipogenically differentiated for 21 days and seeded onto 
filters. Adipocytes were treated with or without OA for 24h prior to seeding the EC. 
Neutrophil adhesion to (A) unstimulated and (B) 100U/ml TNFα-stimulated EC were 
analysed. (C) PBL adhesion to EC mono-cultures and adipocyte co-cultures treated 
with 100U/ml TNFα and 10ng/ml IFNγ was also analysed. Data are mean ± SEM from 
n= 3 independent experiments. In A and B, ANOVA showed no significant effect of 
culture conditions on neutrophil adhesion. In C, ANOVA showed a significant effect of 
culture conditions on PBL adhesion, p<0.01. ** = p<0.01 by Bonferroni post-test 
compared to EC mono-cultures. A different EC and leukocyte donor was used per 
experiment and 2 different BMMSC donors were used in this set of experiments. 
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Figure 5-15: Levels of IL-6 in EC and adipocyte mono-culture and co-culture 
supernatants after OA treatment. BMMSC were adipogenically differentiated for 21 
days and seeded onto filters. Adipocytes were treated with or without OA for 24h prior 
to seeding the EC. Conditioned media from 24h mono-cultures and co-cultures were 
harvested and IL-6 was measured. Data are mean ± SEM from n= 3 independent 
experiments. ANOVA showed no significant effect of culture conditions on IL-6 
secretion.   
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5.2.8. Effects of human adipocytes on leukocyte recruitment 
We then assessed the effects of adult human pre-AD and mature AD on neutrophil and 
PBL adhesion to determine whether they exert the same effects as BMMSC-derived 
adipocytes. Co-culture with pre-AD tended to suppress neutrophil adhesion compared 
to EC mono-cultures, although this was not significant (Figure 5-16A). Pre-AD 
significantly suppressed PBL adhesion compared to EC cultured alone (Figure 5-16B). 
Unlike BMMSC, pre-AD tended to suppress neutrophil and PBL adhesion after 
adipogenic differentiation, although again the effect was not significant (Figure 5-16). 
Co-culture with mature AD also significantly suppressed neutrophil and PBL adhesion 
compared to EC mono-cultures (Figure 5-17A and B) but had no statistically significant 
effect on the behaviour of adherent neutrophils (Figure 5-17C and D). Therefore, 
BMMSC-derived adipocytes do not exert the same effect on recruitment as actual 
human pre-AD and mature AD. However much like BMMSC-derived adipocytes, pre-
AD and mature AD mono-cultures secreted significantly higher levels of IL-6 than EC 
mono-cutlures and co-culture did not alter its secretion (Figure 5-18).  
 
5.2.9. Effect of BMMSC and BMMSC-derived adipocyte co-culture on the behaviour 
of migrated neutrophils 
In a small series of experiments we also analysed the effects of BMMSC-derived 
adipocytes on the onward migration of neutrophils through a 3D collagen gel matrix as 
we wondered whether they could alter neutrophil migration. In response to TNFα-
stimulation, co-culture with BMMSC suppressed neutrophil adhesion at 20min and 
120min, where at the latter time point adhesion was significantly reduced compared to 
EC controls (Figure 5-19A and B).  
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Figure 5-16: Effect of undifferentiated and differentiated pre-AD on neutrophil 
and PBL adhesion. Pre-AD isolated from subcutaneous fat was seeded onto 
Transwell filters and cultured in adipogenic induction media for 21 days. EC were 
seeded onto the filters and co-cultured for 24h. Parallel undifferentiated pre-AD co-
cultures were also set up. (A) Neutrophil and (B) PBL adhesion to EC treated with 
100U/ml TNFα or 100U/ml TNFα and 10ng/ml IFNγ respectively was analysed. Data 
are mean ± SEM from n= 3 independent experiments. In A, ANOVA showed no 
significant effect of culture conditions on neutrophil adhesion. In B, ANOVA showed a 
significant effect of culture conditions on PBL adhesion, p<0.05. * = p<0.05 by 
Bonferroni post-test compared to EC mono-cultures. A different EC, leukocyte and pre-
AD donor was used per experiment. 
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Figure 5-17: Effect of mature AD on neutrophil and PBL recruitment. Mature AD 
isolated from subcutaneous fat were added to a 6-well plate. EC were seeded above 
them onto a Transwell filter and co-cultured for 24h. (A,C) Neutrophil and (B,D) PBL 
adhesion and behaviour to EC treated with 100U/ml TNFα or 100U/ml TNFα and 
10ng/ml IFNγ respectively was analysed. Data are mean ± SEM from n= 4 independent 
experiments. In A and B, paired t-test showed a significant effect of mature AD co-
culture on neutrophil and PBL adhesion respectively. * = p<0.05 and ** = p<0.01. In C 
and D, paired t-test did not show a significant effect of mature AD co-culture on 
neutrophil and PBL behaviour respectively. A different EC, leukocyte and mature AD 
donor was used per experiment. 
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Figure 5-18: Levels of IL-6 in EC, pre-AD and mature AD mono-culture and co-
culture supernatants. IL-6 was measured in supernatants from mono-cultures or co-
cultures of EC, pre-AD and mature AD cultured for 24h on Transwell filters. Data are 
mean ± SEM from n= 5 independent experiments. ANOVA showed a significant effect 
of culture conditions on IL-6 secretion, p<0.01. ** = p<0.01 compared to EC mono-
cultures by Dunnett post-test. 
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Figure 5-19: Effect of adipocyte differentiation on neutrophil adhesion and 
migration into 3D collagen gels in response to TNFα. BMMSC or adipocytes were 
incorporated into collagen gels for 24h. EC were then seeded onto the gels for a further 
24hr and were stimulated with 100U/ml TNFα for 4hr. Neutrophils (5x105) were added 
to gels for 20min, non-adherent cells were washed off. Neutrophil adhesion and 
migration was assessed after 20min and 120min. (A,B) The percentage of neutrophils 
that were added to the gels that adhered after 20min and 120min respectively. The 
percentage of adherent neutrophils that were (C,D) surface adherent, (E,F) 
transendothelial migrated and (G,H) penetrated into the gel were assessed.  Data are 
mean ± SEM from n= 3 experiments. In B, ANOVA showed a significant effect on 
culture conditions, p<0.01, on the percentage of adherent neutrophils. **p<0.01 by 
Bonferroni post-test. In C-H, ANOVA showed no significant effect of culture conditions 
on neutrophil migration through gels. A different EC, neutrophil and BMMSC donor was 
used per experiment.  
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In agreement with the filter flow assay, adipogenic differentiation of BMMSC abrogated 
their suppressive effects on neutrophil adhesion at both time points (Figure 5-19A and 
B). Of those adherent cells, ~20% were surface bound and ~4% had migrated just 
under the endothelium, with the majority (80%) of cells having migrated into the gel at 
20min and 120min (Figure 5-19C-H). 
 
The behaviour of adherent neutrophils was not significantly affected by co-culture at 
both time points (Figure 5-19C-H). Most neutrophils that penetrated the gel tended to 
stay close to the surface after 20min with the average depth of penetration being 
~55µm (Figure 5-20A and Figure 5-21A). After 120min, the migrated neutrophils 
migrated slightly deeper into the gel and the average depth of penetration was 
increased to ~90µm (Figure 5-20B and 5-21B). Co-culture with BMMSC and BMMSC-
derived adipocytes had no significant effect on the depth of neutrophil penetration 
(Figure 5-20 and 5-21). Interestingly, similar effects on neutrophil adhesion and 
subsequent migration into gels were observed when MSC-derived adipocyte 
(Appendix 1-1 to 1-3) and MSC-derived osteoblasts (Appendix 1-3 to 1-6) co-cultures 
were formed with BEC. Therefore, MSC lost the ability to suppress neutrophil adhesion 
upon differentiation but had no effect on the onward migration of neutrophils into gels.  
 
To assess whether MSC-derived adipocytes were pro-inflammatory, neutrophil 
adhesion and onward migration into gels in the absence of cytokines was analysed. 
Adipocytes tended to support binding of a higher percentage of neutrophils compared 
to EC cultured alone or with BMMSC, although the numbers were low and there was 
no significant difference between conditions (Figure 5-22A).  
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Figure 5-20: Effect of adipocytes co-culture on the position of migrated 
neutrophils within 3D collagen gels in response to TNFα. BMMSC or adipocytes 
were incorporated into collagen gels for 24h. EC were then seeded onto the gels for a 
further 24hr and were stimulated with 100U/ml TNFα for 4hr. Neutrophils (5x105) were 
added to gels for 20min and then non-adherent neutrophils were washed off. The 
position of neutrophils that penetrated into the gel were analysed by taking z-stack 
images at 2µm intervals through the gel after (A) 20min and (B) 120min.  Data are 
mean ± SEM from n= 3 experiments. ANOVA showed no significant effect of culture 
conditions on neutrophil migration through gels. A different EC, neutrophil and BMMSC 
donor was used per experiment.  
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Figure 5-21: Effect of adipocyte co-culture on the average depth of neutrophil 
penetration into 3D collagen gels in response to TNFα. BMMSC or adipocytes were 
incorporated into collagen gels for 24h. EC were then seeded onto the gels for a further 
24hr and were stimulated with 100U/ml TNFα for 4hr. Neutrophils (5x105) were added 
to gels for 20min and then non-adherent neutrophils were washed off. The average 
depth to which a neutrophil that penetrated into the gel migrated, was analysed after 
(A) 20min and (B) 120min.  Data are mean ± SEM from n= 3 experiments. ANOVA 
showed no significant effect of culture conditions on the depth of neutrophil 
penetration. A different EC, neutrophil and BMMSC donor was used per experiment. 
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Figure 5-22: Effect of BMMSC and BMMSC-derived adipocytes on neutrophil 
adhesion and migration into 3D collagen gels in the absence of cytokine. BMMSC 
or adipocytes were incorporated into collagen gels for 24h. EC were then seeded onto 
the gels for a further 24hr. 5x105 neutrophils were added to gels for 20min, non-
adherent cells were washed off. Neutrophil adhesion and migration was assessed after 
20min. (A) The percentage of neutrophils that were added to the gels that adhered 
after 20min. The percentage of adherent neutrophils that were (B) surface adherent, 
(C) transendothelial migrated and (D) penetrated into the gel were assessed.  Data are 
mean ± SEM from n= 3 experiments. ANOVA showed no significant effect of culture 
conditions on neutrophil adhesion and migration through gels. A different EC, 
neutrophil and BMMSC donor was used per experiment.  
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Of those adherent cells, 20% were surface adherent and less than 6% were phase 
dark under the endothelium after 20min (Figure 5-22B and C). As with the cytokine-
treated cultures (described above), 80% of adherent neutrophils penetrated into the 
gel but the majority were found close to the gel surface (less than 50µm deep) (Figure 
5-22D and 5-23). The behaviour of adherent neutrophils was unaffected by adipocyte 
co-culture (Figure 5-22 and 5-23).Thus, adipocyte co-culture did not significantly 
promote the adhesion or migration of neutrophils in the absence of cytokines. 
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Figure 5-23: Effect of adipocytes co-culture on the position and average depth 
of migrated neutrophils in 3D collagen gels in the absence of cytokine. BMMSC 
or adipocytes were incorporated into collagen gels for 24h. EC were then seeded onto 
the gels for a further 24h and were stimulated with 100U/ml TNFα for 4hr. Neutrophils 
(5x105) were added to gels for 20min and then non-adherent neutrophils were washed 
off. (A) The position of neutrophils that penetrated into the gel were analysed by taking 
z-stack images in 2µm intervals through the gel. (B) The average depth of neutrophil 
penetration after 20min were analysed.  Data are mean ± SEM from n= 3 independent 
experiments. ANOVA showed no significant effect of culture conditions on neutrophil 
migration through gels and the average depth of neutrophil penetration. A different EC, 
neutrophil and BMMSC donor was used per experiment.  
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5.3. Discussion 
In this chapter we aimed to assess the effects of differentiating MSC on their capacity 
to regulate leukocyte recruitment. We observed that after MSC from all 3 sources were 
differentiated into adipocytes, they had lost their ability to suppress neutrophil adhesion 
to cytokine-stimulated EC. Indeed, adipocyte co-culture tended to prime EC, so that 
when treated with a low dose TNFα (0.1U/ml or 1U/ml instead of 100U/ml), neutrophil 
recruitment was increased. In contrast, PBL adhesion remained suppressed by co-
culture of EC with BMMSC-derived adipocytes. For those leukocytes that did adhere, 
adipocyte co-culture did not alter their capacity to migrate through endothelium and 
into matrix beneath with both EC types tested (HUVEC and BEC). IL-6 levels were as 
high in conditioned media from BMMSC-derived adipocyte mono-cultures and co-
cultures as the levels for MSC co-cultures. Therefore, the loss of MSC-mediated 
suppression of neutrophil recruitment after adipogenic differentiation was not due to a 
reduction in IL-6 secretion. A reduction in IL-6R and IL-6ST gene expression was 
observed in adipocytes from co-culture compared to MSC from co-culture.  However, 
we also observed that neutralisation of IL-6 restored the ability of MSC-derived 
adipocytes to suppress neutrophil adhesion. This suggested that rather than a 
reduction in the sensitivity of adipocyte co-cultures to IL-6, there was a shift in the 
action of IL-6 from being anti-inflammatory in MSC co-cultures to pro-inflammatory in 
MSC-derived adipocyte co-cultures. The suppression of neutrophil adhesion in the 
absence of IL-6 from adipocyte co-cultures, was likely mediated by other soluble 
factor(s) released. TGFβ was found in the previous chapter to play a role in mediating 
suppression of neutrophil recruitment (Section 4.2.6.). Here, expression of each of the 
three isoforms of TGFβ by EC at the gene level was significantly lower in adipocyte co-
cultures than MSC co-cultures. Furthermore, we observed that neutralisation of TGFβ 
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had no effect on neutrophil recruitment to MSC-derived adipocytes co-cultures, 
indicating that TGFβ did not play a role in mediating the effects of the differentiated 
adipocytes. Thus, in MSC co-culture there was complex interplay between IL-6 and 
TGFβ to downregulate neutrophil recruitment which was lost upon differentiation. To 
our knowledge, this is the first report to have examined the effects of adipogenic 
differentiation on the immunosuppressive effects of MSC. We have shown for the first 
time that adipogenic differentiation causes MSC to lose their ability to suppress 
neutrophil recruitment to inflamed EC.  
 
In other models, BMMSC and ADMSC-derived osteoblasts and chondrocytes were 
able to suppress T-cell proliferation to the same extent as undifferentiated MSC 
(Montespan et al., 2014; Niemeyer et al., 2007). In contrast, we found that osteogenic 
differentiation of MSC reduced their capacity to suppress neutrophil adhesion to EC 
cultured on a collagen matrix. This suggests that while differentiation down the 
adipogenic or osteogenic lineages causes MSC to lose their capacity to suppress 
neutrophil recruitment, other immunosuppressive effects such as the inhibition of T-
cell proliferation may persist. However, as the effect of MSC-derived adipocytes on T-
cell proliferation has not yet been examined, we cannot say definitively that the 
suppression of neutrophil recruitment is the only immunosuppressive effect of MSC 
that is lost after differentiation.  
 
Interestingly, we observed that BMMSC retained their capacity to suppress PBL 
recruitment after adipogenic differentiation. The mechanism(s) responsible for the 
suppression of PBL recruitment in this context were not identified and will require 
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further investigation. In addition, whether adipocytes utilise the same mechanism to 
suppress PBL recruitment as MSC in co-culture will also need to be evaluated. The 
capacity of MSC or adipocytes to mediate suppression of PBL recruitment may be due 
to a reduction in chemokine presentation on EC. A previous report showed that co-
culture of fibroblasts in close contact with EC in vitro suppressed PBL, but not 
neutrophil, adhesion from flow (McGettrick et al., 2010b). The suppression of PBL 
recruitment was not due to a reduction in adhesion molecules expression on EC in co-
culture (McGettrick et al., 2010b). Rather, fibroblasts reduced chemokine presentation 
(essential for stabilising PBL adhesion) by EC in response to cytokine-stimulation by 
secreting matrix metalloproteinases that likely cleaved key proteins involved in 
chemokine presentation by EC (McGettrick et al., 2010b). It is possible that MSC and 
adipocytes mediated suppression of PBL recruitment through a similar mechanism. 
The effect of co-culture with MSC and MSC-derived adipocytes on chemokine 
presentation is therefore worthy of examination.   
 
As noted above, the loss of immunosuppression by MSC after differentiation was not 
due to a reduction in IL-6 secretion. Conditioned media from adipocyte mono-cultures 
or co-cultures contained high levels of IL-6, but had no effect on neutrophil recruitment 
when added to EC.  Thus, while IL-6 was present in the culture supernatant, it did not 
exert the same anti-inflammatory effects as it did in MSC co-culture. Expression of the 
components of the IL-6 receptor complex, IL-6R and IL-6ST, was reduced in 
adipocytes during co-culture compared to mono-culture. In contrast, expression of 
these genes was upregulated by MSC during co-culture compared to mono-culture. 
This suggests that adipocytes in co-culture likely had reduced sensitivity to IL-6 present 
in the conditioned medium. However, we found that the levels of sIL-6R protein were 
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the same in MSC and adipocyte co-culture conditioned media, suggesting that this 
mediator of the effects of IL-6 in MSC co-culture [Section 4.2.6. and (Luu et al., 2013)] 
was not lacking in adipocyte co-culture.  However, we observed that neutralisation of 
IL-6 in BMMSC-derived adipocyte co-cultures restored suppression of neutrophil 
recruitment. Therefore, the loss of suppression of neutrophil recruitment by MSC after 
differentiation was not likely to be due to a decrease in IL-6 sensitivity but instead due 
to a shift in the action of IL-6 from being anti-inflammatory (in MSC co-cultures) to pro-
inflammatory (in adipocyte co-cultures).  
 
IL-6 and TGFβ were both required to mediate the suppressive effects of MSC on 
neutrophil recruitment (Section 4.2.6.). Therefore, we hypothesised that the loss of 
suppression by MSC-derived adipocytes was due to a reduction in TGFβ expression 
during co-culture. However, as previously discussed (Section 4.3.), the levels of active 
TGFβ could not be measured in culture conditioned media. Therefore, we analysed 
expression of all TGFβ isoforms at the gene level. We observed that expression of 
TGFβ and its binding partner decorin, were reduced in EC co-cultured with adipocytes, 
compared to EC co-cultured with MSC. Expression of the three TGFβ isoforms were 
reduced in both MSC and adipocytes in co-culture. Reduced expression of TGFβ by 
EC may have contributed to the loss of suppression of neutrophil recruitment. 
Interestingly, a screen of cytokines and receptors found in MSC and adipocyte co-
culture conditioned media suggested that more CD105 (an auxiliary TGFβ co-receptor) 
was present in conditioned medium from adipocyte co-culture compared to MSC co-
culture.  However, more detailed quantification of CD105 by ELISA showed that the 
levels of CD105 shed by the cells were similar in MSC and adipocyte co-culture 
conditioned media. Therefore, the loss of the immunosuppressive effect was not 
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attributable to a decrease in TGFβ signalling through shedding of CD105 in EC or 
adipocytes in co-culture. Nevertheless, we found that neutralisation of TGFβ had no 
effect on neutrophil recruitment to adipocyte co-cultures, suggesting that TGFβ had 
lost any activity in adipocyte co-cultures. Collectively, these data suggest that the loss 
of MSC-mediated suppression of neutrophil recruitment upon adipogenic 
differentiation was due to a change in the action of IL-6, possibly linked to loss of action 
of TGFβ. 
 
Based on these observations, we suggest that suppression of neutrophil adhesion is 
lost upon differentiation of MSC through one or more of the following mechanisms: 
1. The expression of a component of the IL-6 signalling pathway that mediates its 
anti-inflammatory effects is down-regulated or inhibited in adipocyte co-cultures.  
2. A factor is generated that transforms the effect of IL-6 to make it pro-
inflammatory.   
3.  IL-6 acts independently of TGFβ in adipocyte co-cultures and as a result the 
anti-inflammatory is lost.  
 
The filter-based and collagen gel based models were used in this chapter to assess 
the effects of adipocytes on different stages of the recruitment cascade.  The filter 
assay was used to assess neutrophil recruitment under physiological flow rates. The 
collagen gel assay was used to mimic the effects of adipocyte co-culture on the 
migration of neutrophils into tissue. The advantage of the gel model was that it enabled 
the migration of neutrophils through the EC and the underlying stroma to be analysed 
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in the same manner as would occur in tissue. However, the early stages of recruitment 
were not well represented in this model. Nevertheless, in the collagen gel model, we 
observed that differentiation of MSC into adipocytes or osteoblasts reversed the 
suppressive effects of MSC on neutrophil adhesion, as was the case in the flow-based 
adhesion model. In both models the migration of adherent neutrophils through the EC 
monolayer was unaffected by MSC or adipocyte co-culture with EC.  In the matrix 
model specifically, migration (transendothelial migration, gel penetration and the depth 
of penetration) of neutrophils into the gel was unaffected by MSC or adipocyte co-
culture. Thus, MSC exerted their effects on EC to limit neutrophil recruitment but did 
not act on EC to modulate transmigration or directly on neutrophils to alter their 
migration within the matrix'. Upon differentiation, adipocytes had no effect on any stage 
of the process. 
 
The MSC and adipocytes isolated for this study were taken from healthy individuals. 
Previous studies have shown that excess OA (a monounsaturated free fatty acid) in 
the serum is taken up and metabolised by hepatocytes and converted to lipid 
contributing to the pathogenesis of non-alcoholic steatohepatitis (Ricchi et al., 2009; 
Karim, 2013). To assess whether exposure of MSC-derived adipocytes to free fatty 
acids (associated with metabolic disorders) altered their effects on leukocyte 
recruitment, we treated adipocytes with OA for 24h prior to co-culture with EC. OA 
treatment inhibited the suppressive effects of MSC-derived adipocytes on PBL, but did 
not alter neutrophil adhesion. The mechanism by which OA caused loss of suppression 
of PBL adhesion was not explored and will require further investigation. The effect of 
OA treatment on MSC-derived adipocyte function may have physiological implications, 
as during chronic low grade inflammation, cytokines such as TNFα reduce the capacity 
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of adipose tissue to uptake and store lipid (Goossens, 2008; Sevastianova et al., 2008; 
Salles et al., 2012) which increases the levels of circulating fatty acids (such as OA). 
These free fatty acids may be taken up and stored by BMMSC-derived adipocytes and 
could adversely affect their ability to suppress PBL infiltration into inflamed tissue. In 
the future it would be interesting to test whether uptake of free fatty acids by 
undifferentiated MSC affects their adipogenic differentiation or alters their capacity to 
suppress leukocyte recruitment. 
 
A question arising from our observations was whether adipose tissue derived AD 
exerted similar effects on recruitment as BMMSC-derived adipocytes. We observed 
that pre-AD and mature AD isolated from healthy subcutaneous adipose tissues were 
both able to suppress neutrophil and PBL adhesion to the same extent as BMMSC 
when co-cultured with EC. Similarly, co-culture with adipogenically differentiated pre-
AD induced suppression of neutrophil and PBL recruitment to a similar extent as 
undifferentiated pre-AD. Thus, AD much like other stromal cell populations isolated 
from healthy individuals (McGettrick et al., 2010b; Kuravi et al., 2014; McGettrick et al., 
2009; Luu et al., 2013), act as endogenous tissue-resident regulators, limiting the 
recruitment of leukocytes in response to pro-inflammatory cytokines. Interestingly, 
levels of IL-6 were high in co-culture media conditioned by pre-AD (undifferentiated 
and adipogenically differentiated) and mature AD. Thus these forms of AD appeared 
to retain anti-inflammatory effects of IL-6, in contrast to the BMMSC-derived 
adipocytes. Collectively, these data suggest that MSC-derived adipocytes are not the 
same as AD derived for adipose tissue, or AD differentiated from pre-AD from adipose 
tissue. It is reasonable to suggest that adipogenic differentiation of MSC in non-
adipose tissue should not occur naturally, and that it may aberrantly decrease their 
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immunosuppressive capabilities in a way that does not occur in 'true' adipose tissue. 
Thus the lack of suppression by MSC-derived adipocytes observed in this chapter may 
resemble the situation in ectopic fat in chronically inflammatory conditions such as 
atherosclerosis (Liu et al., 2014). To explore this further, the effects of adipocytes 
derived from ectopic fat from sites of chronic inflammation on leukocyte recruitment 
should be analysed, to assess whether they behave similarly to MSC-derived 
adipocytes. In addition, it would be interesting to test the effects of human osteoblasts 
and ectopic bone on leukocyte recruitment to determine whether the loss of 
suppression of neutrophil recruitment by MSC-derived osteoblasts mimics the 
behaviour of osteoblasts from healthy or chronically inflamed tissue.  Results might 
imply that in vitro differentiation of MSC using current methods generates cells that do 
not represent those found in native fat or bone, at least in their effects on the immune 
system.  Perhaps more interestingly, it might suggest that ectopic differentiation in 
chronic inflammation leads to an abnormal tissue unable to regulate leukocyte 
recruitment. 
 
Due to the difficulty in obtaining tissue samples to prepare pre-AD and mature AD, the 
mechanism by which they mediated the suppression of neutrophil and PBL recruitment 
could not be investigated in the time available. In future, the roles of IL-6 and TGFβ in 
these co-cultures could be assessed to test whether they resemble their roles in 
suppression by MSC. 
 
In conclusion, we have shown that MSC lose the capacity to regulate neutrophil, but 
not PBL, adhesion upon adipogenic differentiation using two different in vitro models. 
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Loss of suppression of neutrophil recruitment by MSC-derived adipocytes may be due 
to a switch in the mode of action of IL-6 from anti-inflammatory to pro-inflammatory, 
and loss of effect of TGFβ. Interestingly, adipocytes derived from MSC from all sources 
did not mimic adipose tissue-derived pre-AD and mature AD which were found to 
suppress both neutrophil and PBL recruitment. We suggest that aberrant adipogenic 
differentiation of tissue-resident MSC could 'permit' chronic inflammation by removing 
a constitutive regulation of infiltration of circulating leukocytes.  
 
 
  
170 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. General discussion 
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6.1. Summary of main findings 
This thesis has examined the effects of MSC on the ability of EC to support leukocyte 
recruitment, a key process in inflammation. In particular, we focused on whether MSC 
from different sources (bone marrow, Wharton’s jelly and trabecular bone) and adipose 
tissue-derived stromal cells are capable of modulating recruitment to inflamed vascular 
EC. The effect of adipogenic differentiation of MSC and adipose tissue-derived pre-AD 
on their regulatory capacity was also explored. To examine recruitment, two in vitro 
flow based adhesion assay models were used; a microslide channel model mimicking 
the effects of systemically infused MSC and a filter-based model mimicking the effects 
of direct injection of MSC into the tissue.  A 3D collagen gel based static migration 
system was used to analyse the effect of MSC, adipocyte or osteoblasts on the 
migration of neutrophils. The main findings of this thesis are: 
1. MSC from different tissues have a similar capacity to suppress neutrophil 
adhesion to TNFα-stimulated EC. The effect was diminished albeit to varying 
degrees in the absence of contact and with MSC passage.  
2. The suppressive effect of BMMSC and WJMSC on neutrophil adhesion was 
mediated, at least in part, by IL-6 and TGFβ.  
3. In contrast to differentiated pre-AD and mature AD, differentiation of MSC into 
adipocytes abrogated their suppressive effects on neutrophil, but not PBL, 
recruitment.  
4. IL-6 was identified as a key factor mediating the loss of suppression after 
adipogenic differentiation indicating context-specific differences in its action on 
target cells, to regulate recruitment.  
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6.2. Significance of these findings 
It has previously been shown that direct co-culture of BMMSC with EC in microslide 
channels suppressed neutrophil as well as PBL adhesion and transmigration (Luu et 
al., 2013). Here, it was observed that MSC from different sources shared a similar 
capacity to suppress neutrophil adhesion, but did not affect transmigration. This 
correlates with previous reports that other tissue-resident stromal cells such as dermal 
fibroblasts and podocytes are also capable of suppressing leukocyte recruitment to 
vascular EC (Kuravi et al., 2014; McGettrick et al., 2009). In all cases, IL-6 signalling 
was involved in mediating suppression, although the effects on recruitment varied 
depending on the stromal cells in co-culture. For instance, dermal fibroblast-mediated 
suppression of PBL adhesion was reduced by neutralising IL-6 or TGFβ, where 
complete reversal of the suppression on PBL adhesion only occurred when both 
factors were neutralised (McGettrick et al., 2009).  In contrast, we showed here that 
WJMSC and BMMSC required both IL-6 and TGFβ to mediate their suppressive effects 
as neutralisation of either abrogated the response, with one factor likely acting 
upstream of the other. In podocyte co-cultures, IL-6 alone was sufficient to drive 
suppression of neutrophil recruitment and its neutralisation was found to completely 
abrogate the effect (Kuravi et al., 2014). Therefore, the actions of IL-6 and TGFβ are 
context dependent, and vary depending on the stromal cell type in co-culture with EC. 
Importantly, the exact nature of the interactions between IL-6 and TGFβ during co-
culture is not well understood. Given that MSC from different sources have the same 
immune-protective effects, MSC alongside other tissue-resident stromal cells may act 
in concert to suppress leukocyte recruitment in response to inflammatory cytokines.  
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While MSC from different tissue sources exert similar immunosuppressive effects 
(Roemeling-van Rhijn et al., 2013; Jin et al., 2013; Puissant et al., 2005), here it was 
found that the capacity of BMMSC, and to a much lesser extent WJMSC, to suppress 
neutrophil recruitment was diminished with passage. Previous studies have also 
reported that foetal and neonatal MSC populations such as foetal liver-derived MSC 
retain their capacity to suppress T-cell proliferation at a much higher passage than 
BMMSC (Giuliani et al., 2011; Yu et al., 2014; Zhuang et al., 2014). This suggests that 
foetal and neonatal MSC retain their immunosuppressive effects for longer than 
BMMSC after prolonged culture. However, to our knowledge there are currently no 
studies that have directly compared the effects of passage on the immunomodulatory 
effects of WJMSC and BMMSC. Furthermore, the few studies that have examined the 
effect of passage on MSC immune function, T-cell proliferation and activation were the 
only parameters measured. Whether other immunosuppressive effects of MSC are 
sensitive to passage remains to be explored. For the first time it has been shown that 
in the same model, using the same culture conditions, BMMSC lose their 
immunomodulatory capacity with passage, as assessed by measuring neutrophil 
recruitment at an earlier passage than WJMSC. This has important therapeutic 
implications as it suggests that culture expansion of BMMSC to generate sufficient 
numbers to treat patients with chronic inflammatory conditions may reduce their 
efficacy in suppressing leukocyte infiltration into the inflamed site. Therefore, WJMSC 
could potentially be a better therapeutic intervention in this context. 
 
Importantly, the suppressive effects of all MSC populations on recruitment were shown 
to be mediated by soluble agents (including IL-6) which were only generated during 
crosstalk between EC and MSC, as mono-culture conditioned medium from MSC had 
174 
 
no effect on recruitment. Crosstalk between BMMSC and EC could be achieved at a 
much greater distance (~900µm) than WJMSC and TBMSC, which required close 
proximity with EC to exert their effect. This has important therapeutic implications as 
studies have shown that systemically infused MSC have a low homing efficiency (<1%) 
and tend to become lodged in the lungs where they mediate their effects through the 
release of soluble factors (Eggenhofer et al., 2014; Le Blanc and Mougiakakos, 2012; 
Eggenhofer et al., 2012; Kavanagh et al., 2015). Mechanical trapping of MSC in lung 
vasculature would enable systemically infused MSC to come into contact with EC and 
mediate crosstalk. However, as systemically administered MSC are short lived and 
often migrate to different sites over time [reviewed by (Eggenhofer et al., 2012; Le 
Blanc and Mougiakakos, 2012), the duration of direct contact may be insufficient to 
mediate the crosstalk required to suppress recruitment.  However, as BMMSC retain 
their ability to crosstalk with EC at a distance, systemically infused BMMSC may have 
beneficial effects over greater distances even in the absence of contact with EC. In 
contrast, WJMSC and TBMSC required close proximity with vascular EC to exert their 
immunosuppressive effects on recruitment. Therefore, direct injection of WJMSC and 
TBMSC into the inflamed tissue would be more likely to promote crosstalk with EC, as 
tissue-resident stromal cells are usually in close proximity to the vasculature. As 
BMMSC could mediate their suppressive effects in the presence or absence of contact, 
either route of administration could be used to deliver MSC for treatment of chronic 
inflammatory diseases. Clinicians must consider the effects of MSC passage and 
requirement for proximity with target cells when selecting the optimum MSC for 
therapeutic use, tailoring the treatment to the condition. 
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While it has recently been shown that the inflammatory microenvironment may 
transform MSC and modify their immunosuppressive capabilities (Prasanna et al., 
2010; Waterman et al., 2010), the potential effects of MSC differentiation on their 
suppressive capabilities has not been widely explored. Here, it was observed that 
adipogenic differentiation of MSC from different sources diminished their suppressive 
capacity to suppress neutrophil recruitment in flow and gel based static adhesion 
models. Previous reports have only shown that osteogenic and chondrogenic 
differentiation did not significantly alter the immunosuppressive function of MSC 
(Niemeyer et al., 2007; Montespan et al., 2014; Lohan et al., 2014), although T-cell 
proliferation was the only parameter measured. In a conflicting report, rat MSC-derived 
chondrocytes lost the ability to suppress allogeneic T-cell proliferation in vitro. This was 
thought to be due to a reduction in nitric oxide and PGE2 secretion (Ryan et al., 2014). 
To our knowledge, the abovementioned studies are the only others where the effect of 
differentiation on MSC immunomodulation have been examined. Conflicting findings 
within these studies may be due to differences in the MSC source (rat vs. human MSC) 
used or the method used to isolate and differentiate the MSC. However, the effects of 
adipogenic differentiation on T-cell proliferation has not been previously analysed.  
 
It was also observed that adipogenic differentiation of MSC alters their crosstalk with 
EC, reducing their ability to suppress neutrophil recruitment. IL-6 was a key mediator 
in the loss of immunosuppression by MSC-derived adipocytes, as neutralisation of IL-
6 restored their capacity to limit neutrophil recruitment. Thus, IL-6 acts as a context-
dependent cytokine that promotes suppression of neutrophil adhesion by MSC but 
drives recruitment upon MSC differentiation into adipocytes. These data suggest that 
aberrant adipogenic differentiation of MSC could be pathological as MSC no longer act 
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to dampen the inflammatory infiltrate but rather have the capacity to contribute to 
aberrant inflammation through crosstalk with EC or immune cells, adversely affecting 
their effector functions. MSC may be contributors of ectopic fat formation as cells that 
possess MSC features were found to accumulate lipid in response to tissue damage 
(Sohn et al., 2013, 2015; Uezumi et al., 2010). Furthermore, depletion of these cells 
prevented deposition of ectopic fat in response to tissue damage (Uezumi et al., 2010). 
As ectopic fat is likely caused by the aberrant accumulation of lipid in tissue-resident 
cells in non-adipose tissues (Gustafson and Smith, 2006; Filippin-Monteiro et al., 2012; 
Sevastianova et al., 2008; Salles et al., 2012), it is possible that in the inflammatory 
environment, MSC may undergo adipogenic differentiation taking up excess lipid in the 
local milieu. 
 
Interestingly, it was also observed that MSC-derived adipocytes do not have the same 
effects on recruitment as healthy adipose tissue-derived pre-AD and mature AD, which 
were able to suppress neutrophil and PBL adhesion to the same extent as 
undifferentiated MSC. This suggests that healthy adipose tissue-derived stromal cells, 
much like other tissue-resident stromal populations (i.e. MSC, dermal fibroblasts and 
podocytes) are inherently immunosuppressive and act to dampen leukocyte 
recruitment (Kuravi et al., 2014; McGettrick et al., 2009). Moreover, adipogenically 
differentiated pre-AD in vitro were also capable of suppressing recruitment to a similar 
extent as the undifferentiated cells. This suggests that unlike the other tissue-derived 
MSC tested (BMMSC, WJMSC and TBMSC), adipose tissue-derived stromal cells 
uniquely retain their suppressive effects upon differentiation. This may be a tissue-
specific function of pre-AD and mature AD to limit inappropriate recruitment of 
leukocytes into healthy adipose tissue. It also suggests that upon differentiation MSC 
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lose their immunosuppressive capabilities and adopt a more stimulatory phenotype, 
potentially pro-inflammatory phenotype. 
 
6.3. Conclusion 
In conclusion, tissue-resident MSC from different sources were found to undergo 
crosstalk with vascular EC to limit neutrophil recruitment in response to inflammatory 
cytokines to a similar degree. IL-6 and TGFβ were identified as common bioactive 
agents in all co-cultures and a requirement for close proximity between EC and MSC 
was also observed. Differences in their expansion potential and requirement for 
proximity with EC indicates that there are functional differences between MSC from 
different sources. Other stromal populations from healthy tissues also exert 
suppressive effects on leukocyte recruitment (Kuravi et al., 2014; Luu et al., 2013), 
while stromal cells from chronically inflamed sites may enhance the inflammatory influx 
(Lally et al., 2005; Luu et al., 2013; Kuravi et al., 2014; McGettrick et al., 2009). In 
addition, it was observed that differentiation of MSC, but not pre-AD, into adipocytes 
reduced their suppressive effects on neutrophil recruitment in an IL-6 dependent 
manner. As such, differentiation of MSC in vivo could be pathogenic in chronic 
inflammation, as it would enhance the infiltration of circulating neutrophils. Thus, MSC 
from different tissues share the endogenous capacity to regulate EC and the 
inflammatory infiltrate, akin to other healthy stromal cells.  
 
Triggering MSC adipogenic differentiation in chronically inflamed or damaged tissue 
may contribute to the pathology of the disease by enabling the aberrant influx of 
circulating neutrophils. In terms of therapy, there are advantages and disadvantages 
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to using each of the MSC populations. The limited expansion potential of TBMSC 
makes it an undesirable source for therapy. While WJMSC exhibit a greater expansion 
potential, the requirement for close proximity with EC to mediate their effects may limit 
their use. Furthermore, while BMMSC are able to undergo crosstalk with EC over a 
greater distance, loss of their immunosuppressive effects upon expansion also limits 
their use therapeutically.   
 
6.4. Future work 
The data shown in this thesis raises further questions such as: 
1. How do soluble mediators generated during crosstalk between EC and MSC 
exert their effects on leukocyte recruitment? To address this question, the 
following should be examined: 
a. The mechanism by which IL-6 and TGFβ signal during co-culture to 
mediate the suppressive effects; identifying which cell type in the co-
culture responds to these factors, which factor signals first and how it 
regulates the activity of the other.  
b. Identifying other bioactive mediator(s) that also play a role in suppression 
that are presumably lost in co-culture with later passage MSC or in co-
cultures generated in the absence of contact.  
c. Observing other phenotypic changes e.g. expression of adherens 
junctions in EC during co-culture that might be linked to the 
immunosuppressive effects observed.    
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2. What changes in bioactive mediator(s) are responsible for the loss of 
suppression of neutrophil recruitment upon adipogenic differentiation? To 
address this question, the following should be examined: 
a. Identifying factors regulating IL-6 signalling that are differentially active 
in MSC vs. MSC-derived adipocyte co-cultures that may shift its activity 
from anti-inflammatory to pro-inflammatory.  
b. Identify factors that are present in MSC-derived adipocytes co-cultures 
that may suppress PBL adhesion (e.g. chemokine expression by EC).  
c. Determining if the loss of suppression by MSC-derived adipocytes, but 
not differentiated pre-AD, is a culture induced phenomenon or due to 
tissue-specific differences between the two cell types. 
d. Assessing the bioactivity of MSC and MSC-derived adipocytes co-culture 
conditioned media in vivo. 
e. Determining whether ectopic fat observed in sites of chronic inflammation 
could be derived from aberrant differentiated MSC. 
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Appendix 1-1: Effect of adipocyte differentiation on neutrophil adhesion to BEC 
and their migration into 3D collagen gels in response to TNFα. BMMSC or 
adipocytes were incorporated into collagen gels for 24h. BEC were then seeded onto 
the gels for a further 24hr and were stimulated with 100U/ml TNFα for 4hr. Neutrophils 
(5x105) were added to gels for 20min, non-adherent cells were washed off. Neutrophil 
adhesion and migration was assessed after 20min and 120min. (A,B) The percentage 
of neutrophils that were added to the gels that adhered after 20min and 120min 
respectively. The percentage of adherent neutrophils that were (C,D) surface adherent, 
(E,F) transendothelial migrated and (G,H) penetrated into the gel were assessed.  Data 
are mean ± SEM from n= 3 experiments. In B, ANOVA showed a significant effect of 
culture conditions on neutrophil adhesion, p<0.01. **p<0.01 by Bonferroni post-test. In 
C-H, ANOVA showed no significant effect of culture conditions on neutrophil migration 
through gels. A different EC and neutrophil donor was used per experiment and 2 
BMMSC donors were used in this series of experiments.  
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Appendix 1-2: Effect of adipocytes co-culture on the position of migrated 
neutrophils within 3D collagen gels in response to TNFα. BMMSC or adipocytes 
were incorporated into collagen gels for 24h. BEC were then seeded onto the gels for 
a further 24hr and were stimulated with 100U/ml TNFα for 4hr. Neutrophils (5x105) 
were added to gels for 20min and then non-adherent neutrophils were washed off. The 
position of neutrophils that penetrated into the gel were analysed by taking z-stack 
images in 2µm intervals through the gel after (A) 20min and (B) 120min.  Data are 
mean ± SEM from n= 3 experiments. ANOVA showed no significant effect of culture 
conditions on neutrophil migration through gels. A different EC and neutrophil donor 
was used per experiment and 2 BMMSC donors were used in this series of 
experiments.  
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Appendix 1-3: Effect of adipocyte co-culture on the average depth of neutrophil 
penetration into 3D collagen gels in response to TNFα. BMMSC or adipocytes were 
incorporated into collagen gels for 24h. BEC were then seeded onto the gels for a 
further 24hr and were stimulated with 100U/ml TNFα for 4hr. Neutrophils (5x105) were 
added to gels for 20min and then non-adherent neutrophils were washed off. The 
average depth to which a neutrophil that penetrated into the gel migrated, was 
analysed after (A) 20min and (B) 120min.  Data are mean ± SEM from n= 3 
experiments. ANOVA showed no significant effect of culture conditions on the depth 
of neutrophil penetration through gels. A different EC and neutrophil donor was used 
per experiment and 2 BMMSC donors were used in this series of experiments. 
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Appendix 1-4: Effect of osteoblast differentiation on neutrophil adhesion to BEC 
and their migration into 3D collagen gels in response to TNFα. BMMSC or 
osteoblasts were incorporated into collagen gels for 24h. BEC were then seeded onto 
the gels for a further 24hr and were stimulated with 100U/ml TNFα for 4hr. Neutrophils 
(5x105) were added to gels for 20min, non-adherent cells were then washed off. 
Neutrophil adhesion and migration was assessed after 20min and 120min. (A,B) The 
percentage of neutrophils that were added to the gels that adhered after 20min and 
120min respectively. The percentage of adherent neutrophils that were (C,D) surface 
adherent, (E,F) transendothelial migrated and (G,H) penetrated into the gel were 
assessed.  Data are mean ± SEM from n= 3 experiments. ANOVA showed no 
significant effect of culture conditions on neutrophil adhesion and migration through 
gels. A different EC and neutrophil donor was used per experiment and 2 BMMSC 
donors were used in this series of experiments.  
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Appendix 1-5: Effect of osteoblast co-culture on the position of migrated 
neutrophils within 3D collagen gels in response to TNFα. BMMSC or osteoblasts 
were incorporated into collagen gels for 24h. BEC were then seeded onto the gels for 
a further 24hr and were stimulated with 100U/ml TNFα for 4hr. Neutrophils (5x105) 
were added to gels for 20min and then non-adherent neutrophils were washed off. The 
position of neutrophils that penetrated into the gel were analysed by taking z-stack 
images in 2µm intervals through the gel after (A) 20min and (B) 120min.  Data are 
mean ± SEM from n= 3 experiments. ANOVA showed no significant effect of culture 
conditions on neutrophil migration through gels. A different EC and neutrophil donor 
was used per experiment and 2 BMMSC donors were used in this series of 
experiments.  
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Appendix 1-6: Effect of osteoblast co-culture on the average depth of neutrophil 
penetration into 3D collagen gels in response to TNFα. BMMSC or osteoblasts 
were incorporated into collagen gels for 24h. BEC were then seeded onto the gels for 
a further 24hr and were stimulated with 100U/ml TNFα for 4hr. Neutrophils (5x105) 
were added to gels for 20min and then non-adherent neutrophils were washed off. The 
average depth to which a neutrophil that penetrated into the gel migrated, was 
analysed after (A) 20min and (B) 120min.  Data are mean ± SEM from n= 3 
experiments. ANOVA showed no significant effect of culture conditions on the depth 
of neutrophil penetration through gels. A different EC and neutrophil donor was used 
per experiment and 2 BMMSC donors were used in this series of experiments. 
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